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Summary 
68 million people are infected with lymphatic filariasis (LF) in Sub-Saharan Africa, South-East Asia 
and South America, causing a major health problem with economic repercussions among the 
infected populations. This disease is caused by three species of filarial nematode parasites such 
as Wuchereria bancrofti, Brugia malayi and Brugia timori. In infected patients, only 50% become 
patent (release microfilariae, MF) and this is well represented in the laboratory BALB/c mice 
when naturally infected with Litomosoides sigmodontis (Ls). Infection with Ls has been shown to 
induce regulatory cell populations including Tregs, IL-10 producing cells and alternative activated 
macrophages (AAMs) and more importantly, CD4+  T cells have been found to play a paramount 
role during the infection. In fact, previous observations have revealed the impairment of Ls 
filarial stages induced by these cells. Recently, Myeloid-Derived Suppressor Cells (MDSCs) have 
been characterized in cancer and other pathologies including bacterial, viral and parasitic 
infections. There are two subsets of MDSCs: monocytic MDSCs (Mo-MDSCs) and granulocytic or 
polymorphonuclear MDSCs (PMN-MDSCs) both identified in man and murine models. The 
hallmark of either MDSC populations is the suppression of T and B cell responses using various 
mechanisms which are mostly specific to the pathology or setting. For instance, there is evidence 
that MDSCs can suppress and accumulate through receptors such as the Interleukin 4 receptor-
alpha (IL-4), Tumor necrosis receptor 2 (TNFR2) and C-C motif chemokine receptor 2 (CCR2) or 
they use soluble factors such as nitric oxide (NO), reactive oxygen species (ROS) and 
transforming growth factor-beta (TGF-), to function. MDSCs have been shown to interfere in 
host-pathogen interactions and various research studies consider those cells as a new 
therapeutic target to control resistance to diseases such as cancer. However, it remains unclear 
whether they play a role in helminth infections, especially if they could affect filarial 
development or filarial-specific responses and would be able to serve as tool to overcome 
filariasis. Thus, the current work verified the hypothesis of a possible role of MDSC populations 
during Ls infection in BALB/c mice by means of parasitological analyses, flow cytometry and a 
specifically designed in vitro  cell culture assay to measure their suppressive activities on CD4+  T 
cells. The results revealed that populations of MDSC subsets expanded in the thoracic cavity 
(TC), the site of infection, of infected mice whereas only very few MDSCs were f ound in naive 
mice. This expansion correlated positively with worm burden. Interestingly, although numbers of 
PMN-MDSCs in the TC were higher than amounts of Mo-MDSCs, the latter showed high 
suppressive abilities on the production of IL-13 and IFN- by Ls-specific CD4+ T cells in a cell-
contact independent manner. Further analyses demonstrated that Mo-MDSCs used distinct 
functional mechanisms such as nitric oxide (NO) and TGF- to impair the production of IL-13 and 
IFN-, respectively. Surprisingly, comparisons of PCR array data on isolated MDSC populations 
from infected and naive mice displayed an overall shut-down of inflammatory pathways in both 
infection-derived MDSC subsets and therefore supporting filarial establishment. In conclusion, 
the involvement of MDSCs during Ls infection offered a favorable milieu for parasite 
development, impairing host immunity, and therefore targeting MDSCs may provide a 
therapeutic tool to fight filariasis. 
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Zusammenfassung 
68 Millionen Menschen sind mit lymphatischer Filariose (LF) vorwiegend in Subsahara-Afrika, 
Südostasien und Südamerika infiziert. Die durch LF verursachten gesundheitlichen Probleme sind 
hierbei mit enormen wirtschaftlichen Einbußen für die infizierten Patienten verbunden. Verursacht 
wird LF durch die Filarienspezies Wuchereria bancrofti, Brugia malayi und Brugia timori. Im Falle 
einer Infektion kommt es nur bei ca. 50% zu einer patenten Infektion (freisetzen von Mikrofilarien, 
MF). Dies kann ebenfalls in BALB/c Mäusen beobachtet werden, wenn diese mit dem 
mausspezifischen Parasiten Litomosoides sigmodontis (Ls) infiziert werden. Frühere Studien haben 
gezeigt, dass Infektionen mit Ls die Produktion regulatorischer Zellpopulationen, einschließlich Tregs, 
IL-10 produzierender Zellen und alternativ aktivierter Makophagen (AAM), induzieren können und 
weiter, dass CD4+ T-Zellen während dieser Infektion eine besonders wichtige Rolle spielen. Zum 
Beispiel wurde gezeigt, dass die obengennanten Zellen Ls Filarien schaden konnten. In letzter Zeit, 
wurden Myeloide Suppressorzellen (engl. Myeloid-Derived Suppressor Cells (MDSCs)) sowohl bei 
Krebserkrankungen als auch in anderen Krankheitsbildern wie in bakteriellen, viralen und 
parasitischen Infektionen beschrieben. Es gibt zwei Typen von MDSCs, welche sowohl im Menschen 
als auch in der Maus beschrieben sind, die monozytischen (Mo-MDSCs) und die granulozytischen 
bzw. polymorphkernigen MDSCs (PMN-MDSCs). Die Haupteigenschaft dieser Zellen ist es mittels 
krankheitsspezifischer Mechanismen die T- und B-Zellproliferation zu unterdrücken. Die Suppression 
dieser Zellen wird hierbei durch Rezeptoren wie IL-4R (Interleukin 4 receptor-alpha), TNFR2 (Tumor 
necrosis factor receptor 2) und CCR2 (C-C motif chemokine receptor 2) oder mittels löslicher 
Faktoren wie NO (nitric oxide), ROS (reactive oxygen species) und TGF- (transforming growth factor-
beta) vermittelt. Ebenfalls ist bekannt, dass diese Zellen einen negativen Einfluss auf die Interaktion 
zwischen Wirt und dem jeweiligen Krankheitserreger haben können. Somit könnte n MDSCs als 
Zielstrukturen gegen Krankheiten, nämlich bei Krebserkrankungenstudien benutzt werden. Es ist 
jedoch unklar, welche Rolle MDSCs bei Helminthen-Infektionen haben. Ziel dieser Studie war es, eine 
mögliche Rolle von MDSCs während einer Ls-Infektion in BALB/c Mäusen zu untersuchen. Hierfür 
wurden parasitologische Parameter bestimmt und weiterführende Untersuchungen mittels 
Durchflusszytometrie und einem spezifisch entworfenen In-vitro-Zellkultur-Assay durchgeführt, um 
ihre suppressiven Aktivitäten auf CD4 + T-Zellen zu messen. Hierbei konnte gezeigt werden, dass 
MDSC-Populationen den Infektionsort, die Thoraxhöhle (TC), der infizierten Mäuse besiedeln, 
wohingegen sehr wenig MDSCs in naiven Mäuse gefunden wurden. Diese Besiedelung positiv 
korrelierte mit der Wurmbelastung. Interessanterweise, obwohl die Anzahl von PMN-MDSCs in der 
TC höher war als Mo-MDSCs, weisen Mo-MDSCs eine erhöhte supprimierende Aktivität gegenüber IL-
13 und IFN- durch Ls-spezifische CD4 + -T-Zellen in einer Zell-Kontakt-unabhängigen Weise auf. 
Mittels NO und TGF- konnten Mo-MDSCs hierbei die IL-13 und IFN- Produktion beeinträchtigen. 
Überraschenderweise zeigten Vergleiche von PCR-Array-Daten von isolierten MDSC-Populationen 
infizierter und naiver Mäuse eine allgemeine Reduktion/Abschaltung von Genen, die entzündliche 
Pathways codieren, so dass man schlussfolgern kann, dass die MDSCs die Etablierung der Filarien 
fördern. Die in dieser Arbeit durchgeführten Untersuchen konnten zeigen, dass die Beteiligung von 
MDSCs während einer Filarieninfektion zu einer Beeinträchtigung der Immunreaktion im Wirt führen 
und somit zu einem günstigen Milieu für die Entwicklung der Parasiten beitragen. Ein therapeutischer 
Ansatz in diese Richtung könnte demnach ein neues Werkzeug für die Bekämpfung von Filarien 
bedeuten. 
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Ab Antibody 
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B. malayi Brugia malayi 
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MCF Macrophage colony factor)  
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Nb Nippostrongylus brasiliensis  
NO Nitric oxide 
NOX (NADPH oxydase) 
p.i. Post-infection 
PD-L1 Programmed death ligand 1 
PGE2/COX2 Prostaglandin E2/cyclooxygenase-2 
PMN-MDSCs Polymorphonuclear MDSCs  
PPAR Peroxisome proliferator-activated receptor-gamma 
PSC Pancreatic stellate cells 
Rb Retinoblastoma protein 
RNS Reactive nitrogen species 
ROS Reactive oxygen species 
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1. INTRODUCTION 
1.1 Human lymphatic filariasis  
Parasitic worms known as filariae are microorganisms that cause filariasis which are considered 
tropical neglected diseases. They can inhabit the lymphatics or subcutaneous tissues (Chandy et 
al., 2011) and those that parasitize man lead to filarial infections including lymphatic filariasis, 
onchocerciasis, loiasis and mansonellosis (Pearlman et al., 2002). Lymphatic filariasis (LF) is a 
mosquito-borne filarial infection and is elicited by Wuchereria bancrofti (W. bancrofti), Brugia 
malayi (B. malayi) or Brugia timori (B. timori) with Wuchereria bancrofti responsible for over 
90% of the cases. Together, they constitute a serious source of disability in endemic 
communities and are therefore considered major public health problems. Consequently, LF is 
one of many infectious diseases that have been targetted for global elimination (Cano et al., 
2014). The upcoming sections will relate the current knowledge about LF focusing on its 
pathology, manifestations, available treatments to fight the disease, and manipulation of host  
immune responses. 
1.1.1 Distribution 
Previously, the world health organization estimated that 120 million people are infected with LF 
worldwide and endemic communities can be found in 81 countries including sub-Saharan Africa, 
south-east Asia and South America (WHO, 2015) (Figure 1.1). About 70% of infected cases are  
encountered in India, Nigeria, Bangladesh and Indonesia. However, due to the mass drug 
elimination programs (MDA) mentioned above, new data now suggests that only 67.88 million 
people are infected (Ramaiah and Ottesen, 2014). Interestingly, the disease is more prominent in 
males than females. For instance in India, the male/female ratio was reported to be 10/1 and is 
thought to be due to the fact that women in this country tend to cover most parts of  their bodies 
and have therefore less exposure to potential bites (Chandy et al., 2011). Further findings have 
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suggested that hormonal factors make females more resistant to the infection, especially those 
aged 15-40 and evidence has been provided that children born from infected mothers have a 
higher predisposition for developing LF when compared to those born from non-infected 
mothers (Alexander and Grenfell, 1999; Lammie et al., 1991; Simonsen et al., 2014b). Before 
displaying symptoms of LF, it is necessary to be exposed intensively for long periods of time and 
therefore migrants from countries that are non-endemic are at a lower risk of developing the 
disease. 
 
Figure 1.1: The worldwide distribution of lymphatic filariasis (Adapted from World Health Organization (WH0) 2016). The 
picture depicts  endemic countries  (in colour) that were requiring preventive chemotherapy for lymphatic filariasis in 2015. 
Countries  in white/grey are non-endemic countries. 
 
1.1.2 Life-cycle of lymphatic filariasis 
The life-cycle of LF (see Figure 1.2) starts with the transmission of infective filariae (third-stage 
larvae, L3) (1500 x 20 µm) to humans by infected mosquito vectors (Anopheles, Culex, Aedes and 
Mansonia) during their uptake of a blood meal (Simonsen et al., 2014a; Simonsen et al., 2014b). 
The larvae penetrates the skin and migrates to the lymphatic vessels and after two moults 
develop into male (40 x 0.1 mm) or female (80-100 x 0.25 mm) adult worms; a process which 
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takes several weeks. Female worms that mature and become fertile release microfilariae (MF) 
into the peripheral blood and can do so over 20 years. In W. bancrofti infected individuals, MF 
are released in the blood after 8 months whereas in those with B. malayi, MF appear after only 3 
months. MF measure 260 x 8 µm and are ingested by a vector during another blood meal and 
develop into third-stage larvae in about 10-14 days. These migrate to the mosquito’s proboscis 
and to initiate another cycle, the developing third-stage larvae are transmitted to a new human 
host while taking a further blood meal. Usually, the presence and numbers of MF in peripheral 
blood corresponds with the biting habits of the mosquito vector which can be periodical , and 
thus LF is often diagnosed in night blood (Simonsen et al., 2014b; Simonsen et al., 1997).  
 
Figure 1.2: The life-cycle of the parasites causing lymphatic filariasis (W. bancrofti) (Adapted from Centers  for Disease 
Control and Prevention (CDC)).  
 
1.1.3 The role of Wolbachia 
Many filarial parasites require the endosymbiotic bacteria Wolbachia (Figure 1.3) for fertility, 
reproduction, larval moulting and thus overal l survival purposes (Hoerauf et al., 1999). 
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Investigations have suggested that Wolbachia originally infected the common ancestor of every 
filarial nematode but has been lost by some current filarial species which be came Wolbachia-
free. For instance, Loa loa  filariae are part of this category and are the only filariae that parasitize 
man which are  Wolbachia-free (Desjardins et al., 2013). Wolbachia are gram-negative bacteria of  
the order of Rickettsiales that are located intracellularly, within host-derived vacuoles, 
throughout the syncytial hypodermal cord cells of all forms of the helminth including oocystes, 
embryos, larval stages and adult male and female worms. Furthermore,  they are transmitted 
vertically by adult females which is how they have become target for drug therapy (Hoerauf, 
2003; Kozek, 1977; McLaren et al., 1975). Foster and colleagues have shown that while the 
filarial nematode B. malayi supplies amino acids for the growth of Wolbachia, the latter provides 
its host with essential metabolites including the coenzymes for the biosynthesis of riboflavin, 
flavin adenine dinucleotide. Moreover, heme constitutes another metabolite required by B. 
malayi filariae and this is provided by Wolbachia (Foster et al., 2005). With regards to Wolbachia  
effects on filarial models such as the rodent-specific species Litomosoides sigmodontis (see 
section 1.2), a study from Hoerauf and colleagues described a mutualistic relationship between 
the endobacteria and the rodent parasite. Furthermore, the authors have shown that treatment 
of L. sigmodontis with doxycycline, a tetracycline which is an antibiotic that fights gram-negative 
bacteria, eliminated Wolbachia and resulted in filarial growth retardation and infertility. In 
contrast, such treatment had no effect on Acanthocheilonema viteae, a Wolbachia-free filaria 
(Hoerauf et al., 1999). In addition, researchers have reported that Wolbachia have the ability to 
strongly induce immune responses through the activation of innate cells such as macrophages 
and the recruitment of neutrophils. As a result of this induction, high amounts of pro-
inflammatory cytokines such as IL-6, IL-1β and TNF-α are produced which in turn lead to the 
activation of the vascular endothelial growth factor pathways (VEGFs), which have been 
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implicated in filarial pathologies (Hoerauf, 2003; Kozek, 1977; Saint Andre et al., 2002; Tamarozzi 
et al., 2011; Taylor et al., 2000). 
 
Figure 1.3: Wolbachia, the endosymbiont bacteria. (Adapted from (Simonsen et al., 2014b). Picture shows a  cross-section 
of adult female O. volvulus worm showing Wolbachia endobacteria  stained in red. 
 
1.1.4 Pathology of lymphatic filariasis 
1.1.4.1 Clinical aspects 
In endemic areas of LF, community members show varying impacts of the infection and are  
classified into four groups. The first group encompasses non-infected individuals that show no 
evident signs of disease, even though they are constantly exposed to the infection.  They are 
referred to as “endemic normal (EN) individuals”. The second and third groups comprise 
individuals that are “asymptomatic” and this state is the normal infection scenario. These people 
have a regulated immune response and have “worm nests” that are detectable by ultrasound 
(Mand et al., 2004). These groups present either patent (MF+) or latent (MF-) states and 
research has shown them to have unique immune profiles (Arndts et al., 2012). Individuals of the 
fourth group display acute or chronic manifestations of LF with few or no MF or worms (Maizels 
et al., 1995). Individuals with such manifestations are considered “symptomatic”  and the 
following section describes the clinical features of this group (Simonsen et al., 2014b). 
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1.1.4.2 Acute and chronic manifestations 
Acute phases of filariasis are marked with acute dermatolymphangioadenitis (ADLA) and acute 
filarial lymphangitis (AFL) (Simonsen et al., 2014b). Dilatation of lymphatic vessels, which is 
induced by adult worms and referred to as lymphangiectasia, diminishes the function of the 
lymphatics and causes ADLA and has been linked to secondary microbial infections including 
bacterial and fungal infections (Dreyer et al., 1999; Pfarr et al., 2009). These ADLA phases are  
determined by pain, tenderness, local swelling and warmth in the groin or limbs and 
accompanied by fever, nausea and vomiting. AFL, which is considered to be milder than ADLA 
episodes, is thought to be driven by filariae death which takes place spontaneously after 
treatment.  
90% of chronic manifestations stem from acute episodes (Figure 1.4). Lymphedema, that can 
eventually lead to elephantiasis, is commonly encountered in the lower limb but may, in less 
usual cases, be found in the arms, scrotum, penis, vulva or breast (Mahalingashetti et al., 2014). 
The evolution of lymphedema into severe elephantiasis proceeds through 7 stages with stages 6 
and 7 indicating elephantiasis (Dreyer et al., 2002). Other chronic but rare phases of LF include 
chyluria (presence of chyle in the urine) and tropical pulmonary eosinophilia (TPE)  (Fischer et al., 
2004). 
 
Figure 1.4: Chronic manifestations of lymphatic filariasis. (Adapted from (Simonsen et al., 2014b). From the left to the 
right, pictures  show lymphedema and elepentiasis of the rightleg and hydrocele. 
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1.1.5 Diagnosis of lymphatic filariasis  
Ongoing LF infections are detected via the presence of MF in peripheral blood but due to the 
aforementioned periodic nature of MF, this serological testing has to be performed at night in 
areas endemic for W. bancrofti (Amaral et al., 1994; Anitha and Shenoy, 2001; Chandy et al., 
2011). The detection of adult filarial worms by ultrasonography, the so-called filarial dance sign 
(FDS), can be achieved for both bancroftian and brugian filariasis and can detect latent 
individuals (MF-). The technique offers the benefit to locate and observe the move ment of 
worms in infected areas; again verifying active infections. Further methods to help detect 
infections include the presence of filarial DNA via polymerase chain reaction (PCR) in patient 
blood and for vectors. With regards to the latter another less sensitive and effective method 
consists of dissecting mosquitoes in order to identify infective L3 larvae. In contrast, the use of 
PCR allows sensitivity and is comparable to the traditional detection of MF in the blood. Of high 
sensitivity and effectiveness is the immunochromatographic card test (ICT) for detecting 
circulating filarial antigen (CFA) using whole blood. Blood titres of CFA are associated with worm 
burden in the host and has an advantage over the examination of blood slides since the ICT 
method bypasses the collection of blood at night and offers the privilege of time saving 
(Bhumiratana et al., 1999; Cano et al., 2014; Ivoke et al., 2015; Melrose and Rahmah, 2006; 
Phantana et al., 1999). However ICT testing is only available for bancroftian infection although 
recent findings have provided evidence of cross-reactivity with Loa loa filariae (Wanji et al., 
2015; Wanji et al., 2016). Further tests involve the detection of anti -filarial antibodies such as 
total IgG or filarial-specific IgG4 via ELISA but this method has no consensus among researchers 
and for good reason, a few patients with clinical signs were shown negative to antibody testing 
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(Turner et al., 1993). Finally, overt clinical manifestations (lymphodema and hydrocoele) were 
used as epidemiological tools to detect LF cases.  
1.1.6 Treatment of lymphatic filariasis  
To date a combination of albendazole with diethylcarbamine citrate (DEC) is the first choice of 
strategy used in mass drug administration to fight LF. In countries co-endemic with 
onchocerciasis, ivermectin and albendazole are given together. Using this strategy has allowed 
countries including Togo, Egypt, China, and Japan to eradicate the disease (Cano et al., 2014; De-
Jian et al., 2013; Ramzy et al., 2006; Sodahlon et al., 2013; Tada, 2011; Webber, 1979) . 
DEC has been reported to be the most effective treatment for human filarial infection and has 
been shown to mainly kill MF in an indirect manner (Hussein et al., 2004; Simonsen et al., 2005)  
but it can also affect adult filarial worms. Although its mechanism of action is not yet fully 
understood, studies have shown that administration of 6 mg/kg body weight of DEC for 12 days 
leads to the decrease of acute and chronic cases of MF for at least a year (Simonsen et al., 
2014b; Taylor et al., 2010). Besides its clearance of MF, the swift killing of parasites induced by 
DEC elicits some side effects including scrotal pain and systemic inflammation due to the release 
of Wolbachia (Taylor et al., 2010). Additionally, research has indicated severe reactions including 
fatal encephalopathy after DEC treatment mostly in patients with high Loa loa MF numbers, 
raising concerns in the use of the drug in areas endemic with Loa loa infection (Carme et al., 
1991). 
Findings have reported that Ivermectin has a slower rate  of parasitemia clearance, leading to 
softer side effects compared to DEC. It is administered at doses of 100-200 µg/kg in order to 
reduce MF in LF (Simonsen et al., 2014b; Taylor et al., 2010). Ivermectin has also been shown to 
have efficacy in onchocerciasis and strongyloidiasis, ascariasis, trichuriasis, and enterobiasis. It 
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causes the hyperpolarisation of glutamate-sensitive channels which leads to paralysis of the MF 
(Geary and Moreno, 2012). 
Similarly to ivermectin, albendazole is used as medicine to clear infections caused by intestinal 
nematode and other helminth infections such as echinococcosis and cysticercosis (Horton, 
2002). It decreases MF counts within 6-12 months when given at a daily dose of 400 mg for 21 
days (Simonsen et al., 2014b; Taylor et al., 2010). Albendazole is usually employed in 
combination with DEC or Ivermectin with success obviously due to its direct effect on 
gastrointestinal helminths. 
As evidence has been provided that the endosymbiont Wolbachia is crucial for filarial growth 
and survival, other therapies have been developed to target Wolbachia  for the elimination of 
filarial worms (Hoerauf et al., 1999). Substantiating this, studies using doxycycline a tetracycline, 
have demonstrated that the drug led to the decrease of adult worms in bancroftian and brugian 
filariasis by inducing their sterility and eventually their death (Hoerauf et al., 1999; Simonsen et 
al., 2014b; Taylor et al., 2010). Of note, the treatment has also been proven to ameliorate 
pathological manifestations of LF such as lymphedema and hydrocele and is of general use in LF 
endemic zones with co-endemicity with onchocerciasis. This therapy is not recommended for 
pregnant women and children aged under 5.  
Interestingly, some findings have reported the use of herbs by ayurrveda to treat elephantiasis. 
These herbs include Vitex negundo L. (roots), Butea monosperma L. (roots and leaves), Ricinus 
communis L. (leaves), Aegle marmelos Corr. (leaves), Canthium mannii (Rubiaceae), Boerhaavia 
diffusa L. (whole plant) (Chandy et al., 2011; Jain and Singh, 2010; Sahare et al., 2008; Wabo 
Pone et al., 2010).  
1.1.7 Immune responses during infection with lymphatic filariasis  
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Immune responses to filarial infections appear to be parasite stage -specific (Lawrence and 
Devaney, 2001) and need more investigations. Of note, innate defense mechanisms are initiated 
upon early infection with filarial nematodes, starting with the down-regulation of dendritic cells 
upon encounter with the L3 larvae (Hoerauf et al., 2005). Neutrophils and eosinophils are 
suggested to be found at the site of infection and degranulation of mast cells is induced when 
larvae migrate to the skin (Hise et al., 2004a; Saint Andre et al., 2002). Extracts from filariae have 
been demonstrated to trigger toll-like receptor (TLR) pathways and lead to the release of pro-
inflammatory cytokines such as IL-6 and TNF-. Wolbachia surface protein (WSP) and 
Wolbachia-derived proteins are also capable of inducing innate immune responses by inducing 
TLR-2, 4 and 6 (Hise et al., 2004b; Saint Andre et al., 2002; Taylor et al., 2000) . Moreover, Babu et 
al. reported that stimulation of isolated NK cells of from normal individuals with MF or live L3 of 
B. malayi leads to the production of interferon gamma (IFN-) and TNF- within 24 hours  (Babu 
et al., 2007). Similarly, IFN- has been shown to mediate MF killing through the release of nitric 
oxide, in a model of B. malayi infection (Taylor et al., 1996). In line with this, MF+ subjects 
revealed decreased production of IFN- and IL-2 and elevated levels of IL-4 and IL-5 (Semnani 
and Nutman, 2004).  
With regards to adaptive immunity, filarial parasites have been shown to use multiple means 
including the induction of regulatory cell subsets such as Foxp3+  regulatory T cells (Tregs), IL-10 
producing cells including Tr1 cells and also the induction of alternatively activated macrophages 
(AAM) (Ludwig-Portugall and Layland, 2012). PBMCs from MF+ individuals have been reported to 
secrete higher amounts of IL-10 when compared to those with chronic disease, indicating that 
MF+ subjects develop higher regulatory responses. In addition, transforming growth factor beta 
(TGF-) levels were related to MF+ individuals, since neutralizing this cytokine in in vitro assays 
using PBMCs from those individuals rescued lymphocyte proliferation (King et al., 1993; Mahanty 
Tamadaho R. S. E. Introduction 
11 
 
et al., 1996; Mahanty and Nutman, 1995). The release of such immunosuppressive cytokines 
creates an environment that supports filarial  survival. IL-10 promotes IgG4 responses whereas 
Th2 responses lead to elevated IgE levels as reviewed in Pfarr et al, and MF+ individuals 
presented elevated IgG4 when compared to patients with severe pathology that showed higher 
levels of IgE (Kurniawan et al., 1993; Pfarr et al., 2009). In addition, while the highest quantities 
of IgE are found in TPE patients, the lowest amounts are observed in MF+ individuals (Hussain et 
al., 1981) although individuals with patent infection have been reported to have higher IgE levels 
when compared to those with latent infection (Arndts et al., 2012). In contrast, EN individuals 
produce high levels of IFN- and IL-2 when compared to the other two groups and show elevated 
levels of IgG1 and IgG2 but low amounts of IgG4 when compared to MF+ subjects (Steel et al., 
1996) (Steel et al., 1996). 
Interestingly, patients with acute disease display strong Th1 responses (IL-6 and IL-8) and 
elevated Th17 responses when compared to MF+ individuals (Babu et al., 2009). However, 
amongst asymptomatic patients, PBMCs from MF+ individuals produced low levels of TNF-, IL-
10 and IL-5 upon filarial-specific re-stimulation when compared to those from MF- individuals 
(Arndts et al., 2012; Satapathy et al., 2006). Such pro-inflammatory cytokines and their receptors 
have been shown to be associated with the induction of VEGFs (Ristimaki et al., 1998). 
Furthermore, genomic hybridization can be conferred to individuals with genetic differences, 
such as single-nucleotide polymorphisms (SNPs), which have been associated with various 
disease states. Indeed, different SNPs for TGF- have been observed in patients with severe 
pathology when compared to MF+ individuals (Debrah AY  et al., 2011; Gershon, 2002). 
 
1.2 The murine model of lymphatic filariasis  
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Litomosoides sigmodontis (L. sigmodontis, Ls) (described formerly as L. carinii) is the only rodent-
specific filarial species which can complete its life-cycle (the release of MF into the periphery), in 
BALB/c mice, a common laboratory mouse strain. This is in contrast to C3H and C57BL/6 mouse 
strains which eliminate worms after a period of time (Graham et al., 2005; Hoffmann et al., 
2001; Le Goff L et al., 2002; Petit et al., 1992). Its natural host is the hispid cotton rat (Sigmodon 
hispidus) and belongs to the same family as W. bancrofti and Brugia species: filariae that 
parasitize man. Interestingly, in humans, only 50% of asymptomatic W. bancrofti-infected 
individuals become MF+ (Turner et al., 1993). This partial development of patent infections also 
occurs in Ls-infected BALB/c mice (Graham et al., 2005; Hoffmann et al., 2001; Le Goff L et al., 
2002; Petit et al., 1992; Rodrigo et al., 2016), indicating that Ls infection can serve as a key tool 
for understanding the mechanisms underlying the immunity to filarial infection in general and 
particularly to have deeper insights in the establishment of partial patent infections.  
1.2.1 Litomosoides sigmodontis life-cycle in BALB/c mice  
In this model of Ls infection, the mite Ornithonyssus bacoti, serves as an intermediate host for 
the helminth. During a blood meal, infective L3 larvae from the intermediate host actively 
migrate through the skin and into the lymphatic vessels to the thoracic cavity (TC), the site of 
infection in BALB/c mice after approximately 4 days. Approximately 40% of the initial L3 
numbers reach the TC (Hoffmann et al., 2000). In the TC of BALB/c mice, L3 larvae moult into L4 
larvae from day 8 post-infection (p.i.) and potentially develop into either female (10 cm, length) 
or male (1-2 cm, length) adult worms by the fourth week of  infection. A proportion of adult 
worms then mate and MF are released by the female worms around day 49-50 p.i. The released 
MF (approx. 80 μm in length) which are considered the first larval stage of Ls (L1), are ingested 
by mites during another blood meal. Inside these mites, the L1 stage moults within 6-7 days into 
the L2 stage and after 10-12 days to the infectious L3 larval stage which completes the life-cycle. 
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Another infection takes place when the L3 stage is transmitted to the rodent upon a subsequent 
blood meal (Figure 1.5). 
 
Figure 1.5: The life-cycle of Litomosoides sigmodontis.  (Adapted from (Kochin et al ., 2010). The L3 s tage of the pathogen 
enters  the vertebrate natural  host (the cotton rat) by the bi te of a  mite where i t matures  via  the L4 s tage into adults  that 
produce many MF (microfilariae) that are responsible for transmission. Ci rculating MF in the periphery are taken up by the 
arthropod vector and mature via the L2 s tage into the L3 s tage that is transmitted to the vertebrate host through the skin.  
 
1.2.2 Immune mechanisms in the murine model of lymphatic filariasis  
As mentioned above, patency during Ls infection is strain-dependent and so are the immune 
responses. Here, as with responses in human LF, the observed reactions are linked to the stage 
of the parasite, showing that diverse mechanisms are involved throughout the life -cycle. 
Although the detailed sequence of events involved in the early infection with Ls is not yet fully 
understood, a few studies have assessed the immune responses occurring at thi s stage. For 
instance, during transmission of L3 larvae into the mice, findings have shown that strong pro-
inflammatory responses are induced which leads to their destruction (Bain and Babayan, 2003). 
Interestingly, high amounts of IL-6 and IL-5 have been measured in the lymph nodes of Ls-
infected BALB/c mice 60 hours after infection (Babayan et al., 2003). In addition eosinophils 
accumulate early at the site of infection of Ls-infected mice in an IL-5-dependent manner; with 
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IL-5 being responsible for their maturation and infiltration into tissues (Al-Qaoud et al., 2000; 
Spencer and Weller, 2010). However, deficiencies in IFN- or IL-5 do not affect early parasite 
burden but impact worm load and MF counts at later time points (Al-Qaoud et al., 2000; Saeftel 
et al., 2001). Recent studies have indicated that from day 5 p.i., type 2 innate lymphoid cells 
(ILC2s) expand in the TC of Ls-infected mice but not in the spleen or the blood, pointing out their 
involvement at the early phase of the infection and their local function. Following the expansion 
of these cells, which peaked at the pre-patent stage, elevated amounts of IL-5 and IL-13 were 
produced leading to a strong Th2 response although no mention was made of the impact of 
ILC2s on parasite load (Boyd et al., 2015). Furthermore, investigations have reported that on day 
7 p.i., elevated levels of Tregs have been found at the site of infection, which remained during 
the course of infection and their elimination reduced both worm burden and the MF load (Taylor 
et al., 2009). Expanding on other cell type with modulating effects during Ls infection at early 
stage, are alternatively activated macrophages (AAMs) which were found in the TC of mice a few 
days after infection (Jenkins and Allen, 2010) and were maintained at the site till day 60 p.i. 
(Ajendra et al., 2014). In the chronic phase of infection, these cells can affect CD4+ T cells by 
making them hyporesponsive to the parasite (Taylor et al., 2006).  
At later time point, CD4+ T cells have been found to be essential for larval development into 
adults worms and Th2 responses are of great importance during Ls infection in BALB/c mice (Al-
Qaoud et al., 1997). Similarly to the human filarial parasites, which induce TLRs through WSP and 
Wolbachia-derived proteins, during Ls infection, these receptors are also triggered. Indeed, a 
recent study has shown that while TLR4 plays a crucial role in MF release during Ls infection, 
CD4+ T cell responses occur in a TLR2-dependent manner. Furthermore, such findings have 
indicated the reduced levels of Tregs in TLR2-deficient mice on days 49 and 72 p.i., which were 
also reduced in TLR4-deficient mice only at day 49 and both in the mediastinal lymph nodes but 
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no differences have been observed in the spleen (Rodrigo et al., 2016). While the paramount 
role of CD4+ T cells in fighting Ls infection has been highlighted, a study has provided evidence 
that depletion of CD8+ T cells did not in contrast to CD4+ T cells, influence the outcome of the 
infection (Korten et al., 2002). 
Innate cells such as neutrophils, basophils and eosinophils are highly involved in filarial 
infections. Interestingly, during the chronic phase of  the infection, activated eosinophils release 
granule proteins including ribonucleases (RNASE2 and 3), Eosinophil cationic protein (ECP), 
Major Basic Protein (MBP) and Eosinophil Peroxidase (EPO), which together with eosinophils 
have been shown to favor worm growth during Ls infection using EPO and MBP BALB/c knockout 
mice (Specht et al., 2006). Of note, studies have demonstrated the crucial role of IL-5, which 
promote eosinophil maturation and infiltration, for the control of adult parasite burden in Ls-
infected BALB/c mice lasting from day 60 through day 200 p.i. (Volkmann et al., 2003). However, 
IL-4 that is produced by basophils has been revealed to impact eosinophil count and function  as 
well since depletion of basosphils led to reduced eosinophils and CD4+ T cells proliferation during 
Ls infection. Such findings suggest that basophils do not reduce parasite burden themselves but 
strengthen anti-filarial responses (Torrero et al., 2010). Neutrophils have also been shown to 
function towards the killing of adult worms through the formation of inflammatory nodules 
around adult worms and to accumulate at the TC, in an IL-5 dependent manner. In this study, the 
authors have additionally reported G-CSF, a neutrophil-chemotactic cytokine, to be necessary for 
the formation of nodules (Al-Qaoud et al., 2000). Further findings also provided evidence that 
IFN- is responsible for neutrophil migration and used in the encapsulation process to control 
nodule formation and worm burden (Saeftel et al., 2001). Interestingly, Attout and colleagues 
have observed in Ls-infected BALB/c mice, the formation of 2 types of granulomas with distinct 
cellular composition. Indeed, in the pre-patent phase, eosinophils have been reported to be the 
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major component of granulomas whereas in the late time point, granulomas composed mainly 
of neutrophils, have been found around adult worms. Of interest, the authors have described in 
these later granulomas, the presence of only altered as well as altered though cell-free worms 
and the proportions of the latter decreased with time, indicating that the alteration of the filarial 
worms was a requirement for cell recruitment and granuloma formation (Attout et al., 2008). 
When considering adaptive cells, depletion of natural killer (NK) cells indicated increased worm 
burden although higher numbers of the cells only accumulated a few weeks after infection 
(Korten et al., 2002). Few data are available on the impact of B cells in Ls infection. However, 
µMT mice which lack mature B cells, showed no circulating MF during Ls infection, inferring that 
antibodies may interfere in the stimulation of embryogenesis in adult worms (Martin C et al., 
2001). Using B1 cell-deficient mice BALB.Xid, Al-Qaoud and colleagues have previously shown 
the influence of B1 cells during Ls infection as lack of these cells led to increase worm burden 
and MF load (Al-Qaoud et al., 1998). More investigations are needed to understand the role of B 
cell responses against Ls parasites. With regards to Tregs, Rodrigo and colleagues, when 
comparing immune responses in MF+ versus MF- Ls-infected BALB/c mice have recently noted 
no change in the numbers of Tregs in the two groups on days 35, 49 and 72 p.i., both in the 
spleen and the mediastinal lymph nodes (Rodrigo et al., 2016). Interestingly, a study has shown 
that Ls-infected NOD mice failed to develop type 1 diabetes due to a shift towards Th2 responses 
and Tregs expansion (Hubner et al., 2009), suggesting that Ls worms can prevent the 
development of type 1 diabetes in NOD mice. Similarly, previous data have shown that the 
promotion of Tregs, based on TGF- induction, dampened reactions to airway inflammation 
(Dittrich et al., 2008).  
With regards to MF load, BALB/c mice deficient for IL-4 or IL-5 have shown exponentially high 
numbers of MF compared to WT mice, demonstrating the importance of those cytokines in MF 
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control (Volkmann et al., 2003) and similar results have been noted in BALB/c mice deficient for 
both IL-4R and IL-5 (Ritter et al., 2017). Furthermore, recent findings have reported higher 
levels of IL-5 in cultures of splenic or mediastinal lymph node cells from MF+ Ls-infected BALB/c 
mice when compared to those from MF- Ls-infected BALB/c mice and as mentioned above, the 
control of MF production by Ls-infected mice involves a TLR4-dependent pathway since lack of 
TLR4 permitted all mice to develop patency (Rodrigo et al., 2016).  
When considering the resistant strain C57BL/6, the migration of L3 larvae to the lymphatic 
system as well as the filarial recovery rates were similar in BALB/c and C57BL/6 mice although 
the collected adult worms from C57BL/6 mice were smaller when compared to those from 
BALB/c mice (Babayan et al., 2003). Interestingly, low immune responses have been observed in 
the early stages of infection whereas strong Th1/Th2 responses have been reported on day 30 
p.i. (Babayan et al., 2003). In the skin of C3H/HeN mice on day 10 p.i., the degranulation of mast 
cells is induced by Wolbachia in a TLR2-dependent manner and vascular permeability is impaired 
through the chemokine C-C motif ligand 17 (CCL17) which is released by DC upon microbial 
challenge (Specht et al., 2011). Granzyme A has also been suggested to play a role in the early 
phase of the infection as increased counts of L4 were reported in C57BL/6 mice lacking granzyme 
A when compared to wild type (WT) mice (Hartmann et al., 2011). The formation of granulomas 
has also been observed in C57BL/6 mice with the exception that in these mice, additional 
granulomas have been described around young adults worms (Attout et al., 2008). More recent 
data using C57BL/6 wildtype and Rag2IL-2R deficient C57BL/6 mice, have demonstrated that 
absence of T, B and NK cells regardless of the semi-patency of the mouse strain, was associated 
with dramatically high both worm burden and MF load on day 72 after Ls infection in Rag2IL-2R 
deficient C57BL/6 mice (Layland et al., 2015). Here eosinophils were reported to be lowered in 
such setting.   
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Furthermore, IL-10-/- C57BL/6 mice were able to clear worm burden and MF load faster than 
C57BL/6 wildtype mice whereas overexpression of IL-10 lead to their higher numbers in Ls-
infected mice, suggesting a crucial role for IL-10 in controlling worm burden and MF load in such 
settings (Specht et al., 2012; Specht et al., 2004). While comparing the effect of IL-10 originating 
from either T or B cells, using deficient C57BL/6 mice, Haben and colleagues have also shown 
that T cell-derived IL-10 successfully suppressed Th1 and Th2-mediated responses during Ls 
infection whereas B cell-derived IL-10 had no noticeable impact (Haben et al., 2013). Recently, 
Hartmann and colleagues have described that TGF- and IL-10 participate in the suppression of 
IgG response to DNP-KLH vaccination (Hartmann et al., 2015). The immune responses during Ls 
infection are summarized in Figure 1.6.  
 
Figure 1.6: Immune responses during L. sigmodontis infection. The scheme pictures  the developmental s tages  of the 
parasite with their location as well as  the immune responses that are induced. 
 
In view of the above, Th2 responses constitute a hallmark of Ls infection during which, 
depending on the filarial stage or the time point of the infection regulatory players are also 
evolved. Interestingly, a new population of modulatory cells, MDSCs ( Myeloid-Derived 
Suppressor Cells), has emerged and has recently been shown to be influenced by Tregs in a 
murine model of disease, indicating the existence of interactions between these two cell-types 
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(Lee, 2016). However, to date, no studies have investigated whether these cells play a role in 
filarial infection. The next section will describe the current understanding about MDSCs, what 
they are, their function and association with other immune cells.  
 
1.3 MDSCs as suppressors of adaptive immunity  
1.3.1 Etiology and phenotype of MDSCs  
Myeloid-Derived Suppressor Cells (MDSCs) comprise subsets of immune cells that have a 
myeloid origin and immunosuppressive abilities and may develop into dendritic cells (DC), 
macrophages and/or granulocytes, under steady state conditions (Gabrilovich et al., 2007). Cells 
with suppressive abilities were initially identified more than three decades ago and were 
originally termed natural suppressor cells. Pak and colleagues were the first to report that CD34+  
cells suppressed IL-2 production by intratumoral T cells in patients with head and neck cancer 
(Pak et al., 1995). This was followed by many other studies which aimed to characterize these 
newly discovered cells. Finally, the term MDSCs has been introduced to classify their origin and 
function (Haile et al., 2010; Jiang et al., 2014) and segregate them from mesenchymal stem cells 
(Gabrilovich et al., 2007). Since their identification and characterization has been mainly 
determined using cancer models, MDSCs have been observed in blood, lymph nodes, bone 
marrow and tumor sites. They are generally identified by the co-expression of two surface 
markers: CD11b and Gr-1 (Gabrilovich et al., 2007; Ostrand-Rosenberg and Sinha, 2009) and it is 
now well accepted that there are two distinct subsets: monocytic MDSCs (Mo-MDSCs) and 
granulocytic or polymorphonuclear MDSCs (PMN-MDSCs). These two subsets are becoming well 
defined in human and rodent model settings. 
Generally, MDSCs are referred to as CD33+HLA-DR- cells in cancer patients and different 
combinations of markers including CD33, CD11b, HLA-DR, Lin, CD14 and CD15 have been used to 
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investigate human MDSCs. For human MDSC populations, Mo-MDSCs refer to CD14+ cells 
whereas PMN-MDSCs are CD15+ cells (Gabrilovich and Nagaraj, 2009; Goedegebuure et al., 
2011; Keskinov and Shurin, 2015). Diseased tissues have been proven to impact the phenotypes 
of the cells in human cancer. For example, MDSCs with a monocytic phenotype (CD14+HLA-DR-)  
are predominantly found in individuals with melanoma, as reviewed by Solito et al., (Solito et al., 
2014). Similarly, there was a trend for Mo-MDSC predominance in brain, ovarian, prostate 
cancers as well as in lung and hepatocellular carcinoma (Ho et al., 2015; Huang et al., 2013; Idorn 
et al., 2014; Kohanbash et al., 2013; Obermajer et al., 2011) whereas granulocytic MDSCs were 
dominant in head and neck cancer (Brandau et al., 2011). In contrast, haematological 
malignancies and gastrointestinal cancers led to the generation of both monocytic and 
granulocytic subsets (Brimnes et al., 2010; Gallina et al., 2006; Gorgun et al., 2013; Mundy-Bosse 
et al., 2011). Using whole blood from patients with colon cancer, research has also proposed 
S100A9 as a marker of human monocytic MDSCs (Zhao et al., 2012). In this setting, populations 
of CD14+HLA-DR-/lo MDSCs, or Mo-MDSCs corresponded to CD14+S100A9hi MDSCs. Previously, 
other authors using different conditions, have suggested CD49d and IL-4R  as subsequent 
markers for Mo-MDSCs as well. Both potential markers were claimed to be associated with the 
suppressive activity of these cells and therefore, PMN-MDSCs were either CD49d- or IL-4Rlo and 
poorly limit T cell responses (Gallina et al., 2006; Haile et al., 2010; Mandruzzato et al., 2009) . 
In laboratory mouse strains, MDSCs were first characterized by the expression levels of CD11b 
and Gr1 and in addition immature markers such as CD31 (Hegde et al., 2013). Interestingly, 
MDSC subsets have also been shown to express F4/80, MHC I (Ostrand-Rosenberg and Sinha, 
2009), CD115 (Huang et al., 2006), CD80 (Mencacci et al., 2002) and CD16 (Marshall et al., 2001)  
which have been linked to their suppressive actions. Rose et al., further suggested the utilization 
of Ly6C (Mo-MDSCs) and Ly6G (PMN-MDSCs), as markers for the specific differentiation of 
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splenic myeloid cells (Rose et al., 2012), especially when these populations appear to have 
different functions in cancer infection or autoimmunity (Almand et al., 2000; Young et al., 2001; 
Young et al., 1997). Further investigations are needed before one can make this suggestion for 
all MDSCs in every setting. Currently, the primary marker is CD11b and within the CD11b+  
population, cells are further classified as Mo-MDSCs, CD11b+Ly6C+Ly6G- or PMN-MDSCs, 
CD11b+Ly6Cint/ loLy6G+ (Ostrand-Rosenberg and Sinha, 2009; Youn et al., 2008). In terms of 
proportion, the frequencies of PMN-MDSCs are usually higher in tumor-bearing hosts than Mo-
MDSCs although the latter have a higher reported immunosuppressive activity (Dolcetti et al., 
2010; Peranzoni et al., 2010). Paradoxically, recent data provided evidence that PMN-MDSCs 
were better at impairing proliferation and expression of effector molecules on activated T cells 
when compared to Mo-MDSCs at the tumor site of several tumor models including lung 
carcinoma and melanoma (Raber et al., 2014). However, another group suggested the possibility 
that in cancer, Mo-MDSCs could change phenotypically into PMN-MDSCs with high production of 
ROS after stimulation with GM-CSF in vitro and through Histone deacetylase-2 (HDAC-2)  
mediated silencing of Retinoblastoma protein 1 (Rb1). Such plasticity may explain the large 
proportion of that subset found in cancer (Youn et al., 2013). MDSC populations in mice have 
been identified in the lymphatic organs of mice upon infection (Marshall et al., 2001; Mencacci 
et al., 2002), graft versus host reaction (Bobe et al., 1999) or even stress-associated situations 
such as exposure to staphylococcus endotoxin A (Cauley et al., 2000). 
1.3.2 Mechanisms involved in MDSC suppressive activity 
1.3.2.1 Soluble factor-dependent mechanisms 
Over the years, research has supported the idea that Mo-MDSCs and PMN-MDSCs use different 
mechanisms to suppress immune responses. Indeed, there is strong evidence that the inhibitory 
pathways used by these cells lead to either the starvation of arginine via metabolism of this 
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amino acid by Arg-1 or the production of NO by inducible nitric oxide synthase  (iNOS). Further 
research has shown that MDSCs inhibit T cells through the generation of ROS via nico tinamide 
adenine dinucleotide phosphate (NADPH) oxidase 2 (NOX2) (gp91phox) or the formation of 
peroxynitrites (PNT) released from NO and superoxide anion (O2
-). PMN-MDSCs have also been 
shown to curtail T cell responses by producing PNT from endothelial n itric oxide synthase (eNOS) 
and gp91phox whilst iNOS-induced NO was responsible for Mo-MDSCs suppression (Raber et al., 
2014) (Figure 1.7 B). Some studies indicated that iNOS expression in MDSCs was indispensable 
for their suppression of CD4+ T cells and amelioration of Concanavalin (Con) A-induced liver 
injury (Cripps et al., 2010; Fiorucci et al., 2000; Ignarro et al., 2002; Zhu et al., 2014) . Increased 
levels of ROS, primarily produced by NOX2, in MDSCs have been reported in cells isolated from 
various murine models of tumor diseases and from patients with cancer too (Corzo et al., 2009). 
Moreover, inactivation of ROS reverses the immunosuppressive capacity of  MDSCs on T cell 
responses. In MDSCs from tumor-bearing mice, up-regulation of NOX2 activity and ROS release 
lead to the enhancement of several NOX2 subunits and their stimulation causes abnormally large 
amounts of ROS to be released. This happens for example when MDSCs enter into contact with 
activated T cells (Corzo et al., 2009; Huang et al., 2013). During such interaction, ROS, together 
with peroxynitrite, which are both produced by MDSCs, induces the nitration of amino acids 
exposed at the surface of the T cells. For instance, the nitration of tyrosine on the T cell receptor 
or CD8 molecules changes the conformation of the TCR abolishing antigen-specific recognition 
(Gabrilovich and Nagaraj, 2009; Nagaraj et al., 2007). As indicated above, it has been recently 
suggested that the two subsets of MDSCs function via NO but use different synthetases. Further 
mechanisms of T cell inhibition mediated by MDSCs include the findings from the Ostrand-
Rosenberg’s group who demonstrated that MDSCs depleted the availability of cysteine in the 
microenvironment which is needed during antigen presentation (Srivastava et al., 2010). MDSCs 
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also facilitate the down-regulation of L-selectin (CD26L) thus reducing the migration of naive T 
cells to lymph nodes and therefore limiting the number of T cells responding to the presented 
antigen (Hanson et al., 2009). New investigations have indicated that not only iNOS, ROS or 
cysteine was essential for Mo-MDSC suppressive activity but TGF- was also able to induce such 
function in Mo-MDSCs against B cell responses in a murine model of acquired immune deficiency 
syndrome (AIDS) (Rastad and Green, 2016). Furthermore using TNF humanized (hTNF KI) mice, 
Atretkhany and colleagues have shown that blocking TNF activity ameliorates fibroblastic 
sarcoma growth and led to a decreased MDSC accumulation (Atretkhany et al., 2016). 
1.3.2.2 Receptor-mediated suppression pathways  
Some studies have indicated that MDSCs suppress T cell activity through their IL-4Ra receptor 
that binds the Th2 related cytokines IL-4 and IL-13, which regulate IgE production by B cells. 
Research from Mandruzzato et al., showed that both monocytic and polymorphonuclear MDSCs 
express IL-4R, but that its presence is only associated with the suppressive activity of Mo-
MDSCs in melanoma and colon carcinomas (Mandruzzato et al., 2009). On the other hand, 
research has also provided evidence that the Th1-related cytokine IFN-, plays an essential role 
in both MDSC development and activity. Gallina and colleagues showed for example that IFN - 
producing T cells from mice with tumors induced suppressive activities in MDSCs and made them 
responsive to IL-13 (Gallina et al., 2006). However, Sinha et al., used IFN--deficient, IFN-R-
deficient and IL-4R-deficient BALB/c and C57BL/6 mice in various experimental models and 
revealed that neither receptor was involved in MDSC activity (Sinha et al., 2012). Recently, Hu 
and colleagues provided evidence for the requirement of the tumor necrosis factor receptor 2 
(TNFR2) for MDSCs suppressive activity. This work further suggested that NF-kB and p38 
signalling pathways were involved in MDSCs suppressive activities (Hu et al., 2014) (Figure 1.7 C). 
Substantiating these findings is the work from Polz et al., which demonstrated that TNFR2 
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expression is required for the generation and function of Mo-MDSCs in vitro (Polz et al., 2014). In 
support, findings in both mouse and man have implicated TNFR2 in the suppressive activity of 
MDSCs in diverse types of cancer (Ham et al., 2015). MDSCs also express CD274 or programmed 
death ligand 1 (PD-L1) which when engaged with its receptor PD-1 on T cells, can inhibit 
proliferation and TCR-mediated activation of IL-2. Interestingly, a recent study on Pneumocystis 
infection suggested that during infection, Pneumocystis-derived components such as beta-
glucans interact with TLR2 and trigger pro-inflammatory responses leading to the accumulation 
of MDSCs. These MDSCs interact with the residing alveolar macrophages (AMs) that express PD-
1 through PD-1/PD-L1 ligation, causing suppressive histone modification and DNA methylation 
on the PU.1 gene. The down-regulation of the PU.1 gene led AMs to be defective in phagocytosis 
(Lei et al., 2015). Recently, Song and colleagues using a model of pancreactic cancer, have 
demonstrated that the pancreatic adenocarcinoma up-regulated factor (PAUF) could directly 
bind to MDSCs and then rendered them capable of releasing Arg-1, NO or ROS, factors involved 
in MDSC suppressive activity, as mentioned above (Song et al., 2016). 
1.3.2.3 STAT-pathways are critical for MSDC suppression 
Mo-MDSC and PMN-MDSC suppressive activities are thought to further diverge in the expression 
and phosphorylation of STATs. PMN-MDSC suppressive functions are thought to be mainly 
mediated by STAT3 phosphorylation, whilst STAT1 seems to play a main role in Mo-MDSC 
suppressive biology (Albeituni et al., 2013). In confirmation, the inhibitory activity of Mo-MDSCs 
was decreased when IFN- or STAT1 signalling was removed (Movahedi et al., 2008). As a result, 
in STAT1-/- mice, lung-residing PMN-MDSCs dramatically increased in response to bacterial 
infection (Poe et al., 2013). STAT3 is a crucial transcription factor involved in inflammation since 
Janus kinase 2 (Jak2)/STAT3 signalling is critical for tumor-associated MDSC development and IL-
6-induced STAT3 signalling, downstream of heat shock protein 72 (HSP 72)/TLR2, was shown to 
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be involved in MDSC inhibitory (Chalmin et al., 2010; Condamine and Gabrilovich, 2011) . In 
murine models, phosphorylated STAT3 has been shown to regulate the expansion of myeloid 
progenitors as well as MDSCs (Panni et al., 2014). MDSCs can accumulate via PGE2 and it has 
been shown that PGE2 and STAT3 are potential mechanisms involved in MDSC activity (Mao et 
al., 2013). Pancreatic stellate cells (PSCs) produce IL-6, VEGF, macrophage-colony stimulating 
factor (M-CSF) and chemokines such as SDF (stromal cell -derived factor)-1 and MCP (monocyte 
chemoattractant protein)-1. Co-cultures of PBMCs from healthy individuals with PSC culture 
supernatants induced STAT3 phosphorylation which further correlated with elevated IL-6 and 
MDSC differentiation (Mace et al., 2013). Studies have also shown that the production of ROS 
occurs through STAT3 phosphorylation as well. Interestingly, MDSCs isolated from HNSCC (head 
and neck squamous cell carcinoma) patients secreted Arg-1 in a STAT3-dependent manner 
(Corzo et al., 2009).  
Moreover, using CpG oligonucleotide-mediated delivery of STAT3 siRNA into TLR9+  PMN-MDSC, 
Hossain et al., provided evidence of the association between Arg-1 and STAT3 activities of these 
cells in the prostate (Hossain et al., 2015). MDSCs induced by lipopolysaccharide (LPS) in the lung 
secrete IL-6 and GM-CSF which respectively activate STAT3 and STAT5 and the activation of the 
latter promotes MDSC survival, broadening the repertoire of STAT family members that MDSCs 
employ (Condamine and Gabrilovich, 2011). More recently, a study described the crucial role of 
estrogen in MDSC accumulation. Of note, the STAT3 pathway has been activated in human and 
mouse bone marrow myeloid precursors by estrogen, which leads to the enhancement of JAK2 
and SRC activity (Svoronos et al., 2016). Furthermore, IL-6-dependent phosphorylation of STAT3 
and activation of the Notch signalling pathway induced by MDSCs, have recently been suggested 
as suppressive mechanisms used by the cells in breast cancer (Peng et al., 2016). The 
involvement of STAT3 has also been shown in the interaction of MDSCs with activated T cells. 
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Interestingly, upon STAT3 phosphorylation, the suppressive activity of MDSCs has been induced 
through ARG-1 and Indoleamine 2, 3 dioxygenase-1 (IDO) expression (Pinton et al., 2016). In 
conclusion, the various mechanisms by MDSCs which suppress T cell responses have not been 
determined using the same setting, suggesting that they do not work at the same time.  
1.3.3 Accumulation/activation of MDSCs  
As mentioned above, Mo-MDSCs and PMN-MDSCs can be induced by the presence of diverse 
factors including GM-CSF, VEGF, prostaglandin E2/cyclooxygenase-2 (PGE2/COX2), IFN- and 
may use the STAT1 or STAT3 signalling pathways (see section 1.3.2.3). Factors responsible for 
MDSC accumulation include growth factors, cytokines, chemokines and others molecules such as 
HSP 72 (Chalmin et al., 2010) or complement anaphylatoxin C5a, which facilitates MDSC 
infiltration into tumors and enhances their suppressive abilities through ROS and reactive 
nitrogen species (RNS) pathways (Markiewski et al., 2008). Cytokines such as TGF-, IL-1, IL-6, IL-
3 and GM-CSF can also induce ROS production in MDSCs (Sauer et al., 2001). GM-CSF was the 
first growth factor to be associated with MDSC accumulation and in individuals with head and 
neck cancer, those with recurring disease presented higher levels of CD34+ cells secreting GM-
CSF (Young et al., 1997). Studies have suggested that whereas Mo-MDSCs require GM-CSF for 
accumulation/generation, PMN-MDSCs are more influenced by Granulocyte-colony stimulating 
factor (G-CSF) (Dolcetti et al., 2010; Youn et al., 2013). VEGF levels in plasma have also been 
linked to the presence of MDSCs in breast, head and neck and lung cancer. These investigations 
showed that MDSC frequencies at the tumor site decreased when the tumor has been removed 
or when patients with lung cancer received anti -VEGF therapy (Young et al., 2001). Wu and 
colleagues also demonstrated that the anti-inflammatory molecule peroxisome proliferator-
activated receptor-gamma (PPAR) was also crucial for MDSC expansion  extending the 
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repertoire of molecules and pathways involved in MDSC expansion to include lipid -related 
factors (Wu et al., 2012). 
Rudolf et al., reported that CD11b+CD33+CD14+HLA-DRlo MDSCs were elevated in PBMCs at the 
onset of melanoma malignancies and interestingly, frequencies remained comparable regardless 
of enhanced tumor burden or the progression of the disease. Using serum from patients, they 
further reported that IL-8 levels also remained constant (Rudolph et al., 2014), even though 
several chemokines including IL-8 and cytokines (IL-10, IL-13, IL-6) have also been associated 
with MDSC accumulation in various cancer scenarios (Arihara et al., 2013; Gabitass et al., 2011; 
Rudolph et al., 2014). For instance, individuals with hepatocellular carcinoma presented 
increased concentrations of IL-10, IL-13 and VEGF and concentrations correlated with levels of 
CD14+HLA-DR-/lo MDSCs (Arihara et al., 2013). Furthermore, Gabitass et al., found that patients 
with pancreatic, esophageal or gastric cancer had higher IL-13 levels when compared to healthy 
subjects and this was also reflected in levels of Arg-1 (Gabitass et al., 2011). Th1 cytokines can 
also lead to the accumulation of MDSCs: IFN- was shown to participate in the inhibitory activity 
of MDSCs through NO production since neutrali zing IFN- abrogated MDSCs-mediated 
suppression in TGF1-/- mice (Cripps et al., 2010). Moreover, Tu et al., also showed that high 
levels of IL-1β leads to the mobilization and the recruitment of MDSCs. MDSC activation by IL-1β 
for example was shown to be dependent on NF-κB and the activated MDSCs contributed to the 
development of gastric inflammation and initiation of carcinogenesis in mice (Tu et al., 2008). 
The PGE2/COX2 pathway, which have a key role in influencing colorectal cancer development 
(Greenhough et al., 2009), has also been shown to factor into Mo-MDSCs accumulation in the 
following manner: the exposure of monocytes to PGE2, IL-1, IFN- or LPS, all inducers of COX2, 
leads monocytes to produce COX2 which in turn blocks the differentiation of mature CD1a +  
dendritic cells and drives MDSC development in vitro. Thereafter, endogenous PGE2, IDO, IL-
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4R, NOX 2 and IL-10 were produced, all factors associated with MDSCs suppressive function 
(Mao et al., 2013; Obermajer et al., 2011). 
Further related markers of MDSC accumulation include S100A8 heterodimeric proteins which act 
as danger-associated molecular proteins (DAMPs). These calcium-binding proteins are released 
by neutrophils, activated monocytes and tumor cells and can engage TLR4 or other TLRs which 
are involved in MDSC accumulation or function (Gebhardt et al., 2006). Indeed, when compared 
to healthy volunteers, levels of MDSCs were shown to correlate with the constitutive expression 
of S100A8/9 proteins in plasma samples from gastric cancer patients, and therefore, it is 
suggested that MDSCs require these proteins for their expansion (Wang et al., 2013). Such 
hypotheses have also been proposed by another research group suggesting that these proteins 
could be markers for MDSCs (Zhao et al., 2012). High PMN-MDSCs accumulation has also been 
associated with increased levels of Chemokine C-X-C motif ligand 8 (CXCL8) and advanced or 
late-stage tumors. Of note, this subset was reported to be cryosensitive and therefore 
preservation methods need much attention for studies using PMN-MDSCs (Trellakis et al., 2013). 
As mentioned above, GM-CSF promotes the expansion of Mo-MDSC populations that are  
expressing CD11b and the C-C motif chemokine receptor 2 (CCR2) which recognises C-C motif 
chemokine ligand 2 (CCL2) and human -defensin 3 (HBD3). Utilizing a toxin-mediated ablation 
strategy to target CCR2-expressing cells, it was shown that Mo-MDSCs regulate the entry of  
activated CD8+ T cells into the tumor site, thereby limiting the efficacy of immunotherapy and 
suggesting CCR2 as a chemokine receptor involved in MDSCs accumulation (Lesokhin et al., 
2012). In support of this, MDSCs found in human squamous cell carcinomas (SCC) produced NO, 
TGF- and Arg-1 and inhibited E-selectin in vitro. Interestingly, they expressed CCR2 and since 
HBD3 is present in tumors, the interaction of CCR2/HBD3 could also play a role in the 
recruitment of MDSCs (Gehad et al., 2012). 
Tamadaho R. S. E. Introduction 
29 
 
It is generally accepted that inflammation enhances tumor growth and IL-1 has been shown to 
increase the accumulation of elevated levels of MDSCs (Bunt et al., 2006). On this basis, Bunt 
and colleagues suggested that the effect of inflammation in tumor growth occurs through 
MDSCs. Using tumor secreting IL-1cells versus normal tumor cells, they found that IL-1-
induced inflammation-activated MDSCs through TLR4/CD14 pathway. The activation of this 
pathway in MDSCs enhances the cross-talk between MDSC and macrophages where after 
macrophages up-regulate IL-10 production by MDSCs and in turn MDSCs down-regulate 
macrophage production of IL-12 (Bunt et al., 2009) (Figure 1.7 A). It is intriguing how MDSCs 
suppress through TLR4/CD14 pathway when the activation of this pathway generally promotes 
pro-inflammatory responses. In the lung, tissue resident Arg-1-expressing MDSCs 
(CD11b+Ly6GintLy6Clo/-F480+CD80+) are induced in response to LPS or bacterial infection and can 
phagocytose apoptotic neutrophils during bacterial pneumonia (Ray et al., 2013). The removal of 
these apoptotic cells (efferocytosis) by MDSCs occurs late in infection so as to not hinder 
bacterial clearance by neutrophils; hence MDSC do not accumulate rapidly in this setting.  Their 
secretion of IL-10 also dampens Th2 effector responses elicited during allergic airway 
inflammation (Arora et al., 2010).  
1.3.4 MDSCs in diverse pathological conditions  
1.3.4.1 Cancer and autoimmune diseases 
As mentioned above, the majority of studies on MDSCs have focused on cancer and have 
reported that MDSCs have suppressive activities on CD8+ T cells including reduced proliferation 
and a suppressed release of IFN- and IL-2 production by T cells (Brandau et al., 2011; Cui et al., 
2013; Schilling et al., 2013). Indeed, Brandau et al., reported that PMN-MDSCs were responsible 
for the suppression of CD8+ T cell proliferation and IFN- production in cancer patients (Brandau 
et al., 2011). Similar results were also revealed by Schilling et al., when studying patients with 
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advanced melanoma but those studies showed that both subsets of MDSCs were capable of 
suppressing CD8+ T cell proliferation (Schilling et al., 2013). In addition, Cui et al., using flow 
cytometry, noted the suppression of IL-2 and IFN- production by CD4+ T cells as well as 
granzyme B production by CD8+ T cells in ovarian cancer patients (Cui et al., 2013). In the context 
of sepsis, MDSC were shown to be generated by acute phase proteins and were  shown to be 
crucial for the control of systemic inflammation and sepsis (Sander et al., 2010). In a few studies, 
MDSCs have also been identified in autoimmune models. For example, Kurkó et al., reported the 
presence of PMN-MDSCs in the synovial fluid of patients with rheumatoid arthritis and in an 
experimental autoimmune arthritis mouse model (Egelston et al., 2012; Kurko et al., 2014). 
MDSCs derived from the synovial fluid dampened both DC maturation and T cell proliferation. 
Crook et al., also showed for the first time that Mo-MDSCs inhibited T and B cell function in a 
collagen-induced arthritis model of autoimmune disease. Of interest, Mo-MDSCs limited 
autologous B cell proliferation and antibody production in an NO and PGE 2-dependent manner 
and required cell-cell contact (Crook et al., 2015). Another example of MDSCs identification in 
autoimmune diseases appeared in a study from Zhang et al., which revealed that the levels of 
CD11b+CD33+  MDSCs were increased in PBMCs from children at the onset of asthma. These 
authors have further demonstrated using a murine model of airway allergic inflammation, that 
levels of MDSCs correlated with high amounts of IL-10 and low levels of IL-12 in bronchoalveolar 
fluid (Zhang et al., 2013). Interestingly, Höchst and colleagues showed that whereas a noted 
suppressive capacity in kidney fibrosis was restricted to Ly6G+ MDSC populations, in a model of 
liver inflammation, Ly6C+ cells were exclusively suppressive (Hochst et al., 2015). Interestingly, 
transmigration of monocytes via liver sinusoidal endothelial cells  (LSECs) can drive MDSC 
differentiation and since MDSCs are thought to be activated in acute phases they potentially 
contribute to immunoregulation in the liver (Robinson et al., 2016). 
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1.3.4.2 MDSCs in parasitic and others pathologies  
Although cancer pathologies have had the monopoly on MDSC research for a long time, a few 
studies are now emerging about the activities of MDSCs in other infectious conditions. For 
example, MDSCs, defined as CD11b+GR1+, have been shown to steadily increase during 
infections with Echinnococcus granulosus and in acute toxoplasmosis, these cells were shown to 
accumulate in the lung and had NO-dependent immunoregulatory properties (Pan et al., 2013; 
Voisin et al., 2004). Interestingly, Schmid et al., using an experimental model of leishmaniasis, 
showed that in vitro generated-MDSCs derived from C57BL/6 mice suppressed Leishmania 
major-primed CD4+ T and CD8+ T cells whereas BALB/c-derived MDSCs suppressed only CD4+ T 
cells. In these studies, the authors revealed an impaired generation of Mo-MDSCs in BALB/c mice 
when compared to C57BL/6 mice revealing a strain-dependent activity of MDSCs and perhaps an 
indication to the different susceptibility of these strains to leishmania infection (Schmid et al., 
2014). Studies with Trypanosoma cruzi (T. Cruzi) also indicated that the genetic background plays 
a role in the level of infection.  T cells in BALB/c mice for example produced IL-17 and no IFN- 
and studies have shown that IL-17-producing  T cells modulate MDSC numbers which are  
considered vital for controlling the acute phase of T. cruzi infection (Cardillo et al., 2015). In T. 
brucei brucei infections CD11b+Ly6C+ monocytes were shown to accumulate in spleen, liver and 
lymph nodes and many presented an inflammatory DC phenotype (TNF/iNOS-producing DC) and 
this was dependent on IL-10 (Guilliams et al., 2009). Recently, higher levels of MDSC with the 
potential to reduce T cell population, have been observed in mice after infections with the liver-
affecting Schistosoma japonicum (Pan et al., 2014). In nematode infections caused by 
Heligmosomoides polygyrus bakeri, isolated CD11c-CD11b+Gr1+ cells suppressed OVA-specific 
CD4+  T cell proliferation in an NO-dependent manner and nematode specific IL-4 responses in 
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vitro. Moreover, an adoptive transfer of these cells resulted in higher parasite burden indicating 
that these cells promoted chronic infection (Valanparambil et al., 2017).  
With regards to bacterial infections, a study has noted the relevance of pulmonary-residing 
MDSCs in a murine model of tuberculosis (TB). Here, MDSCs were shown to phagocytose 
Mycobacterium tuberculosis and consequently release IL-10, IL-6 and IL-1. In addition, higher 
numbers of MDSCs correlated with elevated expression levels of IL-4R and targeted depletion 
of MDSCs, using anti-Gr-1 antibodies or all-trans-retinoic acid (ATRA), ameliorated the state of 
the disease (Knaul et al., 2014). MDSCs have also been documented in individuals with chronic 
HIV infection. The authors noted that in vitro, PMN-MDSCs from HIV-infected individuals 
impaired the proliferative activity of CD8+ T cells of healthy donors and of Gag/Nef-specific CD8+  
T cells (which are non-specific CD8+ T cells for HIV peptides) from HIV-patients under highly 
active antiretroviral treatment. Furthermore, the levels of MDSCs in PBMCs correlated positively 
with viral titres and Treg numbers but inversely with the number of CD4+ T (Vollbrecht et al., 
2012). More recently, studies in C57BL/6 mice using LP-BM5 retroviral infection indicated that 
Mo-MDSCs could inhibit both B and T cell responses (Green et al., 2013; Rastad and Green, 
2016). Furthermore, studies in C57BL/6 mice using influenza A virus infection demonstrated that 
the absence of invariant NKT (iNKT) cells induced the suppressive effect of Gr-1+CD11b+CD11c–  
MDSCs on CD8+ T cell proliferation which increased viral titre and mortality. In addition, using 
CD40- and CD40L-deficient mice, the authors further demonstrated that the interaction of iNKT 
cells and MDSCs through CD40/CD40L caused MDSCs to down-regulate Arg-1 and NOS2 but 
released IL-12p40 allowing CD8+ T cells to proliferate and control viral infection (de Santo et al., 
2008) (Figure 1.7 D).Collectively, these initial studies indicate the relevance of MDSCs in varying 
chronic diseases and further research is needed to decipher the significance of MDSC 
populations in such scenarios.  
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Figure 1.7: Mechanisms of MDSCs activity. The scheme shows the A) Cross-talk of MDSCs  with macrophages ; B) Inhibi tion 
of T cells through the release of PNT and by PMN-MDSCs  and Mo-MDSCs  respectively; C) Interaction of MDSCs  with Tregs 
and suppression of T cells via TNFR and D) Interaction of MDSCs  with iNKT cells during influenza  vi rus  infection. 
 
1.4 Aims of the study 
As described in section 1.3, MDSCs evolve during pathologies and intervene in host -pathogen 
reactions leading to immunomodulation and doing so, have either beneficial or detrimental 
effects on the host. Studies have addressed their role in cancer, bacterial, viral and parasitic 
infections but whether they play a role in filarial infections is unclear. One study has reported 
that MDSC levels were inversely associated with T cell population in Schistosoma japonicum  
infection (Pan et al., 2014). Interestingly, Ls serves a model for filarial infections in mice and 
research has shown that during Ls infection, there is an expansion of cells with 
modulatory/suppressive effects including Tregs, AAMs and IL-10-producing cells (see section 
1.2). Of note, no investigations have so far assessed the impact of MDSCs in Ls infection or if 
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targeting these cells could help in the development of new therapies to fight filariasis. Thus, the 
current project proposed to study the relevance of MDSCs in filariasis using the Ls model, as the 
life-cycle of Ls is well established at the Institute of Medical Mi crobiology, Immunology and 
Parasitology (IMMIP). The thesis aimed to: a) identify MDSC populations in Ls-infected BALB/c 
mice as the life-cycle of the rodent filariae is fully completed in this mouse strain; b) develop an 
in vitro  based co-culture assay system to determine whether MDSCs display a suppressive 
function on filarial-specific CD4+ T cells that arise during infection; c) decipher the mechanism(s) 
underlying MDSC activity in the disease. This includes the establishment of gene profiles of Mo-
MDSCs and PMN-MDSCs. 
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2. MATERIALS AND METHODS 
2.1 Materials 
2.1.1 Ethics statement 
Wildtype (WT) and IL-4R/IL-5-/- BALB/c mice were kept under SPF conditions at the Institute of 
Medical Microbiology, Immunology and Parasitology (IMMIP), University Clinic Bonn, Germany 
and were bred in accordance with German animal protection laws and the EU guidelines 
2010/63/E4. Furthermore, all the mice experiments were approved by and conducted in 
accordance with guidelines of the appropriate committee (Landesamt für Natur, Umwelt und 
Verbraucherschutz, NRW, Germany). 
 
2.1.2 Mice 
IL-4R/IL-5-/- BALB/c mice were kindly provided by Prof. Dr. Klaus Matthaei, Australia National 
University College of Medicine, Biology and Environment, Canberra, Australia. WT BALB/c mice  
obtained from Janvier Labs (Le Genest Saint Isle, France).  
 
2.1.3 Plastic and glassware  
All plastic and glassware equipment were purchased at Eppendorf (Hamburg, Germany), Becton 
Dickinson (Heidelberg, Germany), Nunc (Roskilde, Denmark) or Greiner (Frickenhausen, 
Germany) (see details in appendix). 
 
2.1.4 Antibodies and microbeads 
Name  Conjugate  Producer  Method 
Alexa fluor 488 anti-mouse/human CD11b 
(clone M1/70)  
Alexa Fluor 488 BioLegend FACS 
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Alexa fluor 647 anti-mouse CD11c (clone 
N418)  
AF647 BioLegend FACS 
Anti MHC Class II Micro Beads  
 
Miltenyi MACS 
anti-mIL-10 purified Rat monoclonal IgG1 
(clone JES052A5)  
- RD 
 in vitro 
blocking 
anti-mIL-6 purified Rat monoclonal IgG1 
(clone MP520F3)  
- RD 
 in vitro 
blocking 
anti-mouse CD16/32 purified (clone 93)  
 
Thermo Fisher 
Scientific 
 in vitro 
stimuli 
anti-mouse CD25 PE (clone PC61.5)  PE 
Thermo Fisher 
Scientific 
FACS 
anti-mouse CD25 PE-Cy7 (clone PC61.5) PE-Cy7 
Thermo Fisher 
Scientific 
FACS 
anti-mouse CD28 purified (Clone 37.51)  - 
 Thermo Fisher 
Scientific 
 in vitro 
stimuli 
anti-mouse CD3 purified (clone 17A2) - 
Thermo Fisher 
Scientific 
 in vitro 
stimuli 
anti-mouse CD4 APC (clone RM4-5)  APC 
 
FACS 
anti-mouse CD4 FITC (clone RM4-5) FITC 
Thermo Fisher 
Scientific 
FACS 
anti-mouse CD4 PE (clone GK1.5)  PE 
Thermo Fisher 
Scientific  
anti-mouse IFN gamma APC (clone XMG1.2)  APC 
Thermo Fisher 
Scientific 
FACS 
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anti-mouse IL-13 FITC (clone eBio13A)  FITC 
Thermo Fisher 
Scientific 
FACS 
anti-mouse/rat Foxp3 PE (clone FJK-16s)  PE 
Thermo Fisher 
Scientific 
FACS 
anti-mTNF-a/TNFSF1A purified Rat 
monoclonal IgG1 (clone MP6-XT22)  
- RD 
 in vitro 
blocking 
APC/Cy7 anti-mouse Ly-6C (clone HK1.4)  APC-Cy7 BioLegend FACS 
aTGF Iso MOPC-21 
 
BioXcell 
 in vitro 
blocking 
aTGFb 1D11.16.8  
 
BioXcell 
 in vitro 
blocking 
Biotin Rat Anti Mouse IL-10  
 
BD ELISA 
Biotin Rat Anti Mouse IL-5 
 
BD ELISA 
IgG1 Isotype control purified Rat monoclonal 
IgG1 (clone 43414)  
RD 
 in vitro 
blocking 
IgG2B Isotype control purified Rat 
monoclonal IgG2B (clone141945)   
RD 
 in vitro 
blocking 
MC-21 (anti-mCCR2 - 
Kindly provided 
by Prof. Mack 
 in vitro 
blocking 
Monomethyl-L-arginine, monoacetate salt (L-
NMMA) 
- 
abcam 
Biochemicals 
 in vitro 
stimuli 
Mouse IFN- DuoSet ELISA 
 
RD ELISA 
Mouse IL-10 DuoSet ELISA 
 
RD ELISA 
Mouse IL-13 DuoSet ELISA 
 
RD ELISA 
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Mouse IL-17A (homodimer) ELISA Ready-SET-
Go  
RD 
 
Mouse IL-6 DuoSet ELISA 
 
RD ELISA 
Mouse TNF DuoSet elisa 
 
RD ELISA 
near-IR fluorescent reactive dye (liva/dead 
APC Cy7)  
APC-Cy7 
Life 
technologies 
FACS 
PE anti-mouse CD3e (clone 145-2C11)  PE BioLegend FACS 
PE anti-mouse Ly-6G (clone 1A8) PE 
 
FACS 
PerCP/Cy5.5 anti-mouse CD45 (clone 30-F11) PerCP-Cy5.5 BioLegend FACS 
PerCP/Cy5.5 anti-mouse Ly-6C (clone HK1.4) PerCP-Cy5.5 BioLegend FACS 
Recombinant Mouse IL-10 
 
BD ELISA 
Recombinant Mouse IL-5 
 
BD ELISA 
 
2.2 Methods 
2.2.1 Parasitology assessments  
2.2.1.1 Litomosoides sigmodontis infection 
BALB/c mice were infected with Litomosoides sigmodontis (Ls) parasite with Ornithonyssus 
bacoti mites serving as intermediate vectors. For the life cycle of the parasite to be completed, 
Ls was maintained by passage in cotton rats (Sigmodon hispidus). Mites were kept in animal 
bedding at 28°C and 80 % humidity in the dark and fed with murine neonates at least twice a 
week. Passage of MF (L1) was performed by an overnight blood meal on microfilaraemic (≥ 1,000 
MF / μl peripheral blood) cotton rats as final host. The mites subsequently take up MF (L1)  
during their blood meal and can then be used for infection using the bedding. Bedding was 
collected in an Erlenmeyer-flask and closed with polyamide gauze and placed at 28°C and 80 % 
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humidity in the dark, for twelve days allowing development of MF (L1) into infective L3. Prior to 
infection, mites were checked for L3 content under the binocular. BA LB/c mice were naturally 
infected overnight with the infective L3 containing bedding twelve days after MF passage. To 
ensure comparability of infection load, mice were always exposed to the same population of 
mites. The following day, the bedding was removed and mice stayed without bedding overnight. 
Then, clean bedding was provided every day for five successive days. Finally seven days after 
infection, mice were transferred to suitable room until required for experiments.  
 
2.2.1.2 Murine autopsy and pleural lavage 
In order to collect organs for cell preparation, mice were euthanized using overdose of 
Isoflurane (>5 Vol.%) (1-cloro-2, 2, 2-trifluoroethyldifluoro-methylether; Forene, Abbolt, 
Wiesbaden). Thereafter, mice were disinfected with 70 % ethanol and fixed on a Styrofoam 
board dorsally. Using sterile surgical instruments, the spleen was taken out by opening the lower 
right side of the mouse without damaging either the pleural cavity or diaphragm. The spleen was 
transferred in 24 well plate which contained 1 ml sterile PBS (Life Technologies Corporation, 
Grand Island, NY, USA) per well and stored on ice. Then the abdomen was opened and the liver 
carefully separated from the diaphragm. A little hole was made into the upper part of the 
diaphragm and the thoracic cavity (TC) was washed first with 500 µl and further with 10 ml of 
cold PBS (Life Technologies Corporation, Grand Island, NY, USA) using a Pasteur pipette. When 
required, the supernatant of this first 500 µl of TC fluid would serve for cytokine measurements. 
The pellet was added to the 10 ml TC fluid to entirely collect the TC cells. In case of the autopsy 
of an infected mouse, the TC fluid was filtered using a gauze containing filter in order to collect 
the worms. Afterwards, the whole thorax was opened by cutting along the sternum and the 
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draining lymph nodes were taken out and transferred in 96 well plate containing 2-3 drops of  
sterile PBS (Life Technologies Corporation, Grand Island, NY, USA). 
 
2.2.1.3 Determination of worm burden, gender, length and developmental stage 
To assess worm burden, the thoracic cavity of infected mice was washed with PBS (Life 
Technologies Corporation, Grand Island, NY, USA). The thoracic wash was filtered using sterile 
41μm gaze filter which retained the worms and the solution was collected in a sterile 15ml 
Falcon tubes (Becton Dickinson Labware, Franklin Lakes, NJ. USA). Worms are then placed in a 
small Petri dish (VWR, Langenfeld, Germany) and counted immediately or stored at 4°C until 
counting. For further analysis, worms were measured (length), distinguished between males and 
females and the stage was determined using a microscope (Leica Microsystems GmbH, Wetzlar,  
Germany), if necessary. Also, developmental stage was defined microscopically by analysis of the 
anterior buccal capsule and designation of male spiculae and female vulva (see Figure 2.1).  
 
Figure 2.1: Anatomical characteristics to determine L. sigmodontis stages and gender. (A) Male genital s tructure with 
spiculae (arrows). (B) Female genital s tructure with vulva (arrow). (C) L4 s tage: anterior end with buccal capsule (arrow). 
(D) Adult s tage: anterior end with buccal capsule (arrow). Light microscope pictures , 40-fold magni fication, micron bars  50 
μm. 
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2.2.1.4 Determination of MF load 
MF load was determined using Hinkelmann solution (see appendix). 50 µl of blood from 
individual infected mouse were placed in 300 µl Hinkelmann solution. After incubation at RT 
during 20-30 min, the suspension was centrifuged (Multifuge 4KR, Heraeus Holding GmbH, 
Hanau, Germany) at 1800 rpm, 5 min and the SN was discarded. MF were counted in the pellet , 
using a microscope (Leica Microsystems GmbH, Wetzlar, Germany).  
 
2.2.2 Preparation of Litomosoides sigmodontis antigen (LsAg) 
Litomosoides sigmodontis antigen (LsAg) was prepared on ice under sterile conditions using 
worms which were isolated from the TC of infected cotton rats (Sigmodon hispidus). Thus, Ls 
worms were isolated (see section 2.2.1.2) and crushed/disrupted using glass homogenize r (VWR, 
Langenfeld, Germany). The resulting solution was centrifuged (Multifuge 4KR, Heraeus Holding 
GmbH, Hanau, Germany) at 300 g for 10 min at 4°C. Protein concentrations of the extract were 
determined using Bradford protein assay and quantified at 590 nm using a plate reader 
SpectraMax 340 Pc (Molecular Devices). Thereafter, LsAg was plated on MAcconckey and blood 
aggar to test contamination and an endotoxin assay was performed. Aliquots of sterile and 
contamination-free LsAg were frozen at -80°C until when needed. 
 
2.2.3 Cell preparation  
For in-vitro analysis, DC, spleen and mesenteric lymph node cells (mLN) as well as TC cells were 
prepared as detailed in sections 2.2.3.1-2 and 2.2.1.2. In general, mice experiments during which 
cells were prepared, were performed as depicted in Figure 2.2 using Ls-infected mice. 
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Figure 2.2: Scheme of data assessment protocol. BALB/c mice were infected for 70-72 days  with Ls  larvae 3. Thereafter, on 
the day of analysis (day 70-72), cells from the spleen, mesenteric lymph node cells (mLN), thoracic cavi ty (TC, site of 
infection) were prepared and analysed and worms were collected. 7 days  prior to analysis, dendri tic cells (DC) were 
prepared. MF count was assessed on days 50, 60, 66 and 70-72 p.i . 
 
2.2.3.1 Preparation of spleen and mesenteric lymph node cells (mLN)  
To obtain single spleen cells, spleen was crushed through a sieve in a petri dish with sterile PBS 
(Life Technologies Corporation, Grand Island, NY, USA). Cell preparations were depleted of 
erythrocytes with ammonium-chloride-Tris-buffer (ACT buffer) and resuspended in appropriate 
media and counted as described in section 2.2.4. The same procedure was used for mesenteric 
lymph nodes (mLN) except that no depletion of erythrocytes was usually needed. 
 
2.2.1.2 Preparation of bone marrow derived dendritic cells (BMDCs)  
Bone marrow was obtained by rinsing the hind legs of WT BALB/c mice with PBS solution (Life 
Technologies Corporation, Grand Island, NY, USA). Cell preparations were depleted of 
erythrocytes with ammonium-chloride-Tris-buffer (ACT buffer) and counted as described in 
section 2.2.4. Then 1x107 cells were differentiated on Petri dish over seven days in 10 ml of 
IMDM medium supplemented with 10% FCS, 1% Pen/Strep, 1% L-Glutamine, 1% non-essential 
AA, 1% Sodium-pyruvate, 1% Sodium-bicarbonate (all from Thermo Fisher Scientific) and 20 
ng/ml GMCSF (Peprotech, USA) at 37 °C. On day 3, cells were fed: 10 ml of supplemented IMDM 
medium and 20 ng/ml GMCSF were added and on day 6, cells were refreshed: cells were washed 
in PBS (Life Technologies Corporation, Grand Island, NY, USA) and thereafter, 10 ml of 
supplemented IMDM medium and 20 ng/ml GMCSF were added. 
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2.2.4 Cell viability and counting  
The count of living cells was determined using the trypan blue (Sigma-Aldrich, Munich, 
Germany). In brief, cells were 1/10 diluted in 0.4% trypan blue  (Sigma-Aldrich GmbH, Munich, 
Germany) solution. Thereafter, 10 µl of cell suspension were transferred to a cell counting 
Neubauer chamber or hemocytometer (LO Laboroptik GmbH, Bad Homburg, Germany) and 
living cells (non-coloured) were counted. The cell number per ml was ascertained using the 
formula: number of cell counted x 10 (dilution) x 104 (factor).  
 
2.2.5 Flow cytometry 
2.2.5.1 Surface marker staining 
All reagents were obtained from Biolegend (Fell, Germany). To ascertain the frequency of MDSC 
subsets in Ls-infected BALB/c mice, cells collected from the thoracic cavity were resuspended in 
50 µl FACS buffer (see appendix) and blocked with 0.1 µl anti-CD16/32 (Thermo Fisher Scientific, 
Inc., Waltham, MA, USA) and incubated at 4°C for 15 min. Thereafter, cells were washed with 
FACS buffer (see appendix): cells were centrifuged at 1200 rpm at 4°C and the supernatant was 
discarded and stained with 0.1 µl surface marker Abs (CD11b-AF488, CD45-PerCP-Cy5.5, Ly6C-
APC-Cy7 and Ly6G-PE) incubated at 4°C for 20 min. Afterwards, cells were washed as previously 
described with FACS buffer (see appendix), resuspended and acquired on a FACS Canto (BD, 
Heidelberg, Germany). 
 
2.2.5.2 Intracellular staining (ICS)  
For the intracellular staining of IL-13 and IFN- on T cells, cells were stimulated or not with PMA 
(plus inhibitor) (Thermo Fisher Scientific, Inc., Waltham, MA, USA) or LsAg in 200µl RPMI 
medium supplemented with 10% FCS, 1% Pen/Strep, 1% L-Glutamine and 500 µl Gentamycin for 
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4h. Then washed with FACS buffer (see appendix) and permeabilized with 100 µl 
fixation/permeabilization buffer (see appendix) at RT for 30 min. Then cells were washed as 
described in section 2.2.5.1 using permeabilization buffer (see appendix)  and resuspended in 50 
µl master mix containing the antibodies for intracellular and surface marker staining (CD4-PE, 
CD25-PE Cy7, IFN--APC and IL-13-FITC) at 4°C for 30 min. Then, cells were washed with 
permeabilization buffer (see appendix) and resuspended in 200 µl FACS buffer and acquired on a 
FACS Canto (BD, Heidelberg, Germany).  
 
2.2.5.3 Sorting of cell populations 
For the sorting of CD4+  T cells and CD4+CD25hi Tregs, spleen and mLN cells were stained with 
CD4-APC and CD25-PE (Thermo Fisher Scientific, Inc., Waltham, MA, USA) as described above. 
Prior to the sorting, antigen presenting cells (APCs) were depleted from spleen plus mLN using 
MHC class II beads (see section 2.2.5.4) and the negative suspension was used for sorting. In 
addition, cells collected from the TC were stained with CD11b-AF488, Ly6C-PerCP-Cy5.5 and 
Ly6G-PE for the sorting of MDSC subsets. Cells were sorted using BD FACS Aria III Cell Sorter (BD 
Biosciences, Heidelberg, Germany), in the Flow Cytometry Core Facility (FCCF), Bonn. 
 
2.2.5.4 Depletion of MHC class II+ cells 
MHC class II+ cells (APC) were depleted from the spleen and mLN cells using the anti -MHC class II 
microbeads from Miltenyi (Miltenyi Biotech GmbH, Bergisch Gladbach, Germany) according to 
the manufacturer’s protocol. In brief, 1 x 107 PBMCs were resuspended in 90 µl of autoMACS 
running buffer (Miltenyi, Bergisch Gladbach, Germany). Afterwards, 10 µl of anti -MHC class II 
microbeads were added to the cells, mixed and incubated for 15 minutes inside the refrigerator 
(2-8°C). Cells were washed with 2 ml of running buffer and centrifuged for 10 minutes at 400 x g 
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(4°C). Supernatants were discarded and labelled cells were resuspended in 500 µl of running 
buffer. Cells were separated using a suitable MACS separator (Miltenyi Biotech, Bergisch 
Gladbach, Germany). The suspension depleted from MHC class II + cells (negative suspension) 
were checked for their purity by flow cytometry. Purity of isolated MHC class II+ -depleted cells 
was routinely >95%.  
 
2.2.6 In vitro co-culture assays  
In order to assess the ability of filarial-induced MDSCs to suppress filarial-specific CD4+ T cells, a 
co-culture assay was performed as shown in Figure 2.3. In brief, spleen and mLN cells and TC 
fluid from infected BALB/c mice were isolated and CD4+  T cells and MDSCs were sorted according 
to the descriptions above (section 2.2.5). 1x105 CD4+ T cells were then co-cultured with 5x104 
GM-CSF-derived DC (section 2.2.3.2) in the presence or absence of 1x105 Ly6C+  or Ly6G+ MDSCs 
and stimulated with 50 µg/ml LsAg. Upon 72h incubation at 37°C, supernatants were collected 
and analysed for cytokine levels using ELISA technique (see section 2.2.7). For 
neutralization/inhibition assays, neutralizing antibodies or inhibitors were added at least 30 min 
before Ls stimulation. The neutralizing antibodies included anti-CCR2, anti-IL-10, anti-IL-6, anti-
TGF- and anti-TNF- and their isotype controls and L-NMMA served as inhibitor of NOS. 
Following titration assays, it was decided to use L-NMMA at a concentration of 5 µM/well and 
supernatants were screening after 72 hours because the highest amount of nitric oxide was 
produced at that time by Ls-infected CD4+ T cells upon LsAg re-stimulation (see Figure 2.4 A and 
B). Anti-IL-6 and TNF- were used at a concentration of 10 and 0.5 µg/mL, respectively (see 
Figure 2.4 C and D). Prof.Dr. Matthias Mack (University of Regensburg) and Dr. Marc Hübner 
have provided the anti-mCCR2 and anti-TGF-antibodies, respectively and the concentration of  
these antibodies were decided upon following discussion with their providers : anti-mCCR2 (20 
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µg/mL) and anti-TGF- (10 µg/mL). In transwell experiments, culture conditions remained the 
same except that MDSC subsets were cultured in an insert (0.4 µM pore size; Corning), 
permeable to soluble factors but not allowing physical cell -cell contact.  
 
 
Figure 2.3: Experimental set-up for co-culture assay. In a  sterile U-bottom 96 well plate, CD4+ splenic T cells (1x105) were 
cul tured with GM-CSF-derived DC (5x104) and LsAg (50 µg/ml) in the presence or absence of Ly6C+ or Ly6G+ MDSCs  (1x105) 
for 72h and then screening supernatants for cytokines  by ELISA. 
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Figure 2.4: Titration assays. In a  s terile U-bottom 96 well  plate, GM-CSF-derived DC (5x10
4
) were cul tured with or without 
CD4+ splenic T cells  (1x105) and LsAg (50 µg/ml) or LPS (0.1 or 0.05 µg/mL) and with or without L-NMMA (5 mM), IL-6 (10 
µg/ml) or TNF- (0.5 µg/ml). Supernatants  were collected after A) 72h or B) as indicated or C) and D) 24h and then 
screened for cytokines  by ELISA. 
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2.2.7 Enzyme-linked immunosorbent assay (ELISA) 
ELISA is a plate-based assay technique designed for detecting and quantifying substances such as 
peptides, proteins (in the case of this work, cytokines), antibodies and hormones. In the ELISA 
technique used for this work, a first antibody must be immobilized to a solid surface and then 
complexed with a second antibody that is linked to an enzyme. Detection is accomplished by 
assessing the conjugated enzyme activity via incubation with a substrate to produce a 
measureable product. Diverse ELISA kits have been used to measure cytokines levels in 
supernatants, as described below. 
 
2.2.7.1 Ready-Set-Go ELISA kits (Thermo Fisher Scientific)  
ELISA plate was coated with 50 µl of capture antibody (Ab) diluted with coating Buffer (see 
appendix) per well. The plate was covered and incubated overnight at 4°C. Thereafter, it was 
washed five times with washing buffer (see appendix) and blocked with 200 µl of 1x Assay 
Diluent (see appendix) and incubated at RT for 1 h, to remove unspecific bindings. Plate was 
washed five times with washing buffer and the standard and samples were diluted in 1x Assay 
Diluent. A 2-fold serial dilution of the standard was performed in the standard wells and 50 µl of 
1x Assay Diluent were added to the blank wells. Then, 50 µl of the diluted samples were added 
per well. The plate was covered and incubated at RT for 2 h or at 4°C overnight. Thereafter, it 
was washed five times with washing buffer and 50 µl of detection Ab diluted in 1x Assay Diluent 
(see appendix), were added per well. The plate was covered and incubated at RT for 1h; then 
washed five times with washing buffer and 50 µl of avidin-horseradish peroxidase (HRP) diluted 
in 1x Assay Diluent (see appendix), were added per well. The plate was covered and incubated at 
RT for 30 minutes and thereafter, washed seven times with washing buffer. And for the 
revelation, 50 µl of the provided tetramethylbenzidine (TMB) (see appendix) were added per 
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well and the plate was incubated at RT for around 15 minutes and the reaction was stopped by 
adding 50 µl of stop solution (see appendix) per well. The plate was read at 450 nm against  570 
nm using a spectrometer (Spectra Max 340pc384, Molecular Devices, Sunnyvale, USA). 
 
2.2.7.2 Duo Set ELISA kits (R&D)   
ELISA plate was coated with 50 µl of capture Ab diluted with 1 % PBS (see appendix) per well. 
The plate was covered and incubated overnight at 4°C. Thereafter, it was washed three times 
with washing buffer (see appendix) and blocked with 150 µl of 1 % PBS /1 % BSA (see appendix) 
and incubated at RT for 2 h, to remove unspecific bindings. Plate was washed three times with 
washing buffer and the standard and samples were diluted in 1 % PBS /1 % BSA. A 2-fold serial 
dilution of the standard was performed in the standard wells and 50 µl of 1 % PBS /1 % BSA were 
added to the blank wells. Then, 50 µl of the diluted samples were added per well. The plate was 
covered and incubated at RT for 2 h. Thereafter, it was washed five times with washing buffer 
and 50 µl of detection Ab diluted in 1 % PBS /1 % BSA (see appendix) , were added per well. The 
plate was covered and incubated at RT for 2 h; then washed f ive times with washing buffer and 
50 µl of streptavidin-horseradish peroxidase (HRP) diluted in 1 % PBS /1 % BSA (see appendix) 
were added per well. The plate was covered and incubated at RT for 45 minutes  and thereafter, 
washed five times with washing buffer. And for the revelation, 50 µl of the substrate solution 
(see appendix) were added per well and the reaction was stopped by adding 50 µl of stop 
solution (see appendix) per well. The plate was read at 450 nm against 570 nm using a 
spectrometer (Spectra Max 340pc384, Molecular Devices, Sunnyvale, USA). 
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2.2.7.3 BD ELISA 
ELISA plate was coated with 50 µl of capture Ab diluted with coating buffer (see appendix) per 
well. The plate was covered and incubated overnight at 4°C. Thereafter, it was washed four 
times with washing buffer (see appendix) and blocked with 150 µl of 1 % PBS /1 % BSA (see 
appendix) and incubated at RT for 2 h, to remove unspecific bindings. Plate was washed three 
times with washing buffer and the standard and samples were diluted in 1 % PBS /1 % BSA. A 2-
fold serial dilution of the standard was performed in the standard wells and 50 µl of 1 % PBS /1 
% BSA were added to the blank wells. Then, 50 µl of the diluted samples were added per well. 
The plate was covered and incubated overnight at 4°C. Thereafter, it was washed five times with 
washing buffer and 50 µl of detection Ab diluted in 1 % PBS /1 % BSA (see appendix) , were added 
per well. The plate was covered and incubated at RT for 1 h; then washed five times with 
washing buffer and 50 µl of streptavidin-peroxidase (POD) diluted in 1 % PBS /1 % BSA (see 
appendix) were added per well. The plate was covered and incubated at RT for 45 min and 
thereafter, washed five times with washing buffer. And for the revelation, 50 µl of the substrate 
solution (see appendix) were added per well and the reaction was stopped by adding 50 µl of 
stop solution (see appendix) per well. The plate was read at 450 nm against 570 nm using a 
spectrometer (Spectra Max 340pc384, Molecular Devices, Sunnyvale, USA). 
 
2.2.8 Griess assay 
Nitric oxide (NO) is an important physiological messenger and effector molecule in many 
biological systems, including immune responses and one way to investigate nitric oxide 
formation is to measure nitrite (NO2
-) which is one of two primary, stable and nonvolatile 
breakdown products of NO. Thus, to measure NO2
- (and indirectly NO) release, Griess reagent kit 
(Molecular Probes, Inc., Oregon, USA) was used according to the manufactures’s instructions. In 
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brief, Griess reagent was prepared by mixing equal  volumes of components A (N-(1-naphthyl) 
ethylenedi-amine) and B (sulfanilic acid). 10 µl of freshly prepared Griess reagent was then 
mixed with 75 µl of  sample/Aqua dest. (Blank)/standard (serial dilution 10 - 1 µM) and 65 µl of  
Aqua dest., to have a total volume of 150 µl. The mix was incubated for 30 min in the dark. NO 
production was then quantified by the colour change at 548nm using a spectrometer ( Spectra 
Max 340pc384, Molecular Devices, Sunnyvale, USA). 
 
2.2.9 Gene expression analysis  
2.2.9.1 RNA extraction and quantification  
RNA was extracted from isolated MDSCs using a combination of Trizol (Invitrogen) and RNeasy 
Mini kit (Qiagen, Hilden, Germany). In brief, trizol-preserved samples were incubated at 15-30°C 
for 5 min, to allow complete dissociation of nucleoproteins complexes and mixed with 0.1 ml of 
cool 1-Bromo-3-chloropropane (BCP, Sigma-Aldrich GmbH, Munich, Germany) per 1ml Trizol. 
The mixture was shaken vigorously for 15 seconds, incubated at RT for 2-3 minutes and 
centrifuged for 15 min at 12,000 g at 4 °C using Eppendorf 5417R (Eppendorf AG, Hamburg, 
German). Thereafter the upper aqueous phase containing the RNA was removed carefully in new 
tube and 1 volume of 70% EtOH was added, mixed and 700 µl of the mixture were transferred to 
the column placed in a 2 ml collection tube (Qiagen, Hilden, Germany). This was followed by a 
centrifugation step, 16,000 g for 3 min at RT and the flow-through was discarded. Then 700 µl of 
buffer RW1 were added to the column and centrifuged at 16,000 g for 20 seconds at RT. The 
flow-through was discarded and 500 µl of buffer RPE were added to the column and centrifuged 
as described above. This step was repeated with 700 µl RPE buffer except centrifugation for 
2min, before the column was placed in a new 2 ml collection tube and centrifuged at 16,000 g 
for 1 min at RT in order to dry the membrane, which contained the RNA. The 2 ml collection tube 
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was discarded and the column was placed in a new 1.5 ml collection tube. Finally, 30 µl RNAse-
free water were added to the membrane and centrifuged at 16,000 g for 1 min at RT and RNA 
solution was kept on ice followed by a DNase digestion using DNA-free kit (Applied Biosystems) 
according to the manufacturer’s instructions. In short,  0.1 volume of 10X DNAse I buffer and 1 µl 
of rDNAse I were gently mixed with the RNA solution and incubated at 37 °C for 20-30 min using 
a heater (Eppendorf AG, Hamburg, Germany). Thereafter, 0.1 volume of DNAse inactivation 
reagent was added, incubated for 2min at RT and centrifuged at 10,000 g for 2 min. Finally, the 
RNA containing supernatant was transferred into a new tube and the concentration of RNA was 
measured using NanoVue (GE Lifescience, Chalfont St Giles, Great Britain). RNA with a A260/280 
ratio of nearly 2 was considered pure (of good quality). 
To further analyze the quality of the RNA, Experion RNA StdSens Analysis kit (BioRad, Hercules, 
USA) was used according to the manual instruction. In brief, 2 µl of ladder and sample were 
incubated at 70°C for 2 min (denaturation), vortexed and kept on ice. The electrodes were 
cleaned by placing 800 µl of Experion electrode cleaner (EC) on the EC cleaning chip and letting it 
run in the Experion electrophoresis station for 2 min. Then 800 µl of Milli-Q water were placed 
on the DEPC cleaning chip and let run for 5 min; this was repeated once again. Thereafter, the lid 
of the machine was kept opened for 1 min then closed. A gel -stain solution (GS) was prepared by 
mixing 65 µl gel (G) and 1 µl stain (ST). The mixture was vortexed and briefly centrifuged. Next, 
the chip was primed by adding 9 µl of GS to gel priming well and letting it run in the prime 
station and then was removed. 9 µl of GS and 9 µl of G were loaded into the second GS well and 
G well respectively. Then, 5 µl of loading buffer (B) were placed into each sample well and into 
well L. 1 µl of denatured RNA ladder and 1 µl of  denatured sample were loaded into well L and 
sample wells respectively. Caution was taken to fill unused sample wells with 1 µl Milli-Q water. 
The chip was placed in the Experion vortex station and vortexed for 1min and let run in the 
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Experion electrophoresis station within 5 min of loading. After the run was completed, the used 
chip was removed and discarded and the cleaning process described above, repeated.  
 
2.2.9.2 cDNA synthesis 
In order to obtain the first-strand cDNA, good quality RNA (see section 2.2.9.1) was used and 
genomic DNA elimination and reverse-transcription mixes were prepared as shown in Table 1 
and 2, respectively. Genomic DNA elimination mix was incubated at 42 °C for 5 min and placed 
on ice for at least 1 min. Then 10 µl of genomic DNA elimination mix and 10 µl of reverse -
transcription mix were mixed and incubated at 42 °C for 30 min and the reaction was 
immediately stopped, at 95°C for 5 min. For the preamplification procedure (this is to obtain 
enough material for PCR array, see section below), preamplification mix was prepared as 
depicted in Table 3. Then, 5 µl first-strand cDNA synthesis reaction were added to 20 µl 
preamplification mix and cycling performed as indicated in Table 4. 
Table 1: Genomic DNA elimination mix 
Component Amount for one sample  
RNA 1 ng -100 ng 
Buffer GE 2 µl 
Rnase-free 
water variable 
Total volume  10 µl 
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Table 2: Reverse-transcription mix 
Component volume for 1 reaction (µl)  
5x Buffer BC3 4 
Control P2 1 
cDNA synthesis Enzyme Mix 1 
RNA Inhibitor 1 
Rnase-free water 3 
Total volume (µl) 10 
 
Table 3: Preamplification mix 
Component volume for 1 sample (µl)  
RT2 PreAMP PCR Mastermix  12,5 
RT2 PreAMP Pathway Primer Mix 7,5 
Total volume (µl) 20 
 
Table 4: Cycling conditions for preamplification of cDNA (from fresh/frozen samples)  
Cycles Duration Temperature 
1 10 min 95°C 
12 
15 s 95°C 
2 min 60°C 
Hold 
 
4°C 
 
2.2.9.3 PCR array 
PCR Array using the RT2 SYBR Green Mastermix kit (Qiagen, Hilden, Germany) and RT2 Profiler 
PCR Array Mouse Innate and Adaptive Immune Responses kit (Qiagen, Hilden, Germany) were 
used in order to evaluate the differences between the two subsets of MDSC populations isolated 
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from Ls-infected BALB/c mice. These two subsets were also isolated from naive mice to serve as 
controls. The customized array consists of 84 genes related to innate and adaptive responses in 
mouse including: a) Pattern Recognition Receptors (PRRs) ( DDX58 [RIG-I], NLRP3, NOD1 
(CARD4), NOD2, TLR1, TLR2, TLR3, TLR4, TLR5, TLR6, TLR7, TLR8, TLR9), b) cytokines (CCL12, CCL5 
[RANTES], CSF2 [GM-CSF], IFN-2, IFN-1, IL18, IL1, IL1, IL2, TNF, CXCL10 [INP10], IFN-, IL10, 
IL13, IL17A, IL23A, IL4, IL5, IL6), c) Th markers (CCR5, CXCR3, SLC11A1, STAT4, TBX21, GATA3, 
STAT6, CCR6, RORC, STAT3, CCR4, CCR8, FOXP3), d) T cell activation (CD80, CD86, ICAM1) and e)  
other genes (APCS, C3, C5AR1, CASP1 [ICE], CD14, CD4, CD40 [TNFRSF5], CD40LG [TNFSF5], 
CD8A, CRP, H2-Q10, H2-T23, IL1R1, IRAK1, IRF3, IRF7, ITGAM, LY96 [MD-2], LYZ2, MAPK1 [ERK2], 
MAPK8 [JNK1], MBL2, MPO, MX1, MYD88, NFKB1, NFKBIA [IKBALPHA/MAD3], STAT1, TICAM1 
[TRIF], TRAF6, IFNAR1, IFNGR1, JAK2, RAG1, TYK2, FasL [TNFSF6]) (see full names of genes as well 
as the number of sorted cells in Appendix).  
To perform the array, PCR components mix was prepared as shown in Table 5. Then, 20 µl PCR 
components mix were added to each well of the RT2 Profiler PCR Array using Qiagility device 
(Qiagen, Hilden, Germany). This was followed by cycling (Table 6) using a Rotor Gene Q (Qiagen, 
Hilden, Germany). Data were analysed using the online RT2 Profiler PCR Array Data analysis 3.5 
software at the sabiociences.com website (Qiagen) and gene expression was normalized to 
Actine beta (Actb).  
Table 5: PCR components mix  
Array format R (Rotor-Disc 100)  Components volume (µl)  
2x RT2  SYBR Green Mastermix 1150 
Preamplification reaction 102 
RNase-free water 1048 
Total volume (µl) 2300 
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Table 6: Cycling conditions for Rotor-gene cyclers 
Cycles Duration Temperature 
1 10 min 95°C 
40 
15 s 95°C 
30 s 60°C 
 
2.3 Statistics 
Statistical analyses were performed using the software PRISM 5.02 (GraphPad Software, Inc., La 
Jolla, USA). Statistical differences between three or more than three groups were observed using 
a Kruskal-Wallis test (non parametric distribution) or ANOVA (parametric distribution) and whe n 
necessary, a Mann-Whitney-U test (non parametric distribution) or Student’s t test (parametric 
distribution) for a further comparison of two groups. p-value of 0.05 or less were considered 
significant (*p<0. 05, **p<0.01 and ***p<0.001). 
 
2.4 Citations’  management 
The citations in this document were made using the EndNote X7 bibliography software 
(Thomson Reuters, New York, USA), licensed for the Institute of Medical Microbiology, 
Immunology and Parasitology of the University Hospital Bonn.  
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3. RESULTS  
This chapter describes the findings of this thesis that show the significance of MDSCs during Ls 
infection. MDSCs display an immunomodulatory character which can have beneficial or 
detrimental effects on the outcome of pathologies and here, the first section demonstrates that 
both Mo-MDSCs and PMN-MDSCs expand in Ls-infected BALB/c mice. Since it is known that CD4+  
T cells are critical for controlling immune responses during Ls infection, the second section 
provides evidence for the ability of Mo-MDSCs but not PMN-MDSCs to suppress the in vitro  
production of IL-13 and IFN- by Ls-specific CD4+ T cells. The assessment of the mechanisms 
underlying such capacities in Ls infection-derived Mo-MDSCs is described in sections three and 
four and shows that Mo-MDSCs in this setting, function independently on IL-4R but require NO 
and TGF- to impair the production of IL-13 and IFN- by Ls-specific CD4+ T cells, respectively. 
The last section informs on gene regulation in Ls infection-derived Mo-MDSCs and PMN-MDSCs. 
3.1. MDSCs and Litomosoides sigmodontis infection 
MDSCs have been identified and characterized mainly in cancer models and have thus been 
observed in blood, lymph nodes, bone marrow and tumor sites. They are generally identified by 
the co-expression of two surface markers: CD11b and Gr-1 (Gabrilovich et al., 2007; Ostrand-
Rosenberg and Sinha, 2009). In addition, within the CD11b+ population, MDSCs are further 
classified as monocytic (Mo-MDSCs, CD11b+Ly6C+Ly6G-) or polymorphonuclear (PMN-MDSCs, 
CD11b+Ly6Cint/ loLy6G+) (Ostrand-Rosenberg and Sinha, 2009; Youn et al., 2008)  (see section 
1.3.3). Although the role of MDSCs has been documented in other pathological conditions 
including bacterial and viral infections, little research has focused on deciphering the relevance 
of MDSCs in helminth infections. Investigating this could serve as basis for new therapeutics and 
therefore the current study aimed at assessing the impact of MDSCs during Litomosoides 
sigmodontis (Ls) infection which is an established model for filariasis (more detail in section 1.2). 
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Since L. sigmodontis worms can complete a full life-cycle in BALB/c mice, the study began with 
an initial comparison of the number of expanding and infiltrating MDSCs in naive versus Ls-
infected BALB/c mice as well as the proportion of the infiltrating subsets. Furthermore, the 
analysis was expanded to cover the kinetics of systemic-residing MDSC subsets and those found 
at the site of infection, the thoracic cavity (TC). Correlations between MDSC subsets and 
parasitological parameters including worm burden and MF count were also investigated. 
 
3.1.1 MDSCs infiltrate the site of infection in Litomosoides sigmodontis infected mice  
In order to look whether MDSC populations infiltrate the thoracic cavity  and to distinguish 
between monocytic (Mo-MDSCs) and polymorphonuclear MDSCs (PMN-MDSCs), cells were 
collected from the thoracic cavity of naive mice or Ls-infected WT BALB/c mice and analyzed by 
FACS/Flow cytometry using CD11b, CD45, Ly6C and Ly6G antibodies (adapted from (Schumak et 
al., 2015)) (see Figure 3.1).  
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Figure 3.1: Gating strategy to identify MDSC populations. Cells were isolated from the thoracic cavi ty and stained with a 
combination of CD45, CD11b, Ly6C and Ly6G antibodies  to dis tinguish between monocytic (CD11b+Ly6C+Ly6G-, Mo-MDSCs 
or Ly6C) and polymorphonuclear (CD11b+Ly6Cint/loLy6G+, PMN-MDSCs or Ly6G) MDSC populations  by flow cytometry. 
Images show flow cytometry data from a day 72 Ls -infected BALB/c mouse. 
 
The amounts of infiltrating MDSCs in naive or day 42 p.i. Ls-infected mice (there all worms are 
adults) are depicted in Figure 3.2. Interestingly, very few Mo-MDSCs were present in the TC of 
naive mice whereas there was a substantial proportion in the TC fluid of Ls-infected mice 
(p<0.01, Figure 3.2 A). Similarly, there was only a nominal amount of PMN-MDSCs in the TC of 
naive mice when compared to Ls-infected BALB/c mice (p<0.01, Figure 3.2 B). Collectively these 
data show for the first time that MDSC populations infiltrate the site of infection in Ls-infected 
BALB/c mice whereas naive mice display very few MDSCs. 
Tamadaho R. S. E. Results 
61 
 
Naive Inf.
0
5
10
15
**
A
%
 L
y
6
C
 i
n
 C
D
1
1
b
+
Naive Inf.
0
10
20
30 **
B
%
 L
y
6
G
 i
n
 C
D
1
1
b
+
 
Figure 3.2: Higher levels of MDSC subsets in the thoracic cavity of Ls-infected mice when compared to uninfected mice. 
Wildtype (WT) BALB/c mice were left uninfected or naturally infected with Ls . On day 42 p.i ., cells were isolated from the 
thoracic cavi ty and s tained with a  combination of CD45, CD11b, Ly6C and Ly6G antibodies to di fferentiate monocytic 
(CD11b+Ly6C+Ly6G-, Mo-MDSCs  or Ly6C) and polymorphonuclear (CD11b+Ly6Cint/loLy6G+, PMN-MDSCs  or Ly6G) MDSC 
populations . Graphs  show percentage of A) Mo-MDSCs  and B) PMN-MDSCs  within the CD11b+ population in uninfected 
(white bars) and in day 42 p.i . Ls -infected (black bars). Graphs  show mean ± SEM of 4 infection s tudies  using 3-5 mice. 
Asterisks indicate signi ficant differences  (Mann-Whitney test) between the groups  indicated by the brackets (**p<0.01). 
 
3.1.2 PMN-MDSC accumulate to a higher extent when compared to Mo-MDSCs  
As mentioned in section 1.2, Ls infection in BALB/c mice allows the release of MF into the 
periphery (patency). Indeed, in a parallel study, after screening the blood of Ls-infected mice 
from day 45 p.i. until day 120 p.i., it could be determined that MF production began around day 
49 p.i. and peaked around day 70-72 p.i (Figure 3.3) (Petit et al., 1992; Rodrigo et al., 2016). This 
pointed out that the time frame day 70-72 p.i. was critical during the chronic phase of Ls 
infection especially in terms of patency and therefore further experiments were performed at 
such time points to address immune responses during chronic  Ls infections.  
Since researchers found in a cancer setting that PMN-MDSCs accumulated to a higher extent 
when compared to Mo-MDSCs (Youn et al., 2008) and having observed the infiltration of MDSC 
subsets at the site of infection and their higher numbers in Ls-infected mice when compared to 
uninfected controls, the next step compared the frequencies of the two subsets of MDSCs at the 
peak of patency (days 70-72 p.i.).  
Interestingly, although both MDSC subsets infiltrated the TC (Figure 3.2), the frequencies 
(p<0.001, Figure 3.4 A) and absolute cell numbers (p<0.05, Figure 3.4 B) of PMN-MDSCs were 
higher when compared to Mo-MDSCs on day 72 p.i. Thus, PMN-MDSCs infiltrated the thoracic 
cavity of Ls-infected BALB/c mice to a higher degree than Mo-MDSCs.  
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Figure 3.3: MF release during Ls infection. Wild-type BALB/c female mice were naturally infected with L. sigmodontis. From 
day 45 to 120 p.i . individual  mice were screened for the number of MF in blood. Symbols  represent mean ± SEM of infected 
mice from six independent infection experiments  (n = 20 Mf+ mice). Taken from Rodrigo et al., 2016. 
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Figure 3.4: Increased frequencies of PMN-MDSCs when compared to Mo-MDSCs during Ls infection. Wildtype BALB/c mice 
were naturally infected with Ls. On day 72 p.i ., cells were isolated from the thoracic cavi ty and stained with a combination of 
CD45, CD11b, Ly6C and Ly6G antibodies  to differentiate monocytic (CD11b +Ly6C+Ly6G-, Mo-MDSCs  or Ly6C) a nd 
polymorphonuclear (CD11b
+
Ly6C
int/lo
Ly6G
+
, PMN-MDSCs  or Ly6G) MDSC populations . Comparison of MDSCs  within the 
CD11b+ compartment of day 72 infected mice as A) percentage or B) absolute cell number. Symbols show values  from 
individual  mice (n=20) from 2 independent infection s tudies. Asterisks  indicate signi ficant di fferences  (Mann-Whitney test) 
between the groups indicated by the brackets  (*p<0.05, ***p<0.001). 
 
3.1.3 Differential accumulation of Mo-MDSCs and PMN-MDSCs during Ls infection in 
the thoracic cavity and blood  
MDSCs accumulate at different levels and stages and the kinetics of this accumulation and their 
development have been suggested to affect the outcome of cancer, especially in diverse murine 
models of hepatocellular carcinoma (Kapanadze et al., 2013). To observe whether such effects 
also occur in Ls model, the frequencies of MDSCs in the thoracic cavity was compared to that in 
blood of Ls-infected WT BALB/c mice.  
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At the site of infection, PMN-MDSC numbers increased dramatically at the stage of final molting 
around day 30 p.i. (from 1% to 37%) whereas, Mo-MDSC numbers only showed a slight 
augmentation throughout the entire infection period (3-15%) (Figure 3.5 A). In contrast, MDSC 
subsets showed different accumulation rates in blood (Figure 3.5 B). In detail, Mo-MDSC levels 
were high at the very beginning of the infection whereas PMN-MDSC levels were low (32.5% and 
0.2% respectively). Then from day 4 p.i., levels of PMN-MDSCs went up exponentially to over 
80% and only slightly dropped down again around day 72 p.i. During that same time, Mo-MDSC 
numbers decreased from 55% to between 5% and 30% until day 72 p.i.  
0 20 40 60 80
0
20
40
60
A (Thoracic cavity)
Day post infection (dpi.)
%
 C
D
1
1
b
+
c
e
ll
s
0 20 40 60 80
0
20
40
60
80
100
B (Blood)
%Ly6C
%Ly6G
Day post infection (dpi.)
%
 C
D
1
1
b
+
c
e
ll
s
 
Figure 3.5: MDSC subsets activity during Ls infection. Wild-type BALB/c mice were naturally infected with L. sigmodontis. 
From day 0 to 72 p.i ., cells were isolated from the thoracic cavi ty or blood and s tained with a  combination of CD45, CD11b, 
Ly6C and Ly6G antibodies to differentiate monocytic (CD11b +Ly6C+Ly6G-, Mo-MDSCs  or Ly6C) and polymorphonuclear 
(CD11b
+
Ly6C
int/lo
Ly6G
+
, PMN-MDSCs  or Ly6G) MDSC populations . Percentage of MDSCs  subsets  within the CD11b
+
 cell 
compartment in A) the thoracic cavi ty or B) blood  were determined by flow cytometry. Symbols show the percentage of 
cells in infected (n=3-5 per time point {n=50 in total}) mice from one infection. 
 
3.1.4 MDSC infiltration positively correlates with worm burden  
Findings have suggested that MDSC levels were associated with the level and evolution of 
pathology especially in cancer (Almand et al., 2000; Arihara et al., 2013). This led to the 
speculation that MDSC infiltration could be associated with parasite parameters including worm 
burden and MF counts. To test this hypothesis, a correlation analysis was performed between 
the numbers of MDSC subsets and either worm burden or MF count at d ay 70-72 p.i.  
Interestingly, levels of both Mo-MDSCs and PMN-MDSCs positively correlated with worm burden 
(r=0.8377; p<0.0001 and r=0.7777, p<0.0001, respectively) (Figure 3.5 A). However an opposite 
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outcome was displayed in the correlation between MDSC levels and MF count when assessing 
systemic MF numbers or MF numbers in the TC. Indeed, the systemic MF counts showed no 
correlation with any of the two MDSC subsets (r=0.0967; p= 0.6312 and r=0.1900, p=0.3426)  
(Figure 3.6 C). In contrast, MF at the site of infection showed a slight positive correlation with 
MDSC populations (r=0.4660; p=0.0143 and r=0.4381, p=0.0223) (Figure 3.6 B), although this 
correlation was not as strong as the one observed between the same populations and worm 
burden. Ultimately, these data demonstrated that MDSC frequencies positively correlated with 
worm burden during Ls infection.  
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Figure 3.6: Positive correlation between 
MDSCs frequency and worm burden. On 
day 71 p.i ., worms were isolated from the 
thoracic cavi ty of individual mice and 
counted and MF release was quantified. 
Cells  were also isolated from the thoracic 
cavi ty and stained with a  combina tion of 
CD45, CD11b, Ly6C and Ly6G antibodies 
to differentiate monocytic 
(CD11b+Ly6C+Ly6G-, Mo-MDSCs or Ly6C) 
and polymorphonuclear 
(CD11b+Ly6Cint/loLy6G+, PMN-MDSCs  or 
Ly6G) MDSC populations . Plots  show 
spearman correlations  between the 
number of MDSCs  subsets and A) worm 
burden, B) MF number in thoracic cavi ty 
(TC) and C) MF number in blood. Data are 
from infected mice (n=27) from 3 
independent infection studies. P-values 
show significant di fferences between 
worm burden and each of the two 
subsets and r the coefficient of 
correlation. 
 
3.2 Characterization of MDSC-mediated suppression of Ls-specific CD4+ T cell responses 
The hallmark of MDSCs is their ability to suppress T cell responses (Gabrilovich et al., 2007). This 
has been shown in several cancer scenarios (Solito et al., 2014) and many other pathological 
conditions including bacterial, viral and parasitic infections but not in helminths (as reviewed in 
(Tamadaho et al., 2018)). In the previous section (section 3.1) it was demonstrated that there 
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was an expansion of MDSC subsets inthe thoracic cavity of Ls-infected BALB/c mice and that 
there was a higher frequency of the PMN-MDSC subset when compared to the Mo-MDSCs. In 
addition, a statistically strong positive correlation was shown between MDSC subsets and worm 
burden. Here, the ability of the two MDSCs subsets to suppress Ls-specific CD4+ T cells and its 
association with parasitic parameters were evaluated.  
 
3.2.1 Mo-MDSCs suppress Ls-specific CD4+ T cell responses  
As described above, MDSC populations share the capacity to suppress T and even B cells 
responses (as reviewed in (Tamadaho et al., 2018)). Therefore, to test the suppressive property 
of Mo-MDSCs and PMN-MDSCs that arose during Ls infection, an in vitro co-culture assay was 
developed (see Figure 2.1). In brief, CD4+ T cells were isolated from the spleen and medLN of Ls-
infected mice on day 72 p.i. Cells were then activated in vitro over 72 hours with LsAg, an extract 
prepared from adult Ls worms in the presence of  GM-CSF derived DC from BALB/c mice. 
Suppression of cytokine release was then measured after co-culturing isolated Mo-MDSCs or 
PMN-MDSCs with CD4+ T cells in a 1:1 ratio. Of interest, as noted in other helminth infections 
CD4+ T cells from uninfected mice do not respond to Ls-antigen during in vitro recall assays. 
Therefore, no co-cultures were performed using CD4+ T cells isolated from uninfected mice 
(Figure 3.7 A and B). In addition, when compared to the main controls (DC+CD4++LsAg or 
DC+CD4++CD3/28), other controls had negligible levels of IL-13 and IFN- (Figure 3.7 C and D, 
respectively). 
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Figure 3.7: Hyporesponsiveness of naive CD4+ T cells upon LsAg stimulation. CD4+ T cells  were isolated from Ls -infected 
or naive mice by flow cytometry. CD4
+
 T cells  (1x10
5
) were cultured with GM-CSF-derived DC (5x10
4
) and LsAg (50 µg/ml) 
for 72h. Supernatants  were then screened for A) IL-13 and B) IFN-by ELISA. Graphs  show mean ± SEM 1 of 2 co-culture 
assays  using cells from 2-3 pooled mice from 1 infection s tudy. On day 71 p.i., CD4+ T cells and MDSCs subsets were 
isolated from Ls-infected mice by flow cytometry. CD4
+
 T cells (1x10
5
) or Ly6C
+
/Ly6G
+
 MDSCs(1x10
5
) were cul tured alone or 
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with GM-CSF-derived DC (5x104) and LsAg (50 µg/ml) or CD3/28 (5 and 1,25 µg/ml) for 72h. Supernatants were then 
screened for C) IL-13 and D) IFN-by ELISA. Graphs show mean ± SEM of 1 of all co-culture assays  performed in this  thesis 
using cells from 4-10 pooled mice from independent infection s tudies. C) IL-2 and D) IL-5 Asterisks  show significant 
di fferences (Mann-Whitney test) between the indicated groups  (***p<0.001). 
 
Figure 3.8 depicts data demonstrating that Mo-MDSCs (black bars) were able to significantly 
suppress the production of IL-13 (p<0.05 in Figure 3.8 A), IFN- (p<0.01 in Figure 3.8 B) and IL-2 
(p<0.05 in Figure 3.8 C) but not IL-5 (p=0.37 in Figure 3.8 D) by filarial-specific CD4+ T cells, 
comparatively to the negative control which contained no MDSCs (white bars). Surprisingly, 
PMN-MDSCs (grey bars) were not able to suppress the production of any of the above 
mentioned cytokines. The comparison of the cytokine levels between the Mo-MDSCs (black bars)  
and PMN-MDSCs (grey bars) showed no differences. The production of IL-10 was suppressed by 
neither Mo-MDSCs nor PMN-MDSCs and measuring the suppression of TNF- and IL-5 was not a 
stable parameter. Thus to assess the effects of Mo-MDSCs on filarial-specific CD4+ T cells in the 
rest of the study, only the suppression of IL-13 and IFN- (representing Th2 and Th1 responses, 
respectively) was measured since these cytokines were the most stable. 
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Figure 3.8: Suppression of filarial-specific CD4+ T cells responses by Mo-MDSCs. On day 70-72 p.i ., CD4+ T cells  and MDSCs 
subsets  were isolated from Ls -infected mice by flow cytometry. CD4+ T cells (1x105) were cul tured with GM-CSF-derived DC 
(5x10
4
) and LsAg (50 µg/ml) in the presence or absence of Ly6C
+
 or Ly6G
+
 MDSCs  (1x10
5
) for 72h. Supernatants  were then 
screened for A) IL-13; B) IFN-; C) IL-2 and D) IL-5 by ELISA. Graphs  show mean ± SEM 1 of 3 co-culture assays  using cells 
from 4-6 pooled mice from 3 independent infections . Asterisks show signi ficant di fferences ( Mann-Whitney test) between 
the indicated groups (*p<0.05, ***p<0.001). 
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3.2.2 Mo-MDSCs suppress cytokine production by Ls-specific CD4+ T cell responses 
regardless of MF status  
In section 3.1.4, systemic MF counts were revealed to not have any correlation with MDSC 
levels. On this basis, it was tempting to speculate that the suppressive activity mediated by Mo-
MDSCs (see Figure 3.8) was not associated with systemic MF status. To verify this, Mo-MDSCs 
and CD4+  T cells were isolated from MF-producing (MF+) or non-MF-producing mice (MF-) on 
day 70-72 p.i. and co-cultured with GM-CSF-derived DC and LsAg for 72h. Thereafter, cytokine 
release was measured in the supernatant.  
As expected, Figure 3.9 shows that Mo-MDSCs derived from either MF-producing (MF+) or non-
MF-producing mice (MF-) were able to significantly suppress the production of IL-13 by Ls-
specific CD4+ T cells (p<0.05 and p<0.05 respectively; Figure 3.9 A). The production of IFN- was 
also suppressed (Figure 3. 9 B) but suppression was only significant with Mo-MDSCs from MF- 
mice. These data confirmed the correlation showed in section 3.1.4. 
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Figure 3.9: Suppression of filarial-specific CD4+ T cells responses by Mo-MDSCs stemming from MF+ and MF- mice Ls-
infected mice. On day 70-72 p.i ., CD4+ T cells  and MDSCs  subsets were isolated from Mf-producing Mf+) or non Mf-
producing (Mf
-
) Ls-infected mice by flow cytometry. CD4
+
 T cells (1x10
5
) were cul tured with GM-CSF-derived DC (5x10
4
) and 
LsAg (50 µg/ml) in the presence or absence of Ly6C+ or Ly6G+ MDSCs  (1x105) for 72h. Supernatants  were then screened for 
A) IL-13; B) INF- by ELISA. Graphs show mean ± SEM of 2 co-culture assays using pooled cells from 4-16 mice from 2 
independent infections. Asterisks  show signi ficant differences  (Mann-Whitney test) between the indicated groups  (*p<0.05, 
***p<0.001). 
 
3.2.3 Mo-MDSCs derived from pre- and post-patent Ls-infected mice suppress CD4+ T 
cell responses  
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As mentioned in section 1.2.1, MF production in Ls-infected BALB/c mice begins around day 49-
50 p.i. and peaks around day 72 p.i (Figure 3.3). However, immune responses to MF are 
indicated to be of considerable importance since ingestion of this life-stage (MF) by blood 
feeding vectors is paramount to their survival . It is known that immune responses are altered in 
patent and latent infections (Arndts et al., 2012; Rodrigo et al., 2016) and immune responses 
differ during infections in BALB/c mice (see Figure 3.10). 
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Figure 3.10: Immune responses in pre- and post-patent Ls-infected BALB/c mice. Wildtype BALB/c mice were naturally 
infected with L. Sigmodontis for 35, 49 and 72 days . On day 72, mice  were screened for the presence of peripheral MF and 
lymphocytes  were isolated from the spleen (A-D) or medLN (E-H). Cells were s timulated with 50µg/ml  LsAg for 72 hours. 
Thereafter, levels of TNF- (A,E), IL-5 (B,F), IL-13 (C,G) and IL-10 (D,H) were determined in the cul ture supernatant by ELISA. 
Graphs  show mean ± SEM of individually assessed mice from 3 independen t infection experiments  (n=6 day 35, n=7 day 49, 
n=20 MF+ and n=11 MF- mice). Asterisks indicate signi ficant differences  (ANOVA or Student's t tes t) between the groups 
indicated by the brackets  (*p<0.01, **p<0.05, ***p<0.001).  
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To test whether the suppression observed with Mo-MDSCs derived from day 72 p.i. infected 
mice was specific or not to that particular time point or to the post-patent stage, Mo-MDSCs and 
CD4+ T cells were isolated from Ls-infected mice on day 45 (pre-patent) or 60 p.i. (post-patent) 
and were cultured with GM-CSF-derived DC and LsAg.  
Figure 3.11 shows the levels of cytokines that were produced by Ls-specific CD4+ T cells. 
Importantly, as with Mo-MDSCs isolated from Ls-infected BALB/c mice on day 72 p.i. (see Figure 
3.8), Mo-MDSCs isolated on day 45 p.i. (Figure 3.11 A and B) or 60 p.i. (Figure 3.11 C and D) were 
able to suppress the production of IL-13 (p<0.01 and p<0.01; respectively) and IFN-(p<0.01 and 
p<0.05; respectively), by Ls-specific CD4+ T cells. These data show that Mo-MDSCs isolated from 
both pre-patent and post-patent Ls-infected mice are equally capable of suppressing Ls-specific 
CD4+ T cell responses. 
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Figure 3.11: Suppression of filarial-specific CD4+ T cells responses by pre-patent and post-patent Mo-MDSCs. On day 45 
and 60 p.i ., CD4+ T cells and Mo-MDSCs (Ly6C+) subsets  were isolated from Ls-infected mice by flow cytometry. In brief, CD4+ 
T cells  (1x105) were cultured with GM-CSF-derived DC (5x104) and LsAg (50 µg/ml) in the presence or absence of Ly6C+ 
MDSCs  (1x105) for 72h. Supernatants  were then screened for IL-13 (A,C) and IFN- (B,D) by ELISA. Graphs show mean ± SEM 
of 1 co-culture assay using pooled cells from 3-5 mice that were all  infected at the same time  point. Asterisks show 
signi ficant differences  (Mann-Whitney test) between the indicated groups (*p<0.05, **p<0.01). 
 
3.2.4 Ls-specific CD4+ T cells produce IFN- and IL-13 upon LsAg stimulation  
To further demonstrate that the cytokines (IFN- and IL-13) that were shown to be suppressed 
by Mo-MDSCs were being specially released by T cells upon LsAg activation, CD4+ T cells were 
isolated from Ls-infected mice on day 71 p.i., and stimulated with PMA (plus inhibitor) or LsAg 
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for 4h and then stained with CD4, IFN- and IL-13 antibodies to detect CD4+ T cell-specific 
cytokine release. 
Figure 3.12 shows that although Ls-specific CD4+ T cells were able to produce IFN- and IL-13 
without further stimulation (white bars), upon LsAg stimulation slightly higher levels of cytokines 
were observed (black bars). However, PMA was capable of inducing the highest levels of IFN- 
but the lowest levels of IL-13 (grey bars). These data indicate that Ls-specific CD4+ T cells release 
Ls-specific IL-13 upon LsAg stimulation and IFN-release is not entirely dependent on LsAg 
stimulation. 
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Figure 3.12: LsAg stimulation induces IFN-  and IL-13 production by Ls-specific CD4+ T cells. Wildtype BALB/c mice were 
naturally infected with Ls . On day 70-72 p.i ., CD4+ T cells were isolated from the spleen and left unstimulated or s timulated 
with LsAg or PMA for 4h and s tained with a  combination of CD4, IFN- and IL-13 antibodies to quanti fy levels of produced 
cytokines . Graphs show percentage of A) IL-13 and B) IFN- for LsAg (black bars), PMA (grey bars ) and no further 
s timulated CD4+ T cells (white bars ). 
 
3.3 IL-4R alpha and IL-5 deficiencies during Ls infection: role in MDSC-mediated 
suppression 
Findings have indicated that IL-4 plays an important role in the immunity against murine Ls 
infection especially for the release of MF in BALB/c mice (Le Goff L et al., 2002; Volkmann et al., 
2001). In addition, using adoptive transfer studies of viable MF, IL-5 –deficient BALB/c mice have 
been shown to have increased MF survival when compared to WT mice (Volkmann et al., 2003). 
These studies have explored the effects of IL-4R alpha (IL-4R and IL-5 deficiencies separately 
but the outcome of infection and immune responses resulting from the lack of IL-13, IL-4 and IL-
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5 activity in the same mice during Ls infection remains unclear. Furthermore, Mandruzzato and 
colleagues have suggested that the presence of the IL-4R is associated with the suppressive 
activity of Mo-MDSC in melanoma and colon carcinomas (Mandruzzato et al., 2009). Therefore, 
using IL-4R/IL-5 dKO BALB/c, the impact of such deficiencies during Ls infection and on MDSC 
function was investigated. 
 
3.3.1  MDSC-mediated filarial specific CD4+ T-cell suppression occurs in an IL-4R -
independent manner  
Studies have indicated that MDSCs suppress T cell  responses through their IL-4Ra receptor 
that binds the Th2 related cytokines IL-4 and IL-13, which regulate IgE production by B cells. 
Indeed, cancer patients have been shown to have higher levels of IL-4R+ MDSCs (Movahedi et 
al., 2008). Moreover, although researchers have provided evidence that receptor exists on both 
Mo-MDSC and PMN-MDSC subsets, further reports have shown that the suppression is only 
attributed to the Mo-MDSC subset (Mandruzzato et al., 2009). Thus, to investigate the role of IL-
4/IL-5 signalling in regards to the suppressive ability of Mo-MDSCs during Ls infection, co-culture 
assays were performed as described in section 2.2.6 using cells from Ls-infected WT BALB/c or IL-
4R/IL-5 dKO BALB/c mice.  
Surprisingly, as shown in Figure 3.13, Mo-MDSCs derived from IL-4R/IL-5 dKO BALB/c mice as 
well as those derived from WT BALB/c, were able to suppress IL-13 (Figure 3.13 A, p<0.01) and 
IFN- (Figure 3.13 B, p<0.01) production by Ls-specific CD4+ T cell responses indicating that 
neither the IL-4R nor IL-5 were involved in the observed suppression. Although Mo-MDSCs 
derived from IL-4R/IL-5 dKO BALB/c mice seemed to display a better suppressive ability 
compared to those from WT BALB/c mice, this trend was not statistically significant. 
Tamadaho R. S. E. Results 
75 
 
0.0
0.5
1.0
1.5
2.0
2.5 ***
**A
CD4+     +    +        +
LsAg         +    +         +
Ly6C
+
WT --    +        --
Ly6C+dKO --          --         +
IL
-1
3
 [
n
g
/m
l]
0
1
2
3
CD4+     +    +        +
LsAg         +    +         +
Ly6C
+
WT --    +        --
Ly6C+dKO --          --         +
**
**B
IF
N
- 
 [
n
g
/m
L
]
 
Figure 3.13: Mo-MDSCs suppression is IL-4R-independent. WT and IL-4R/IL-5 dKO BALB/c mice were naturally infected 
with Ls . On day 70-72 p.i ., CD4+ T cells  and Mo-MDSCs  subsets  were isolated from Ls-infected mice by flow cytometry. WT 
CD4+ T cells (1x105) were cultured with GM-CSF-derived DC (5x104) and LsAg (50 µg/ml) in the presence or absence of Ly6C+ 
MDSCs  (1x10
5
) from WT (in black) or IL-4R/IL-5 dKO (in grey) for 72h. Supernatants  were then screened for A) IL-13 and B) 
IFN- by ELISA. Graphs show mean ± SEM of 2/3 independent co-culture assays  using pooled cells from 3-4 equally infected 
mice. Asterisks show signi ficant differences  (Mann-Whitney test) between the indi cated groups  (**p<0.01, ***p<0.001). 
 
3.3.2  High frequencies of Mo-MDSCs in the TC of Ls-infected IL-4R/IL-5 dKO BALB/c 
mice  
Since Mo-MDSCs derived from IL-4R/IL-5 dKO have shown differences in the suppressive ability 
compared to that from WT mice (although not statistically significant), the infiltration of MDSC 
populations within the TC was analyzed. 
In the TC, levels of Mo-MDSC in either percentage or absolute cell number were higher in Ls-
infected IL-4R/IL-5 dKO BALB/c when compared to WT mice (Figure 3.14 A and C, p<0.01 and 
0.05, respectively) whereas populations of PMN-MDSC remained comparable (Figure 3.14 B and 
D). The baseline of MDSC frequencies was equal in naive WT and IL-4R/IL-5 dKO controls. This 
suggests that either the IL-4R or IL-5 or both had an impact on Mo-MDSC infiltration but not on 
that of PMN-MDSCs.  
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Figure 3.14: Increased frequencies and absolute cell numbers of Mo-MDSCs in Ls-infected IL-4R/IL-5 dKO BALB/c mice 
when compared to WT controls. WT and IL-4R/IL-5 dKO mice were left uninfected or naturally infected with Ls . On d70-72 
p.i ., cells  were isolated from the thoracic cavi ty and s tained with a  combination of CD45, CD11b, Ly6C and Ly6G antibodies 
to di fferentiate monocytic (CD11b+Ly6C+Ly6G-, Mo-MDSCs  or Ly6C+) and polymorphonuclear (CD11b+Ly6Cint/loLy6G+, PMN-
MDSCs  or Ly6G+) MDSC populations . Comparison of percentage or absolute number of A) or C) Mo -MDSCs  and B) or D) 
PMN-MDSCs  within the CD11b+ compartment. Symbols show values of n= 24 WT mice and n= 26 dKO mice in 3 independent 
infection s tudies . Asterisks indicate signi ficant differences  (Mann-Whitney test) between the groups  indicated by the 
brackets (*p<0.05, **p<0.01). 
 
3.3.3 Ls-infected IL-4R/IL-5 dKO BALB/c mice harbor a higher worm burden and MF 
count when compared to WT BALB/c mice  
As mentioned above, MDSC populations positively correlated with worm burden but not 
systemic MF load (see section 3.1.4) and both the IL-4R and IL-5 were shown to impact parasite 
growth and MF clearance in Ls infection (Le Goff L et al., 2002; Volkmann et al., 2003; Volkmann 
et al., 2001). In accordance with this, parasitological parameters were analyzed in WT and IL-
4R/IL-5 dKO BALB/c Ls-infected mice in the chronic phase. On day 72 p.i., worms were 
harvested from the thoracic cavity and screened for gender and length. MF counts were 
assessed in both blood and thoracic cavity fluid.  
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Importantly, worm burden was dramatically higher in IL-4R/IL-5 dKO when compared to WT 
BALB/c mice (Figure 3.15 A, p<0.001). In accordance, MF loads were also significantly elevated in 
IL-4R/IL-5 dKO when compared to WT BALB/c mice in blood (Figure 3.15 B, p<0.001) and at the 
site of infection, the TC (Figure 3.15 C, p<0.001) and also during the course of the infection 
(Figure 3.15 D). Furthermore, even though it has been reported that only a portion of Ls-infected 
BALB/c mice develop patency, all of the IL-4R/IL-5 dKO BALB/c mice became patent although 
wolbachia levels were higher in WT when compared to IL-4R/IL-5 dKO BALB/c mice (Figure 3.15 
E, p<0.05) (Petit et al., 1992; Rodrigo et al., 2016). Collectively these data suggest that IL-4R  
and IL-5 deficiencies in BALB/c mice, increased worm burden and was associated with the 
induction of full patency and dramatic MF count during Ls infection (Ritter et al., 2017). 
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Figure 3.15: Elevated worm burden and MF count in IL-4R/IL-5 dKO versus WT BALB/c mice during Ls infection.  WT 
BALB/c mice and IL-4R/IL-5 dKO mice were naturally infected with Ls. On day 71 p.i ., worms were isolated from the 
thoracic cavi ty of individual  mice and counted. A) displays  worm burden  on day 72 p.i . Mice were individually screened for 
the number of MF which was ascertained from 10 µl of B) blood or C) thoracic cavi ty fluid . D) shows MF counts during Ls 
infection. E) Levels of Wolbachia DNA were determined via a  duplex PCR in individual adult female  worms (n=51 WT and 
n=48 IL-4R/IL-5 dKO worms) on d72 p.i ., data  are from one of two independent infection s tudies  (n=12 WT and n=15 IL-
4RIL-5 dKO mice) showing comparable results Graphs A), B) and C) show mean ± SEM of n= 36 WT mice and n= 43 dKO 
mice in 4 independent infection s tudies. Data  in D) shows mean ± SEM from one of two independent infection studies (n=12 
WT and n=15 IL-4R/IL-5 dKO mice) showing comparable results . Asterisks show signi ficant differences  (Mann-Whitney test) 
between the indicated groups (***p<0.001, *p<0.05). 
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Significantly higher worm burden and MF counts were observed in the thoracic cavity and 
periphery of Ls-infected IL-4R/IL-5 dKO when compared to WT BALB/c mice (see Figure 3.15). 
Subsequently, worms were counted according to their gender and the length was measured for 
each worm to analyze whether the two groups displayed any differences.  
In line with the previous data, Ls-infected IL-4R/IL-5 dKO harbored significantly elevated 
numbers of male and female worms when compared to WT BALB/c mice in number (Figure 3.16 
A, p<0.001) but not in percentage (Figure 3.16 B). Surprisingly, only male worms from the Ls-
infected IL-4R/IL-5 dKO group were longer when compared to males from the WT BALB/c 
group (Figure 3.16 C, p<0.001). Female worms showed no significant differences between the 
two groups. Thus, these data demonstrated that Ls-infected IL-4R/IL-5 dKO not only harbor 
higher number of male and female worms when compared to WT BALB/c mice, but also offer a 
more suitable environment for the growth of male worms (Ritter et al., 2017). 
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Figure 3.16: Male worms are longer in Ls-infected IL-4R/IL-5 dKO when compared to those from WT BALB/c mice. WT 
BALB/c mice and IL-4R/IL-5 dKO mice were naturally infected with Ls. On day 72 p.i ., worms were isolated from the thoracic 
cavi ty of individual  mice. They were counted, identified as  male or female  in A) number or percentage B) and C) the length of 
each worm was  measured. Graphs  show mean ± SEM of n= 36 WT mice and n= 43 dKO mice in 4 independent infection 
s tudies . Asterisks  show significant differences (Mann-Whitney test) between the indicated groups (***p<0.001). 
 
3.3.4  IL-13 and IFN- production during Ls infection in IL-4R/IL-5 dKO BALB/c mice 
As mentioned above, no studies have demonstrated the implications of simultaneous IL-4R and 
IL-5 deficiencies in response to Ls infection. In the previous results sections, evidence was 
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provided that Mo-MDSCs could suppress IL-13 and IFN- production by Ls-specific CD4+ T cells. 
Furthermore, IL-4R and IL-5 were not crucial for Mo-MDSC function. It is clear that Ls-infected 
IL-4R/IL-5 dKO BALB/c mice would have negligible levels of IL-13 but since it could be that Ls-
infected IL-4R/IL-5 dKO and WT BALB/c mice display distinct ability for IFN- release, the 
possible differences in the production of IFN- in the two groups, have been evaluated in bulk 
cell and T cell assays. For confirmation of the dKO background, IL-13 release was also measured. 
 
3.3.4.1 Ls-specific IFN- release is higher in co-cultures of cells from IL-4R/IL-5 dKO 
BALB/c mice  
To compare the production of IFN-in IL-4R/IL-5 dKO BALB/c mice to that in Ls-infected WT 
BALB/c mice, single splenic and mediastinal lymph node (medLN) cells were cultured with or 
without LsAg.  
As expected, regardless of the site (spleen or medLN) IL-13 production was higher in WT BALB/c 
mice when compared to IL-4R/IL-5 dKO BALB/c mice (Figure 3.17 A and C, p<0.01 and p<0.001, 
respectively) whereas IFN- production was interestingly higher in IL-4R/IL-5 dKO BALB/c mice 
when compared to WT BALB/c mice (Figure 3.17 B and D, p<0.01 and p<0.001, respectively), 
suggesting that IL-4R and IL-5 deficiencies significantly boost IFN- production (Ritter et al., 
2017). 
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Figure 3.17: High levels of IFN-  in cell co-cultures fromIL-4R/IL-5 dKO BALB/c mice. WT and IL-4R/IL-5 dKO BALB/c mice 
were naturally infected with Ls . On day 72 p.i ., lymphocyte cultures were prepared from the spleen and medLN of individual 
mice and cul tured with or without LsAg (50 µg/ml) for 96h. Supernatants were then screened for A) and C) IL-13 and B) and 
D) IFN- by ELISA. Graphs  show mean ± SEM of (n= 20 WT mice and n= 24 dKO mice,for A) and B)) and (n= 24 WT mice and 
n= 25 dKO mice,for C) and D)) in 3 independent infection studies. Asterisks show signi ficant differences  (Mann-Whitney test) 
between the indicated groups (**p<0.01, ***p<0.001). 
 
3.3.4.2 CD4+ T cells derived from IL-4R/IL-5 dKO BALB/c mice secrete elevated levels 
of IFN- production upon re-stimulation with LsAg 
In the above section it was shown that in vitro cultures of cells from the spleen or medLN of Ls-
infected IL-4R/IL-5 dKO BALB/c mice produced strong IFN- responses. To assess the source of  
IFN-, CD4+ T cell responses were measured in response to filarial-specific (LsAg) and filarial non-
specific stimulation (CD3/28).  
Of interest, IFN- production was higher in IL-4R/IL-5 dKO upon both specific (LsAg) or non-
specific stimulation (CD3/28) when compared to WT BALB/c mice (Figure 3.18 B and E, p<0.05 
and p<0.01, respectively), indicating that CD4+ T cells might be the inducers of IFN- elevation in 
IL-4R/IL-5 dKO BALB/c mice. IL-13 data were similar to the results in the section above (Figure 
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3.16 A and D, p<0.001 and p<0.001, respectively). Since findings have described high Th17 
responses along with increased Th2 responses in patients with severe dermal pathologies during 
onchocerciasis (Katawa et al., 2015), IL-17A levels have been assessed in T cell cultures. 
Importantly, results revealed that CD4+ T cells from IL-4R/IL-5 dKO BALB/c mice, when in 
presence of GM-CSF-derived DC, were able to produce elevated amounts of IL-17A without 
stimulation or stimulated with non-specific Ag (CD3/28) (Figure 3.18 C and F, p<0.05 and 
p<0.05, respectively) although CD4+ T cells from WT BALB/c mice induced higher levels of the 
cytokine under LsAg stimulation (Ritter et al., 2017). 
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Figure 3.18: CD4+ T cells as producers of IFN-  in Ls-infected IL-4R/IL-5 dKO BALB/c mice. WT BALB/c mice and IL-4R/IL-5 
dKO mice were naturally infected with Ls . On day 72 p.i ., CD4+ T cells were isolated from Ls -infected mice by flow cytometry. 
CD4+ T cells (1x105) were cul tured with GM-CSF-derived DC (5x104) with or without LsAg (50 µg/ml) or CD3/28 (5 and 1,25 
µg/ml) for 72h. Supernatants  were then screened for A) and D) IL-13, B) and E) IFN- and C) and F) IL-17A by ELISA. Graphs 
show mean ± SEM of 4 cul ture assays using cells from 5-8 pooled mice from 2 independent infections . Asterisks show 
signi ficant differences  (Mann-Whitney test) between the indicated groups (*p<0.05, **p<0.01, ***p<0.001). 
 
Apart from the full patency, elevated worm burden and longer male worms and higher MF count 
in Ls-infected in IL-4R/IL-5 dKO when compared to WT BALB/c mice, these mice show a more 
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pronounced inflammation in the pleural lung and diaphragm when compared to WT controls.  
This occurs at the final moult when worms become adults.  With regards to the systemic 
responses, several chemokines like IP-10, MIP-1, MIP-1 MIP-2 and RANTES were significantly 
increased in infected IL-4R/IL-5 dKO mice which have been shown to be crucial for immune 
cells recruitment. In addition, it could be that such milieu with increased chemokine gradients 
supports filarial development (Ritter et al., 2017). 
 
3.4 Screening of mechanisms that may underline MDSC-mediated suppression 
during Ls infection 
In the above sections, Mo-MDSCs were shown to have suppressive activity against Ls–specific 
CD4+ T cell responses in vitro including IL-13 and IFN- production (see section 3.2). The 
suppression was demonstrated not to be dependent on whether the developed a patent state, 
that is, MF release into the periphery (section 3.2.2) and the suppressive nature of Mo-MDSCs 
was seen in both pre-patent (day 45) and patent (days 60 and 70-72) phases of infection (section 
3.2.3 and 3.2.1). In addition, lack of IL-4/IL-5 signalling had no significant effect on the 
suppression (see section 3.3). Consequently, in this section the mechanisms involved in Mo-
MDSC activity were more deeply investigated. As mentioned above, evidence has been provided 
that MDSCs function through either soluble factors (Hu et al., 2014; Sauer et al., 2001) or 
receptors (Lesokhin et al., 2012; Polz et al., 2014). This section explored different pathways that 
had the potential to be the underlying relevant mechanism(s) involved in Mo-MDSC-mediated 
suppression. 
 
3.4.1 CCR2 blockade does not impact Mo-MDSC function 
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CCR2 is a receptor present on the surface of Mo-MDSCs but not PMN-MDSCs (Huang et al., 
2007). Furthermore, some findings have suggested that this receptor influences the suppressive 
activity of Mo-MDSCs as seen models of cancers including skin cancer and in patient with 
melanoma (Gehad et al., 2012; Lesokhin et al., 2012). Accordingly, the implication of CCR2 in the 
Mo-MDSC-mediated suppression of filarial-specific CD4+ T cell responses was analysed using 
anti-CCR2 neutralizing antibody (see section 2.2.6).  
Figure 3.17 depicts the levels of cytokines that were produced by Ls-specific CD4+ T cells 
following in vitro culture with Mo-MDSC and anti-CCR2. Interestingly, Mo-MDSCs were capable 
of suppressing IL-13 (Figure 3.19 A, p<0.01) and IFN- production (Figure 3.19 B, p<0.01) by Ls-
specific CD4+ T cells, even in the presence of anti-CCR2 neutralizing antibody: suggesting that 
they function independently of CCR2. However, the production of IFN- by Ls-specific CD4+ T 
cells went significantly down in the presence of anti-CCR2 neutralizing antibody (Figure 3.19 B, 
p<0.05) which indicates that the absence of CCR2 receptor signalling hinders the production of 
IFN- following specific recall. Of note, mouse IgG1B, which is an isotype control for anti -CCR2 
antibody showed no significant changes Collectively, these data demonstrated that blockade of 
CCR2 receptor did not remove the inhibition of Ls-specific CD4+ T cell responses exerted by Mo-
MDSCs. 
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Figure 3.19: Mo-MDSC suppression of filarial-specific CD4+ T cell responses is CCR2-independent. WT BALB/c mice were 
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naturally infected with Ls . On day 71 p.i ., CD4+ T cells and Mo-MDSCs  were isolated from Ls-infected mice by flow 
cytometry. CD4+ T cells (1x105) were cultured with GM-CSF-derived DC (5x104) and LsAg (50 µg/ml) in the presence or 
absence of Ly6C
+
 MDSCs  (1x10
5
) and with or without anti-CCR2 (20 µg/ml) for 72h. Supernatants were then screened for A) 
IL-13 and B) IFN- by ELISA. Graphs  show mean ± SEM of 1 of 3 co-culture assays  using pooled cells from 5-10 mice from 3 
independent infection s tudies  showing comparable results . Asterisks  show significant differences  (Mann-Whitney test) 
between the indicated groups (*p<0.05, **p<0.01). 
 
3.4.2 Mo-MDSCs suppressive activity on filarial-specific CD4+ T cells is not cell-cell  
contact dependant  
Recently, a study indicated that the suppressive activity of MDSCs occur red when these cells 
came into contact with T cells (Crook et al., 2015). To determine whether the suppressive activity 
of Mo-MDSC function on filarial-specific CD4+  T cells required cell-cell contact, co-culture assays 
were performed using transwell inserts. In short, isolated Mo-MDSCs and CD4+ T cells from 
infected WT BALB/c mice, day 70-72 p.i., were cultured with GM-CSF-derived DC and LsAg for 
72h. In some cultures, the Mo-MDSCs were placed in the transwell insert, which is permeable to 
soluble factors but does not allow physical cell-cell contact.  
Figure 3.20 reveals that in the absence of cell-cell contact, the ability of Mo-MDSCs to suppress 
IL-13 (Figure 3.20 A, p<0.01) and IFN- production (Figure 3.20 B, p<0.01) by filarial-specific CD4+ 
T cells was maintained. This indicated that the suppression mediated by Mo-MDSCs on CD4+ T 
cells was not cell-cell contact dependent and suggested that a soluble factor might be 
responsible for that function. These data tallied with the findings that neither the IL4R- nor the 
CCR2 receptor was required for the suppression (see sections 3.3.1 and 3.4.1, respectively). 
Unexpectedly, in contrast to IFN-, the production of IL-13 by filarial-specific CD4+ T cells was 
further suppressed in the absence of cell-cell contact (Figure 3.20 A, p<0.05), pointing out that 
cell-cell contact could interfere in Mo-MDSC-mediated suppression of IL-13. Of note, 
suppression of neither IL-13 nor IFN-,was abrogated in the absence of cell-cell contact. This 
indicated that although cell-cell contact could strengthen the suppression of IL-13 production by 
filarial-specific CD4+ T cells, soluble mediators might be crucial for Mo-MDSC function.  
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Figure 3.20: Suppression of filarial-specific CD4+ T cell responses by Mo-MDSCs is not cell-cell contact dependent. WT 
BALB/c mice were naturally infected with Ls . On day 71 p.i ., CD4+ T cells and MDSCs  subsets  were isolated from Ls-infected 
mice by flow cytometry. CD4+ T cells  (1x105) were cul tured with GM-CSF-derived DC (5x104), LsAg (50 µg/ml) and Ly6C+ 
MDSCs  (1x105) for 72h. For cell-cell  contact analysis, Ly6C+ MDSCs  were placed in an insert. Supernatants  were then 
screened for A) IL-13 and B) IFN- by ELISA. Graphs  show mean ± SEM of 2 co-culture assays  using pooled cells from 5 
infected mice. Asterisks  show significant differences  (Mann-Whitney test) between the indicated groups (*p<0.05, 
**p<0.01). 
 
3.4.3 Neutralizing IL-10, IL-6 or TNF-  does not rescue IL-13 and IFN- production  
It has been reported that increases in IL-10 and IL-6 levels correlated with augmentation of Mo-
MDSC levels in patients with cancer (Arihara et al., 2013; Mao et al., 2013). Using a murine 
model of airway allergic inflammation, Zhang and colleagues also  showed that levels of total 
MDSCs correlated with high amounts of IL-10 and low levels of IL-12 in bronchoalveolar fluid 
(Zhang et al., 2013). Moreover, studies have suggested that the induction of Mo-MDSC subset 
can also occur upon TLR2/6 activation and infections with cutaneous bacteria led to elevated IL-6 
production via TLR2/6 which favoured MDSC accumulation in the skin; in turn those MDSCs 
suppressed both CD4+ and CD8+  T cell responses (Skabytska et al., 2014). Recently MDSCs were 
shown to phagocytose Mycobacterium tuberculosis in a murine model of tuberculosis (TB) and 
consequently release IL-10, IL-6 and IL-1 (Knaul et al., 2014). In addition, Hu and colleagues 
have provided evidence for the requirement of the tumor necrosis factor receptor 2 (TNFR2) for 
MDSCs suppressive activity (Hu et al., 2014). However, Polz et al., did demonstrate that TNFR2 
expression is required for the generation and function of Mo-MDSCs in vitro (Polz et al., 2014). 
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On the basis of these findings, the influence of IL-10 and IL-6 on Mo-MDSC suppressive activity 
was explored using anti-IL-10 and anti-IL-6 neutralizing antibodies (see section 2.2.6). Since 
TNFR2 has been suggested as a potential mechanism for MDSC suppression as well, this 
parameter was studied too using anti-TNF- neutralizing antibody (see section 2.2.6). 
Figure 3.21 shows that neutralizing IL-10, IL-6 or TNF- did not rescue IL-13 production by Ls-
specific CD4+ T cells, indicating that these cytokines were not relevant for Mo-MDSC suppressive 
activity (Figure 3.21 A, B and C, p<0.05, p<0.01 and p<0.001, respectively) . Similarly, IFN- 
production was not impaired in the presence of anti-IL-10, anti-IL-6 or anti-TNF- neutralizing 
antibodies (Figure 3.21 D, E and F, p<0.05, p<0.01 and p<0.01, respectively).  In addition, mouse 
IgG1, which is an isotype control for anti-IL-10, anti-IL-6 or TNF- antibodies showed no 
significant changes.  
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Figure 3.21: Mo-MDSCs suppression of filarial-specific CD4+ T cell responses does not require IL-10, IL-6 or TNF- . WT 
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BALB/c mice were naturally infected with Ls . On day 71 p.i ., CD4+ T cells and Mo-MDSCs  were isolated from Ls -infected mice 
by flow cytometry. CD4+ T cells  (1x105) were cultured with GM-CSF-derived DC (5x104) and LsAg (50 µg/ml) in the presence 
or absence of Ly6C+ MDSCs  (1x105) and with or without anti -IL-10 (2 µg/ml), IL-6 (10 µg/ml) or TNF- (0.5 µg/ml) for 72h. 
Supernatants  were then screened for A, B and C) IL-13 and D, E and F) IFN- by ELISA. Each graph shows mean ± SEM of 3 of 
7 co-culture assays  using cells  from 5-10 infected mice  from 7 independent infection s tudies . Asterisks  show significant 
di fferences (Mann-Whitney test) between the indicated groups  (*p<0.05, **p<0.01, ***p<0.001). 
 
3.4.4 TGF- blockade removes the suppression of IFN- production  
A study has indicated that there is a release of TGF-, NO, ROS and IL-10 by MDSCs, which have 
been found to be suppressive, upon transmembrane and secreted tumor necrosis factor (tm-TNF 
and s-TNF) activation (Hu et al., 2014). On this basis, the involvement of the TGF-/pathway in 
Mo-MDSC function was investigated using anti-TGF- neutralizing antibody (see section 2.2.6).  
Figure 3.22 demonstrates that the presence of anti-TGF- neutralizing antibody in the culture did 
not impair the ability of Mo-MDSCs to suppress IL-13 (Figure 3.22 A, p<0.01) but the suppression 
on IFN- production by filarial-specific CD4+ T cells, was significantly abrogated (Figure 3.22 B, 
p<0.01), inferring that this cytokine might play a partial role in Mo-MDSC suppression. 
Interestingly, the production of both IFN- and IL-13 was boosted in the presence of the 
neutralizing antibody in control wells (Figure 3.22, white bars) but the abrogation of IFN- 
production occurred only in the presence of Mo-MDSCs (Figure 3.22 B, p<0.01). Of note, MOPC-
21, which is an isotype control for anti-TGF- antibody showed no significant changes. This 
emphasized that TGF- was involved in Mo-MDSC-mediated suppression of IFN-production. 
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Figure 3.22: Mo-MDSCs suppression of IFN-  by Ls-specific CD4+ T cell is TGF-  dependent. WT BALB/c mice were naturally 
infected with Ls . On day 71 p.i ., CD4+ T cells and Mo-MDSCs  were isolated from Ls -infected mice by flow cytometry. CD4+ T 
cells (1x105) were cul tured with GM-CSF-derived DC (5x104) and LsAg (50 µg/ml) in the presence or absence of Ly6C+ MDSCs 
(1x105) and in the presence or absence of anti -TGF- (10 µg/ml) for 72h. Supernatants were then screened for A) IL-13 and 
B) IFN- by ELISA. Graphs show mean ± SEM of 1 of 3 co-culture assays  using cells  from 5-10 infected mice from 3 
independent infection s tudies. Asterisks  show significant differences  (Mann-Whitney test) between the indicated groups 
(**p<0.01). 
 
3.4.5 Nitric oxide is involved in Mo-MDSC mediated suppression of IL-13 production  
In a collagen-induced arthritis model, Crook et al. have demonstrated that Mo-MDSCs limited 
autologous B cell proliferation and antibody production in an NO and PGE 2-dependent manner 
(Crook et al., 2015). Thus, in the following experiment the requirement of NO in Mo-MDSC 
mediated suppressive activity on Ls-specific CD4+ T cell responses, was tested. Again, Mo-MDSCs 
and CD4+ T cells were isolated from infected WT BALB/c mice and cultured with GM-CSF derived 
DC and LsAg in the presence or absence of L-NMMA (Abcam, Cambridge, UK), which is an 
inhibitor of NOS (NOS being an enzyme which catalyzes NO production) (see section 2.2.6). 
Surprisingly, inhibiting NOS in the culture milieu, rescued the production of IL-13 (Figure 3.23 A) 
by Ls-specific CD4+ T cells whereas the production of IFN- remained suppressed (Figure 3.23 B, 
p<0.01) and NO levels were higher in the wells with positive control when compared to those 
with Mo-MDSCs (Figure 3.23 C, p<0.01). Of note, sterile PBS was used as isotype control for the 
NOS inhibitor and showed no significant changes. These data suggested that NO is a mediator of 
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Mo-MDSC-mediated suppression on IL-13 production and shows that there are two potential 
pathways in which MDSCs suppress filarial specific responses. 
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Figure 3.23: Differential  role of nitric oxide (NO) in Mo-MDSCs mediated suppression. WT BALB/c mice were naturally 
infected with Ls . On day 71 p.i ., CD4+ T cells and Mo-MDSCs  were isolated from Ls -infected mice by flow cytometry. CD4+ T 
cells (1x105) were cul tured with GM-CSF-derived DC (5x104) and LsAg (50 µg/ml) in the presence or absence of Ly6C+ MDSCs 
(1x105) and with or whithout L-NMMA (5 mM) for 72h. Supernatants  were then screened for A) IL-13 and B) IFN- by ELISA 
or C) ni tri te oxide by Griess  reaction. Graphs show mean ± SEM of 1 of 3 co-culture assays using cells from 5-10 infected 
mice from 3 independent infection s tudies . Asterisks  show signi ficant differences (Mann-Whitney test) between the 
indicated groups (*p<0.05, **p<0.01, ***p<0.001). 
 
3.5 Gene profilling of MDSC subsets arising during Ls infection: innate and adaptive 
immune responses 
In order to perform an in-depth analysis of MDSC subsets, Mo-MDSCs and PMN-MDSCs were 
isolated and sorted from the TC of infected WT BALB/c mice on day 71 p.i . and naive mice 
(standing for controls). Their extracted RNAs served to assess the profile of innate and adaptive 
genes using the RT2 profiler PCR array mouse Innate & Adaptive Immune Responses kit (Qiagen, 
Gielgen).  
An overview of the genes that were down- or up-regulated in Mo-MDSCs and PMN-MDSCs 
isolated from Ls-infected WT BALB/c mice when compared to those from naive mice, is depicted 
in Tables 3.1, 3.2, 3.3 and 3.4, respectively. Surprisingly, data from the PCR array showed that 
both Mo-MDSCs and PMN-MDSCs isolated from infected mice displayed an up-regulation of  
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FOXP3 (Forkhead box P3), a transcription factor for regulatory T cells (Tregs) that is actively 
involved in their regulatory pathway (Tables 3.3 and 3.4). However, a down-regulation of genes 
including C3 (Complement component 3), CCR6 (Chemokine (C-C motif) receptor 6) and IL-18 
(Interleukin 18) was observed in the two subsets (Tables 3.1 and 3.2). The three latter genes play 
a major role in complement activation, migration and recruitment of effector cells and cell-
mediated immunity, respectively; during inflammatory responses. In addition, the array 
demonstrated that the two subsets from infected mice up-regulated the gene NFKB1 (Nuclear 
factor of kappa light polypeptide gene enhancer in B-cells 1, p105), of which the product NF-kB, 
stimulates the expression of a range of genes involved in biological functions. This globally 
indicated that the two subsets seem to share high regulatory and rather low inflammatory 
properties.  
When considering the Mo-MDSC population, the array further showed that MYD88, the central 
adaptor protein used by most TLRs (Toll-like receptors) to activate NF-kB was highly expressed in 
Mo-MDSCs isolated from infected mice when compared to the naive control (p=0.005016) (see 
Table 3.3). Substantiating this, was the positive fold-change observed in TLR8 (p=0.015218) and 
together with the up-regulation of NFKB1, indicated that NF-kB might play a role in Mo-MDSC 
suppressive activity. Interestingly, the genes for the cytokines IFN- and IL-13 were also up-
regulated in Mo-MDSCs isolated from Ls-infected WT BALB/c mice when compared to those  
from naive controls (p=0.002364 and 0.027058, respectively) (Table 3.3), suggesting the ability of 
the cells to release such cytokines. Other genes that were up-regulated in Mo-MDSCs included 
FasL (Fas ligand, p= 0.000814), LY96 (Lymphocyte antigen 96, also known as MD2, a protein 
which is associated with TLR4 and induces responsiveness to LPS, p= 0.03942), Mpo 
(Myeloperoxidase, p= 0.017737) and TBX21 (T box 21, p= 0.012174) (Table 3.3). Such genes are  
primarily involved in innate responses against cancer, bacteria and other microorganisms and 
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their up-regulation illustrates that Mo-MDSCs, in this setting, could qualify for an innate immune 
group of cells. On the other hand these data were unexpected since it is well established that 
MDSC subsets inhibit anti-cancer immunity. 
In contrast, IRF3 and 7 (Interferon regulatory factor 3 and 7), genes involved in immunity against 
viral infection were down-regulated (p=0.000229 and 0.004402, respectively), implying that 
there may be an impaired ability of these infection-derived Mo-MDSCs to counteract viruses. 
Data from the PCR array further indicated that Mo-MDSCs possessed no capacity for antigen 
presentation to Tcells, as shown by the negative fold-change of H2-T23 gene 
(Histocompatibility 2, T region locus 23, p=0.000019). In line with the down-regulation of IL-18 in 
both MDSC subsets, Mo-MDSCs showed additionally a negative fold-change in the expression of 
IL-1, a cytokine that can be released upon inflammasome activation (p=0.014621). NOD1 
(Nucleotide-binding oligomerization domain containing 1, a receptor involved in the secretion of 
IL-1, a major pro-inflammatory cytokine following inflammasome activation) was also down-
regulated as revealed by the array (p=0.045602), ruling out the implication of the 
inflammasomes in Mo-MDSC suppressive activity. In fact, frequencies of MDSC populations  in 
the TC of Ls-infected ASC-deficient mice (a central adaptor molecule in the inflammasome 
pathway) and WT BALB/c mice on days 10 and 72 p.i. indicated that the lack of ASC did not 
impair the two MDSC subsets although  PMN-MDSC levels were found to be increased in ASC-
deficient mice on day 10 (Figure 3.24). Surprisingly, MAPK1 (Mitogen-activated protein kinase 1) 
was also down-regulated (p=0.000283), although CXCR3 (Chemokine (C-X-C motif) receptor 3) 
which when bound by its ligands activates MAPK1, was up-regulated (p=0.005499). More 
intriguing was the opposite regulation observed in IFNGR1 (Interferon gamma receptor 1)  
(down-regulated, p=0.002929) and IFN- (up-regulated, p=0.002364), contrasting with the 
results of in vitro assays (see Figure 3.7). Further down-regulated genes included ITGAM (Integrin 
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alpha M, p=0.000007), CCR5 (Chemokine (C-C motif) receptor 5, p=0.015038), TRAF6 (Tnf  
receptor-associated factor 6, p=0.000131) and RORC (RAR-related orphan receptor gamma, 
p=0.00539) (Table 3.1).  
With regards to the genes regulated in the PMN-MDSC subset alone, the PCR array data showed 
a down-regulation of NFKBIA (polypeptide gene enhancer in B-cells inhibitor, alpha; p=0) which 
supports the up-regulation of NFKB1 (p=0.01314) and the gene responsible for NLRP3 (NOD-like 
receptor family, pyrin domain containing 3) inflammasome was also down-regulated (p= 
0.006923) (Table 3.2). The up-regulated genes comprised of CD86 (p=0.014497), CXCL10 
(p=0.024228), IFNAR1 (p=0.040521), NOD2 (p=0.01544) and STAT3 (p=0.009197) (Table 3.4). 
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Table 3.1: Down-regulated genes in Mo-MDSCs 
Gene  Description  p-value 
C3 Complement component 3 0 
CCR5 Chemokine (C-C motif) receptor 5 0.015038 
CCR6 Chemokine (C-C motif) receptor 6 0.00881 
H2-T23 Histocompatibility 2, T region locus 23 0.000019 
IFNGR1 Interferon gamma receptor 1 0.002929 
IL18 Interleukin 18 0.041412 
IL-1 Interleukin 1 alpha 0.014621 
IRF3 Interferon regulatory factor 3 0.000229 
IRF7 Interferon regulatory factor 7 0.004402 
ITGAM Integrin alpha M 0.000007 
MAPK1 Mitogen-activated protein kinase 1 0.000283 
NOD1 Nucleotide-binding oligomerization domain containing 1 0.045602 
RORC RAR-related orphan receptor gamma 0.00539 
TRAF6 TNF receptor-associated factor 6 0.000131 
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Table 3.2: Down-regulated genes in PMN-MDSCs 
Gene  Description  p-value 
C3 Complement component 3 0 
CCR6 Chemokine (C-C motif) receptor 6 0.022937 
IL-18 Interleukin 18 0.020914 
NFKBIA polypeptide gene enhancer in B-cells inhibitor, alpha 0 
NLRP3 NLR family, pyrin domain containing 3 0.006923 
 
Table 3.3: Up-regulated genes in Mo-MDSCs 
Gene  Description  p-value 
CXCR3 Chemokine (C-X-C motif) receptor 3 0.005499 
FasL Fas ligand (TNF superfamily, member 6) 0.000814 
FOXP3 Forkhead box P3 0.00323 
IFN- Interferon gamma 0.002364 
IL-13 Interleukin 13  0.027058 
LY96 Lymphocyte antigen 96 0.03942 
MPO Myeloperoxidase 0.017737 
MYD88 Myeloid differentiation primary response gene 88 0.005016 
NFKB1 Nuclear factor of  kappa light polypeptide gene enhancer in B-cells 1, p105 0.045602 
TBX21 T-box 21 0.012174 
TLR8 Toll-like receptor 8 0.015218 
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Table 3.4: Up-regulated genes in PMN-MDSCs 
Gene  Description  p-value 
CD86 CD86 antigen 0.014497 
CXCL10 Chemokine (C-X-C motif) ligand 10 0.024228 
FOXP3 Forkhead box P3 0.003258 
IFNAR1 Interferon (alpha and beta) receptor 1 0.040521 
NFKB1 Nuclear factor of  kappa light polypeptide gene enhancer in B-cells 1, p105 0.01314 
NOD2 Oligomerization domain containing 2 0.01544 
STAT3 Signal transducer and activator of transcription 3 0.009197 
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Figure 3.24: Higher frequencies of PMN-MDSCs in Ls-infected ASC-deficient mice at an early time point. WT and ASC-/- 
BALB/c mice were naturally infected with Ls  for 10 and 72 days . Thereafter, cells were isolated from the thoracic cavi ty and 
s tained with a  combination of CD45, CD11b, Ly6C and Ly6G antibodies  to di fferentiate monocytic (CD11b+Ly6C+Ly6G-, Mo-
MDSCs  or Ly6C) and polymornuclear (CD11b
+
Ly6C
int/lo
Ly6G
+
, PMN-MDSCs  or Ly6G) MDSC populations. A) Mo-MDSC and B) 
PMN-MDSC subsets within the CD11b+ cell compartment of infected mice. Day 10 WT n= 10 and ASC-/- n=14; day 72 WT 
n=6 and ASC-/- n=5. Graphs  show mean ± SEM from one infection study per time point. Asterisks  indicate significant 
di fferences (Mann-Whitney test) between the groups  indicated by the brackets (***p<0.001). 
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4. DISCUSSION 
67.88 million people are infected with LF in countries including sub-saharan african, south-east 
asian and south american countries (Ramaiah and Ottesen, 2014). Three species of filarial 
nematode parasites known as W. bancrofti, B. malayi and B. timori cause the disease with W. 
bancrofti being responsible for 90% of cases (WHO, 2015). In endemic areas for LF, populations 
are classified as endemic normal, asymptomatic which are either patent (MF+) or latent (MF-) 
and symptomatic individuals which present swelling of the limbs or hydrocele. Since MF+ 
subjects pose the higher risk of transmitting the infection, they should be given special attention 
in order to control the spread of the disease (Arndts et al., 2012). In infected patients, only 50% 
will become patent and this is well represented in the laboratory BALB/c mouse strain when 
naturally infected with Ls; which is then used as a murine model to study filarial infections 
(Graham et al., 2005; Hoffmann et al., 2001; Le Goff L et al., 2002; Petit et al ., 1992; Rodrigo et 
al., 2016). Ls infection has been shown to induce regulatory cell populations including Tregs, IL-
10 producing cells and AAMs (Ajendra et al., 2014) (see section 1.2). Recently, another 
regulatory cell population termed MDSCs have been described. MDSCs are immature myeloid 
cells and are precursors of dentritic cells (DC), macrophages and/or granulocytes and it is now 
well accepted that they encompass two subsets: monocytic MDSCs (Mo-MDSCs) and 
granulocytic or polymorphonuclear MDSCs (PMN-MDSCs). These subsets function through 
different mechanisms: whilst Mo-MDSCs function via nitric oxide (NO), PNM-MDSCs react 
through ROS (reactive oxygen species) and Arg-1. In human or murine models of disease, MDSCs 
have been shown to have a role in cancer, bacterial and parasitic infections, acute and chronic 
inflammation and other pathological conditions including AIDS as reviewed in Tamadaho et al 
(Tamadaho et al., 2018) (see section 1.3). Data described here show that MDSCs are induced and 
expand at the site of infection during Ls infection and displayed distinct functional activities 
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according to their subsets. Interestingly, in contrast to PMN-MDSCs, Mo-MDSCs had the ability 
to suppress IFN- and IL-13 production by Ls-specific CD4+T cells through the release of TGF- 
and NO, as the blockade of these two components prevented IFN- and IL-13 respectively. 
However, both subsets significantly up-regulated regulatory genes while the expression of pro-
inflammatory genes was at very low levels. 
 
4.1 Identification of MDSC subsets during Ls infection  
MDSCs present phenotypic and functional features that discriminate them from mature innate 
cells including DC, macrophages and granulocytes as reviewed by Bronte et al (Bronte et al., 
1999). They can be distinguish as CD11b+Ly6ChiLy6G- for Mo-MDSCs and CD11b+Ly6Clo/intLy6G+  
for PMN-MDSCs. Studies have reported the role of MDSCs in malignancies, infectious and other 
pathological conditions (Knaul et al., 2014; Pan et al., 2013; Voisin et al., 2004)  but their role in 
helminth infections remains unclear. Thus, using the laboratory BALB/c mouse strain, which 
allows the complete Ls life-cycle, MDSC subsets at the site of infection were investigated during 
Ls infection by flow cytometry. Data revealed that in the absence of infection, very few MDSCs 
were within the TC fluid whereas large numbers of the cells were identified after infection. 
Furthermore, there was a significantly high number of PMN-MDSCs when compared to Mo-
MDSCs in the period of time where MF release reached its peak: days 70-72 p.i. These data 
confirmed results from Youn et al., which have demonstrated that in contrast to Mo-MDSCs 
which accumulated at lower levels, PMN-MDSCs have been seen to exponentially accumulate in 
tumor models (Youn et al., 2008). However, other studies from the same authors have claimed 
for a possible switch of Mo-MDSCs into PMN-MDSCs through Rb1 (Youn et al., 2013). It is 
unlikely that this same scenario applies in this study as tracking MDSC populations throughout 
the course the infection showed no indication of significant increases in Mo-MDSCs whereas 
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PMN-MDSC levels dramatically increased after moulting into adult worms, at approximately day 
30. 
In cancer, MDSC frequencies have been associated with both the state and progression of 
pathology (Almand et al., 2000; Arihara et al., 2013) and the presence of these cells has become 
a sign for mortality (Gabitass et al., 2011). Here, MDSC infiltration positively correlated with 
worm burden (strongly) as well as with MF counts in the TC fluid (at least weakly) but not at a 
systemic level. On the one hand, these data suggest that the worms offer a favourable ground 
for MDSC infiltration or vice versa, promoting chronic infection. This is in line with recent 
findings which demonstrated that after adoptive transfer of MDSCs, there was a persistent 
chronic phase of infection with the nematode Heligmosomoides polygyrus bakeri,  
(Valanparambil et al., 2017). On the other hand, since the release of MF has been reported to be 
indispensible for transmission (Arndts et al., 2012), the irrelevance of systemic MF for MDSC 
infiltration might indicate that these cells only act during ongoing infections and do not 
guarantee further infection. However more in depth analysis are need to support this 
hypothesis. 
 
4.2 Mo-MDSCs suppress filarial-specific CD4+ T cell responses 
The hallmark of MDSCs is their suppressive ability on T cell responses and within the context of 
this thesis, a co-culture assay was designed in order to evaluate MDSC function on CD4+ T cell 
responses during Ls infection; as studies have provided evidence that those cells play a critical 
role during the inflammation (Al-Qaoud et al., 1997). Here, data revealed for the first time that 
upon re-stimulation of CD4+ T cells from infected mice with LsAg, the presence of Mo-MDSCs but 
not PMN-MDSCs from infected mice was sufficient to impair the release of IL-2, IFN-, and IL-13 
but not IL-5 and suppression was not dependent on patency. In line with this, Cui et al., using 
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flow cytometry, demonstrated the suppression of IL-2 and IFN-production by CD4+ T cells and 
also that of granzyme B production by CD8+ T cells in ovarian cancer patients (Cui et al., 2013). In 
addition, Ren and colleagues described an increase of IFN- production by CD4+ T cells after 
MDSC depletion from PBMCs of HCV patients, suggesting a suppressive function of MDSCs 
although the effect of Mo-MDSCs was not specifically ascertained (Ren et al., 2016). In contrast,  
data from primary glioblastoma patients have found that Mo-MDSCs were not able to suppress T 
cell responses, confining the suppressive function in that scenario to neutrophilic MDSCs. 
Indeed, these authors have observed diverse MDSC subsets including monocytic, granulocytic,  
neutrophilic, eosinophilic and immature MDSCs and have reported a slight inhibition of T cell 
responses by eosinophilic MDSCs (Dubinski et al., 2016).  
In regards to murine settings, Zhu and colleagues have found that in a murine model of hepatitis, 
SSChighCD11bhighLy-6ChighLy-6GlowMDSCs, corresponding to Mo-MDSCs, were the only subsets 
capable of suppressing CD4+ T cell responses (and weakly CD8+ T cells), while the other MDSC-
like (likely PMN-MDSCs) compartment was not capable of doing so (Zhu et al., 2014). Recently, 
isolated CD11c-CD11b+Gr1+ cells from mice infected with Heligmosomoides polygyrus bakeri 
infection suppressed OVA-specific CD4+ T cell proliferation (Valanparambil et al., 2017). Although 
these findings were partially in accordance with the suppression observed in this study, they did 
not differentiate between Mo-MDSCs and PMN-MDSCs and did not inform on the role of MDSCs 
on helminth-specific responses. Elsewhere, studies in C57BL/6 mice have noted the inhibition of 
not only T cell responses but also that of B cell responses by Mo-MDSCs in murine LP-BM5 
retroviral infection (Green et al., 2013; Rastad and Green, 2016). However, such investigations 
do not explain the non-suppressive ability of PMN-MDSCs observed here. This study revealed 
that the MDSC-mediated suppressive function was not associated with cell accumulation, as 
PMN-MDSC numbers in the TC were higher when compared to Mo-MDSCs. Considering the fact 
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that, these results were observed in an in vitro co-culture, in those scenarios, a compenent 
(cytokine/chemokine/cell type) may be missing that aids the suppression of CD4+ T cell 
responses by PMN-MDSCs. Also, it is possible that the parameter being suppressed by these cells 
were not measured. Future investigations could look at the effect of the lack of PMN -MDSCs on 
patency or filarial development or whether there are able to suppress other cells such as CD8+ T 
cells or B cells during infection. Previously, the suppressive activity of both PMN and Mo-MDSCs 
was claimed to be comparable in various models of tumor-bearing mice (Youn et al., 2008). In 
contrast, Raber and colleagues indicated that PMN-MDSCs were better at impairing proliferation 
and expression of effector molecules in activated T cells when compared to Mo-MDSCs at the 
tumor site of several tumor models including lung carcinoma and melanoma (Raber et al., 2014). 
It could be that a different scenario occurs at systemic level. In this study, only Mo-MDSCs were 
isolated from the site of infection whereas CD4+ T cells were from the spleen of infected mice. 
Further studies could investigate the impact Mo-MDSCs on CD4+ T cells, coming both from the 
same site; either from the TC, blood or other tissues. 
 
4.3 Impact of Ls infection on IL-4R/IL-5 dKO BALB/c mice  
Firstly, highly increased numbers of MF and adult worms and 100% patency were observed in Ls-
infected IL-4R/IL-5 dKO BALB/c mice on days 70-72 p.i., when compared to wildtype controls. 
This confirms data of previous studies that provided evidence for elevated MF release in the 
absence of IL-4 and IL-5 secretion in murine filariasis (Le Goff L et al., 2002; Volkmann et al., 
2003; Volkmann et al., 2001). In addition, IL-4 has been reported to retain MF development in 
Brugia pahangi infected mice (Devaney et al., 2002). Interestingly, these findings suggested no 
conflicting role of IL-13 on parasite development as the authors found that both WT and the IL-4-
deficent mice groups had comparable levels of IL-13. Data described here showed that, while an 
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increase was observed in the numbers of both male and female worms in Ls-infected IL-4R/IL-5 
dKO BALB/c mice, an increase in length was observed only in male worms, arguing for a possible 
relevance of Th2 cytokines on worm gender. Interestingly, while no immune-competent 
laboratory mouse strain has been found to be permissive for human Loa loa infection, 
Tendongfor and colleagues have noted higher survival of Loa loa worms in IL-4R/IL-5 dKO BALB/c 
mice (Tendongfor et al., 2012), suggesting that IL-4/IL-5 signalling is also critical for controlling 
the development other filarial parasites. 
Secondly, co-culture experiments revealed that spleen and mLN from Ls-infected IL-4R/IL-5 
dKO BALB/c mice produced elevated levels of IFN- following re-stimulation with LsAg. 
Correspondingly, higher levels of this cytokine were measured in cell-culture supernatants of Ls-
specific CD4+ T cells from these mice when compared to WT clearly suggesting that those cells 
are a source of IFN-. As expected, IL-13 levels were lower in Ls-infected IL-4R/IL-5 dKO BALB/c 
mice when compared to that of WT mice. This implied a dramatic polarization towards Th1 
responses in these deficient mice. In 2012, findings from Ziewer and colleagues described the 
induction of IFN- in BALB/c mice after immunization with Alum-MF which led to decreased 
microfilaraemia (Ziewer et al., 2012). It will be interesting to investigate the effects of such 
immunization in IL-4R/IL-5 dKO BALB/c mice. Of note, IFN- induction in Ls-infected IL-4R/IL-5 
dKO BALB/c mice was accompanied by elevated IL-17A levels and accentuated pathology at the 
site of infection (Ritter et al., 2017). In a recent study on onchocerciasis it was reported that 
patients with severe dermal pathologies presented elevated Th2 (IL-4) and Th17 responses 
(Katawa et al., 2015).  
Thirdly, increased numbers of Mo-MDSCs were found in Ls-infected IL-4R/IL-5 dKO BALB/c mice 
when compared to WT controls whereas the proportion of PMN remained unchanged within the 
two groups. As mentioned above, the Mo-MDSCs, that were shown to be suppressive, remained 
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at a constant steady state throughout infection whereas numbers of PMN-MDSCs continued to 
increase in Ls-infected WT BALB/c mice (see section 3.1.3). The data here clearly shows that the  
lack of IL-4/IL-5 signalling seems to facilitate Mo-MDSCs in Ls-infected IL-4R/IL-5 dKO BALB/c 
mice on days 70-72 p.i. However, the kinetics of the two MDSCs subsets was not traced during 
the course of infection in those mice and therefore future research could compare the influence 
of the simultaneous lack of IL-4R and IL-5 on MDSC expansion during infection. Furthermore, 
the suppressive function of Mo-MDSCs was not impaired in IL-4R/IL-5 dKO BALB/c mice 
contrasting with studies from Mandruzzato and colleagues who have suggested that the 
presence of IL-4R is only associated with the suppressive activity of Mo-MDSCs in melanoma 
and colon carcinomas (Mandruzzato et al., 2009). In line with the findings of this study, are data 
which used IL-4RKO mice and indicated that IL-4R is not indispensible for MDSC function 
(Sinha et al., 2012) and in this study,  Mo-MDSCs did not suppress IL-5 production by Ls-specific 
CD4+ T cells from WT mice. Further investigations using single IL-5 KO and IL-4R could help to 
rule out clearly the relevance of such pathways in the observed Mo-MDSC suppressive activity. 
 
4.4 Mo-MDSCs function through receptor-independent pathway 
In the recent years, authors have provided evidence for diverse mechanisms used by MDSCs for 
their suppressive activities. These include receptor- (CCR2, TNFR2, IL-4R), or soluble factor-
based pathways (mostly NO and ROS) as reviewed by Nagaraj et al. (Nagaraj et al., 2013). 
Previously, patients with cancer have been reported to exhibit high levels of IL-4R+ MDSCs with 
suppressive abilities (Movahedi et al., 2008). Here, as already discussed in the precedent section, 
the lack of this receptor induced an environment that allowed a higher number of Mo-MDSCs at 
the site of infection (see section 3.3.2). In fact, co-cultures of Mo-MDSCs isolated from Ls-
infected IL-4R/IL-5 dKO BALB/c mice could suppress IL-13 and IFN- production by Ls-specific 
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CD4+  T cells even further (although not significantly). This confirmed data from Sinha and 
colleagues who described a maintained suppressive function of MDSCs after using MDSCs 
derived from IL-4R KO mice in several model of tumors. The impact of PMN-MDSCs could be 
excluded since the authors have performed assays using separately Mo-MDSCs and PMN-MDSCs 
similar to the isolation procedure performed in these studies. 
Recently, studies in obese mice with renal tumors have highlighted the implication of the 
CCL2/CCR2 pathway in the development of an immunosuppressive environment through MDSCs 
(Hale et al., 2015). CCR2 played a role in specifically facilitating the recruitment of mature 
monocyte/macrophages as well as MDSCs to areas of inflammation and injury (Charo and 
Ransohoff, 2006; Gehad et al., 2012; Lesokhin et al., 2012) . In an attempt to evaluate the role of 
CCR2in MDSC function during Ls-infection, anti-CCR2 neutralizing Ab was used in the 
aforementioned co-culture assays (see section 3.4.1) and showed that Mo-MDSCs kept their 
suppressive ability even during CCR2 blockade: conferring no significance to the chemokine 
receptor in the setting of this thesis. In contrast to that and using MDSCs generated from CCR2-/- 
C57BL/6 mice, Qin and colleagues showed that these cells failed to migrate to islet allografts and 
to suppress CD8+ T cells under in vivo conditions which resulted in enhanced Tregs activity. 
However, they were able to exert in vitro  inhibition (Qin et al., 2016). Since CCR2 is mainly 
involved in the migration of cells, which occurs during the course of infection, it is possible that 
the anti-CCR2 neutralizing Ab as used in this study, was not able to block the activity of the 
receptor in vitro and perhaps that Mo-MDSCs require CCR2 to influence only CD8+ T cell but not 
CD4+ T cell responses. These reasons could explain the conflicting results observed here and also 
the fact that these authors used generated MDSCs. In addition, data from Schmid et al, indicated 
that the CCR2 receptor was impaired in Mo-MDSCs derived from Leishmania major infected 
BALB/c when compared to those from C57BL/6 mice (Schmid et al., 2014), suggesting that the 
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presence and thus the activity of this receptor in mice may be strain-dependent. Therefore to 
clarify the role that CCR2 plays in MDSC function during Ls infection, more experiments are 
needed using CCR2-/- BALB/c mice and especially, using MDSCs that lack the receptor. In 
addition, it will be interesting to investigate whether MDSC act synergistically with Tregs to 
control Ls-stemmed inflammation since research related to this thesis reported an expansion of 
Tregs throughout Ls-infection in BALB/c mice (Rodrigo et al., 2016).  
In 2016, studies demonstrated that MDSCs promoted the expansion of IgA-producing B cells in a 
contact-dependent manner and MDSC function was abrogated in TNFR2 KO mice (Xu et al., 
2016). These findings are in line with other researches that have demonstrated the role of TNFR2 
in MDSC generation and suppressive activities (Hu et al., 2014; Polz et al., 2014). Results 
generated here, using anti-TNF- neutralizing Ab due to the lack of acces to genetically deficient 
TNFR2 BALB/c KO mice, informed on the non-relevance of such cytokine for Mo-MDSC function. 
This contrasts with the recent observations reported by Atretkhany and colleagues who used 
TNF humanized (hTNF KI) mice, to show that blockade of TNF activity ameliorated fibroblastic 
sarcoma growth and led to a decreased MDSC accumulation (Atretkhany et al., 2016). However, 
more in depth analysis are required before such findings can be generalized to the Ls infection 
system. Nonetheless, cell-contact pathways could be clearly excluded as the main functional 
mechanism for Mo-MDSC suppressive activity since Mo-MDSCs were able to suppress IL-13 
(here even better) and IFN- production by Ls-specific CD4+ T cells in transwell assays (section 
3.4.2). This contradicts earlier data which explained that Mo-MDSCs inhibit CD4+ T and B cell 
proliferation and antibody production by B cells in a cell-contact dependent manner in the CIA 
model of autoimmune disease (Crook et al., 2015) suggesting that these cells may employ a 
different mechanism in non-pathogenic scenarios.  
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4.5 Soluble factors control Mo-MDSC function during Ls infection 
Under pathological conditions, studies have suggested an association between MDSC 
accumulation and IL-6 in both mouse and human settings (Knaul et al., 2014; Mao et al., 2013; 
Skabytska et al., 2014). Recently, Peng and colleagues proposed a cross-talk between the release 
of IL-6 from MDSCs. This release phophorylates STAT3 and activates Notch in an NO-dependent 
manner to prolong STAT3 activation (Peng et al., 2016). However, their suggested pathway was 
deciphered using total MDSCs and evidence has been provided that Mo-MDSCs and PMN-MDSCs 
require STAT1 and STAT3, respectively (Albeituni et al., 2013). Their argument, might on the one 
hand, be partially supported by the fact that the suppressive function of Mo-MDSCs can be 
abrogated in the presence of a NOS inhibitor. On the other hand; it contrasts data presented in 
the current setting since here, there was no requirement of IL-6 for Mo-MDSC function during Ls 
infection. Paradoxically, others have illustrated that in the presence of mesemchymal stem cells 
(MSCs) from chronic myeloid leukemia (CML), the generation of G-MDSCs (likely PMN-MDSCs)  
has been induced which was associated with a high expression of TGF-β, IL-6 and IL-10. 
Moreover, they recorded higher expression levels of TNF-α, IL-1β, COX2 and IL-6 in these CML-
MSCs derived G-MDSCs when compared to those stemming from healthy donors (HD)-MSCs 
(Giallongo et al., 2016). Although this did not match the setting used in the described Ls infection 
studies, due to differences in the subset of MDSCs: here, the function of Mo-MDSCs but not 
PMN-MDSCs was assessed, it nevertheless indicated probable factors implicated in MDSC 
function. 
Co-culture experiments with anti-IL-10 neutralizing Ab also revealed that Mo-MDSCs did not 
require this cytokine for their functional activity, neither for the suppression of IFN - production 
nor that of IL-13. These observations differ from those noted in a murine model of airway 
allergic inflammation or individuals with hepatocellular carcinoma (Arihara et al., 2013; Zhang et 
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al., 2013). Likewise, evidence has been provided that MDSCs synthesize IL-10 in response to 
biofilm-associated S. aureus where they lead to the persistence of the bacterial infection (Heim 
et al., 2015). Findings in Ls infection with C57BL/6 mice have shown that the suppression of the 
onset of Ag-specific cellular responses requires T cell-derived IL-10 (Haben et al., 2013) but other 
reports have pointed out a hyporesponsiveness of CD4+ T cells occurring in Ls infection with 
BALB/c mice in an IL-10 independent manner (Taylor et al., 2006; Taylor et al., 2005). However 
the role of IL-10 for Ls infection-derived Mo-MDSCs remains unclear.  
Another immunomodulatory molecule relevant in filarial infections is TGF- and studies using 
cells from LF infected patients have demonstrated the rescue of IFN- production in the 
presence of anti-TGF- blocking Ab in vitro. In addition, elevated levels of TGF-producing CD4+  
T cells have been shown in Ls-infected mice upon induction of airway disease in a murine model 
of asthma, which participated in the amelioration of airway reactivity and dramatically 
decreased after administration of anti-TGF-blocking Ab (Babu et al., 2006). Here, results 
revealed a role of TGF- in the suppression of IFN- production by Ls-specific CD4+  T cells by 
infection-derived Mo-MDSCs. These results build on findings in a murine model of AIDS that 
have illustrated a crucial role for iNOS, ROS or cysteine in Mo-MDSC suppressive activity and 
more importantly, have shown TGF- to enable the induction of such function in these cells 
against B cell responses (Rastad and Green, 2016). Conversely, a new report has demonstrated a 
direct relationship between Tregs and MDSC differentiation and function in a murine model of 
colitis (Lee et al., 2016). Indeed, these investigations have shown that TGF-, induced by Tregs, 
polarizes MDSCs towards Mo-MDSC differentiation with strong inhibitory effects. Based on the 
results of this thesis, it might seem obvious that Mo-MDSCs employed TGF- to suppress IFN-
production by Ls-specific CD4+  T cells. 
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In the presence of L-NMMA, which is an inhibitor of NOS, Mo-MDSCs failed to suppress IL-13 
production by Ls-specific CD4+ T cells whereas IFN- suppression remained intact. In support of 
this, investigations using a murine model of hepatitis described the involvement of NO in the 
suppressive function of Mo-MDSCs. However, in contrast to the studies described here it was  
shown to be a cell-contact dependent mechanism and there were elevated expression levels of 
CCR2 on the cells (Zhu et al., 2014). In addition, isolated CD11c-CD11b+Gr1+ cells have been 
found to suppress OVA-specific CD4+ T cell proliferation in infection caused by Heligmosomoides 
polygyrus bakeri. This suppression occurred in an NO-dependent manner and nematode specific 
IL-4 production in vitro (Valanparambil et al., 2017). With regards to filariasis, previous studies 
have demonstrated an IFN--dependent induction of NO which impaired the in vitro proliferation 
of Ag-specific splenocytes and CD4+ T cells in a Brugia pahangi model upon MF infection. These 
findings suggested parasite stage-based responses as infection with L3-stage larvae led to 
different responses (O'Connor and Devaney, 2002; O'Connor et al., 2000). This suggests the 
requirement of IFN- for Mo-MDSC suppression of IL-13 and might explain the failure of the 
suppression of IFN- production by Ls-specific CD4+ T cells in the presence of NOS inhibitor. 
Therefore, in further co-culture experiments, it will be interesting to examine the scenario during 
in vitro IFN- blockade. Furthermore, in vivo MF clearance in an Ls model, which is a completely 
different scenario than a chronic setting, has been shown to use a NO-independent mechanism 
(Hoffmann et al., 2001; Pfaff et al., 2000). Similar results have been found using in vivo assays 
with B. malayi infection (Gray and Lawrence, 2002), setting out seemingly possible conflicting 
data for in vivo function of Mo-MDSCs during Ls infection. 
 
4.6 Profile of gene regulation in MDSC subsets during Ls infection 
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This section discusses, the observations related to the gene expression profiles observed in 
MDSC populations during Ls infection. Interestingly, when compared to Mo-MDSCs isolated from 
naive mice, Mo-MDSCs from Ls-infected mice showed significantly, a) up-regulation of the genes: 
CXCR3, FasL, FOXP3, IFN-, IL13, LY96, MPO, MYD88, NFKB1, TBX21 and TLR8 and b) down-
regulation of: C3, CCR5, CCR6, H2-T23, IFNGR1, IL-1, IL-18, IRF3, IRF7, ITGAM, MAPK1, NOD1, 
RORC and TRAF6. With regards to PMN-MDSCs, comparison between cells isolated from naive 
versus Ls-infected showed a) up-regulation of the genes: CD86, CXCL10, FOXP3, IFNAR1, NFKB1, 
NOD2 and STAT3 and b) the down-regulation of genes including: C3, CCR6, IL18, NFKBIA and 
NLPR3. 
 
4.6.1 The regulation of genes responsible for soluble factors in Mo-MDSC function 
The pro-inflammatory activity of inflammasomes induces IL-1 and IL-1 secretion and the 
release of IL-1 is both NLRP3-dependent and NLRP3-independent (Gross et al., 2012; Ritter et 
al., 2010; Yazdi and Drexler, 2013). For instance, the NLRP3-dependent release of IL-1 has been 
shown to be activated upon exposure to nanoparticles (Yazdi et al., 2010). Using deficient-mice, 
IL-1 has been found to participate in the control of Candida albicans infection (Vonk et al., 
2006) and also to be relevant in diabetes (Kamari et al., 2011). Here, results provided evidence 
that the gene responsible for IL-1 expression is shut down in Mo-MDSCs during Ls infection and 
the presence of Mo-MDSCs in co-culture assays did not affect IL-1 production (data not shown), 
suggesting that Mo-MDSC function might not be influenced by IL-1 cytokines. In agreement with 
these findings, studies in patients with Cryopyrin-associated periodic syndromes under anti-IL-1 
therapy have noted elevated MDSC numbers that displayed suppressive activity (Ballbach et al., 
2016). This indicated the non-requirement of IL-1 for MDSC function in such settings. In contrast, 
MDSCs that stemmed from adipocyte-tissues have been reported to impair B lymphopoiesis in 
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an IL-1 (both IL-1 and IL-1) dependent manner (Kennedy and Knight, 2015), suggesting a 
differential role for IL-1 molecules in MDSC function according to the pathology, cell type and 
location. Furthermore, MDSCs have been shown to phagocytose Mycobacterium tuberculosis  
and produce high levels of IL-1 (Knaul et al., 2014). Additionally, IL-18, another component 
released upon activation of the inflammasomes, was found to be down-regulated in both Mo-
MDSCs and PMN-MDSCs subsets isolated from Ls-infected mice when compared to those of  
naive mice. Considering the fact that in this study, at day 72 p.i., FACS data revealed no 
differences in the infiltration of either Mo-MDSCs or PNM-MDSCs in WT when compared to ASC-
deficient (apoptosis-associated speck-like protein containing CARD) mice (Figure 3.24); and since 
the Nlrp3 gene was also found to be down-regulated in PMN-MDSCs from infected mice, the 
involvement of the expression of inflammasome molecules for MDSC expansion could be 
excluded, although it could be that the inflammasomes support Mo-MDSC function in other 
ways. For instance, studies have reported that IL-18-induction promote the differentiation and 
suppressive activities of generated Mo-MDSCs in C57BL/6 mice (Lim et al., 2014). Further studies 
should investigate whether inflammasome pathways play a role in Mo-MDSC suppressive 
activities in BALB/c during Ls infection. 
PCR array data revealed a high expression of IL-13 in Mo-MDSCs isolated from Ls infected mice, 
which is interesting since these cells were able  to suppress the release of IL-13 by CD4+ T cells 
upon re-stimulation with Ls antigen and in vitro levels of IL-13 from infection-derived Mo-MDSCs 
were megligible. Building on these observations were findings from Gabitass and colleagues who 
have measured increased levels of IL-13 in PBMCs from patients with pancreatic, esophageal and 
gastric cancers. Interestingly, IL-13 levels also correlated with MDSCs numbers (Gabitass et al., 
2011). Elsewhere, CD11b+IL-4R+ MDSCs have been reported to produce IL-13 and IFN- which 
led to the suppression of CD8+ T cells (Gallina et al., 2006). Previously, studies have shown the 
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generation of MDSCs within four days from BM using G-CSF and GM-CSF and the addition of IL-
13. These IL-13-induced MDSCs exhibited high in vitro and in vivo suppressive abilities during 
graft-versus-host disease and have been revealed to correspond to Mo-MDSCs (Highfill et al., 
2010). Also patients with hepatocellular carcinoma have displayed elevated concentrations of IL-
10, IL-13 and VEGF concentrations which correlated with levels of CD14+HLA-DR-/ lo MDSCs (Mo-
MDSCs) (Arihara et al., 2013). An association has been observed between IL-13 and MDSCs and 
M2 macrophages in esophageal cancer (Gao et al., 2014). However, data from these results 
showed an opposite trend for IFN-, contrasting with the PCR results found here as both IL-13 
and IFN- were highly expressed in Mo-MDSCs. Nevertheless, studies by Gabitass et al., have 
shown the production of IL-13 and IFN- by MDSCs (Gabitass et al., 2011), supporting the PCR 
data but contrasting with the in vitro measurements of these cytokines in Mo-MDSCs. To 
respond to IFN-, cells require the surface expression of a heterodimeric receptor, IFNGR, which 
consists of the IFNGR1 and IFNGR2 subunits (Rayamajhi et al., 2010). Unexpectedly, PCR data 
revealed down-regulation of IFNGR1 in Mo-MDSCs isolated from Ls infected mice, ruling out any 
autocrine effect of IFN- on Mo-MDSCs. In accordance with these results are findings that have 
reported an association between the reduced activation of macrophages by IFN- and an 
increased reduction of  ifngr1 (but not ifngr2) transcripts in L. monocytogenes  infection 
(Rayamajhi et al., 2010). Furthermore, the present data showed a down-regulation of interferon 
regulatory factors (IRF-3 and IRF-7) in support to the down-regulation of IFNGR1. However, 
regulation of IRF7 has been documented only for PMN-MDSCs but not Mo-MDSCs in various 
cancer patients (Yang Q et al., 2017), indicating that these investigations conflicted data of this 
study. Interestingly, results from the PCR array showed that the gene s responsible for IFNAR1 
(Interferon (alpha and beta) receptor 1)  was up-regulated in the PMN subset, corroborating with 
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recent findings which have suggested that the activation of MDSCs through IFNAR pathway in a 
model of cancer (Shime et al., 2014). 
The gene controlling the production of the chemokine CXCL10, an attractant for CD8+ T cells 
(CTLs), was up-regulated in PMN-MDSCs from Ls-infected mice. In contrast, a study has shown 
the inverse association of this chemokine with MDSC development in human prostate cancer 
(Muthuswamy et al., 2016). When considering PMN-MDSCs specifically, a report has previously 
indicated that an increase in CXCL10 and CTLs levels has been attributed to a reduction of PMN-
MDSC numbers in the tumor microenvironment and has been accompanied by a delay of  
pathogenesis in a model of glioma (Fujita et al., 2011). Here although PMN-MDSCs were 
elevated in the TC, an up-regulation of CXCL10 was observed implying that CXCL10 supported 
PMN-MDSC accumulation. It was also probable that this chemokine negatively regulated PMN -
MDSC suppressive activity but further experiments are needed to confirm such hypothesis.  
Myeloperoxidase (MPO) is a major component of the primary (azurophilic) granules especially in 
young neutrophils and is also present in much lower concentrations in monocytes and 
macrophages (Prata et al., 2016). It has been suggested as a characteristic for chronic 
inflammation, as reviewed elsewhere (Prokopowicz et al., 2012). Here, high expression of the 
MPO gene was found in Mo-MDSCs isolated from Ls-infected mice when compared to those of 
naive mice, suggesting that Ls infection induced elevated MPO expression in Mo-MDSCs. 
Previously, MPO has been demonstrated to have the potential of controlling disease activity and 
treatment outcomes in patients with ulcerative colitis (Wagner et al., 2008). However, recent 
studies have shown decreased MPO activity after the transplantation of bone marrow -derived G-
MDSCs from normal mice to colitis models resulting in increased survival rate (Su et al., 2013). 
Different results have been generated in the context of this thesis, as the up-regulation of the 
MPO gene observed here was related to the Mo-MDSC subset.  
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PCR data further demonstrated down-regulation of the Complement component C3 in both Mo-
MDSCs and PMN-MDSCs. Consistent with these results, a report has indicated that complement 
component C3 deficiency is associated with a favorable condition for MDSC induction wi th 
beneficial effects, in a model of diabetes (Gao et al., 2014). Inversely, hepatic stellate cells 
derived from mice lacking Complement component C3, have been shown to display an impaired 
MDSC induction and in doing so exhibited no protection on co-transplanted islet allografts (Hsieh 
et al., 2013), suggesting a pathology-related regulation by the complement component C3.  
 
4.6.2 The regulation of receptor and transcription factor genes and other genes in 
MDSC populations 
NOD1 mediates the sensing of a motif of peptidoglycan that is produced by most Gram-negative 
and specific Gram-positive bacteria such as Listeria monocytogenes (Chamaillard et al., 2003; 
Girardin et al., 2003). In addition, NOD1 has been shown to trigger the recruitment of immune 
cells (Masumoto et al., 2006). Results generated during this thesis indicated the down-regulation 
of this molecule in Mo-MDSCs, suggesting that Mo-MDSCs might not be recruited through 
recognition of NOD1. In contrast,  findings in B. malayi subjects have shown elevated expression 
of NOD1 and NOD2 in lymphedema patients compared to asymptomatic individuals  (Babu et al., 
2009). Recently, studies have reported that NOD1 activation can occur in a Wolbachia-
dependent manner (Ajendra et al., 2016). Here, Mo-MDSC suppression function was ascertained 
upon re-stimulation with LsAg which contains Wolbachia  and therefore it would be interesting to  
assess the behavior of Mo-MDSCs upon stimulation with Wolbachia-depleted LsAg. Importantly 
the aforementioned study has deciphered a NOD2-dependent mechanism for neutrophil 
recruitment at early stage of Ls infection (Ajendra et al., 2016), suggesting elevated numbers of  
neutrophils at this phase. However, in this thesis PMN-MDSCs, which are a granulocytic 
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(neutrophilic) subset, that were isolated from Ls-infected mice at later time point (on day 71 
p.i.), elicited an up-regulation of NOD2, pointing out their requirement of such a receptor to 
accumulate in the TC even at late stage of infection. 
CCR6, a chemokine receptor associated with DC and T cell housing, was found down-regulated in 
both subsets of MDSCs during Ls infection. Furthermore, data from Mo-MDSCs especially 
indicated the down-regulated expression of CCR5. In support with this are data that have been 
recently provided in a collagen-induced arthritis (CIA) mouse model in which, Mo-MDSCs have 
been associated with lower expression levels of IL-10, TGF-1, CCR5, and CXCR2 mRNA (Wang et 
al., 2015). In contrary, other studies have demonstrated the up-regulation of CCR5 ligands in Mo-
MDSCs and have conferred an up-regulation of CCR5 itself on Tregs. In fact, the auth ors have 
claimed that MDSCs have been capable of attracting Tregs based on their increased expression 
of CCR5 (Schlecker et al., 2012).  
Surprisingly, here, data from the PCR array demonstrated the up-regulation of the FOXP3 gene in 
Mo-MDSCs and PMN-MDSCs during Ls infection, indicating that both subsets might share the 
expression of the surface marker Foxp3 together with Tregs that could support their role as 
regulator of immune responses and this also indicated that not only Tregs express FOXP3. 
Further studies should investigate the role of FOXP3 on MDSCs and how this marker could 
possibly influence MDSC function. Also intriguing was the observed up-regulation of CXCR3 
expression in Mo-MDSCs during Ls infection, since this chemokine receptor is mainly expressed 
on Th1 cells. Similar observations have been noticed with the up-regulation of TBX21 (T-bet), the 
key regulator of the Th1 phenotype differentiation system, in Mo-MDSCs during Ls infection. The 
down-regulation of RORC, a transcription factor of Th17 cells, was noted in Mo-MDSCs in the 
current model of Ls infection. This is not supported by recent findings which have attributed a 
role for RORC1 in MDSC expansion. Indeed, mice lacking this nuclear transcriptor failed to induce 
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MDSC differentiation (Strauss et al., 2015). Interestingly, the gene responsible for the expression 
of STAT3 is up-regulated in PMN-MDSCs, corroborating with previous findings. In fact, a study 
has reported that STAT3 played a main role in PMN-MDSC-mediated function (Albeituni et al., 
2013). Furthermore, PMN-MDSCs have been shown to facilitate immunotolerance in pregnant 
mice and have been found to differentiate and be activated through STAT3 signalling (Pan et al., 
2016). In contrast, authors have suggested that STAT3 activation promoted Mo-MDSCs in a 
murine model of pancreatic cancer (Panni et al., 2014). 
NF-kB is required for both innate and adaptive immune responses and using BMP4 which causes 
a defect in NF-kB signalling authors generated a reduced amount of MDSCs that showed 
impaired immunosuppressive abilities (Cao et al., 2014). Consistent with these findings, data of 
this thesis showed an up-regulation of NFKB1 (NF-kB) in the two subsets of MDSCs isolated 
during Ls infection and in PMN-MDSCs this up-regulation was supported by a down-regulation of 
NFKBIA: an inhibitor of NF-kB. This was followed by high expression levels of TLR8 and 
Lymphocyte antigen 96 (Ly96) (also known as MD2 a protein which binds to TLR4 and is 
associated with responsiveness to lipopolysaccharide (LPS)) in Mo-MDSCs. In support with this, 
studies by Shirota et al., have shown the presence of TLR7, 8 and 9 on MDSCs (Shirota et al., 
2012). Furthermore, an elevated expression of MYD88 the adaptor protein was observed, 
providing evidence for potent activities in Mo-MDSCs during Ls infection. However, TNF receptor 
associated factor-6 (TRAF6), a receptor induced in response to proinflammatory cytokines and 
MAPK1, both involved in MYD88-dependent and TRIF-dependent pathways (Liu and Cao, 2016)  
are also down-regulated in Mo-MDSCs, suggesting an overall reduced inflammation driven by 
the presence of these cells. 
An up-regulation of Fas ligand (FasL) was markedly displayed in the PCR array results of Mo-
MDSCs isolated during Ls infection. Conflicting data have shown the expansion of Mo-MDSCs, 
Tamadaho R. S. E. Discussion 
115 
 
Tregs and PD-1/PD-L1 expression which led to lower survival, during FasL deficiency in mice 
bearing Lewis lung carcinoma tumors (Peyvandi et al., 2015). With regards to the capacity of 
MDSCs for antigen presentation, H2-T23 exhibited a down-regulation in Mo-MDSCs during Ls 
infection which could possibly not enable the cells to present antigens. Inversely, CD86 a 
costimulatory molecule is up-regulated in PMN-MDSCs. In line with this, recent findings have 
indicated up-regulation of CD86 in MDSCs in a mouse model of hepetocelluler carcinoma 
(Lacotte et al., 2016). 
It is well known that MDSCs express CD11b and Gr-1 (Gabrilovich et al., 2007; Ostrand-
Rosenberg and Sinha, 2009). Here data from PCR array indicated a down-regulation of ITGAM in 
Mo-MDSCs isolated from Ls-infected compared to those of naive mice. In contrast, data have 
been provided by Sun et al.  in human colorectal carcinoma and have found an up-regulation of  
CD11b (ITGAM)/CD18 expression in patients when compared with the MDSCs from he althy 
donors (Sun et al., 2012). More in depth examination of Mo-MDSCs are needed to clarify such 
down-regulation of genes and thus potential functional pathways. 
 
4.7 Conclusion 
Using the Ls model, this study aimed to explore the impact of MDSCs on immune responses 
during filariasis and specifically to examine whether MDSC subsets evolve during ongoing 
infection. Moreover, it was determined whether they affect specific-filarial responses and 
another goal of the study was to assess molecular mechanisms implicated in MDSC activities. 
Current knowledge on MDSCs indicates that, by means of receptors and/or cytokines pathways, 
MDSCs display a detrimental role in cancer and other pathological conditions, where they impair 
the defense system of the host whereas in some others conditions such as graft transplantation, 
understanding and enhancing MDSC capacities may represent a tool to improve such conditions. 
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In this view, parasitological analyses, flow cytometry and culture assays were used to address 
diverse aspects of MDSC abilities. The results revealed that during Ls infection, MDSC subsets 
expanded in the TC which is the site of infection, whereas only very few MDSCs were found in 
naive mice and this expansion positively correlated with worm burden (strongly) and MF count 
(weakly), at the site of infection but no correlation was found between MDSC infiltration and MF 
count in blood. Interestingly, although large numbers of PMN-MDSCs with no consistent 
suppressive activities were observed, Mo-MDSCs amounts were low but these cells showed high 
suppressive abilities on the production of IL-13 and IFN-, but not IL-5 by infection-derived CD4+ 
T cells upon re-stimulation with Ls-antigen. Further analyses demonstrated that Mo-MDSCs used 
distinct functional mechanisms such as NO and TGF- to impair the production of IL-13 and IFN-
, respectively. Surprisingly, infection-derived Mo-MDSCs displayed an up-regulation of IFN-, IL-
13 and T-bet among many other genes and a down-regulation of RORC in a PCR array. However, 
both subsets were found to down-regulate IL-18 and up-regulate FOXP3 gene. The summary of 
the mechanisms used by Mo-MDSCs is depicted in Figure 4.1. In addition, using mice 
simultaneously deficient in IL-4R and IL-5, data showed that in the absence of Th2 responses, 
dramatically increased numbers of worms and MF were observed followed by high levels of IFN -
 produced by CD4+ T cells and also higher amounts of Mo-MDSCs were found at the site of 
infection during Ls infection. Nevertheless, lack of this receptor and thus recognition of Th2 
cytokines was not required for the suppression of CD4+ T cell responses in vitro. In conclusion, 
the involvement of MDSCs during Ls infection offered a favorable milieu for parasite 
development, impairing the host immunity and therefore targeting MDSCs may supply a key for 
therapy in order to eliminate filariasis. 
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Figure 4.1: Hypothetical mechanisms of Mo-MDSCs on Ls-specific CD4+ T cells during Ls infection 
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6. APPENDIX 
 
APPENDIX A: EQUIPMENTS 
 
Equipments Compagny and location 
5 ml Polystyrene Round Bottom Tube  Falcon 
Automatic pipettes (10-1000μl)  Eppendorf AG, Hamburg, Germany  
BD FACS Diva flow cytometer BD Biosciences, Heidelberg, Germany  
BD FACSAria III Cell Sorter BD Biosciences, Heidelberg, Germany  
BD FACSCanto™ I flow cytometer  BD Biosciences, Heidelberg, Germany  
Bench (for PCR pipetting) Peqlab, Erlangen, Germany 
Bench (human lab)  HeraSafe  
Cell scraper Sartedt, Inc.,  Newton, USA 
Cellstar 96-Well Cell Culture Plate, 
sterile, U-bottom, with lid 
Greiner bio-one, Frickenhausen, Germany  
Cellstar serological pipette, 5mL, 10mL Greiner bio-one, Frickenhausen, Germany  
Centrifuge (Eppendorf 5417 R)  for RNA 
extraction 
Eppendorf AG, Hamburg, Germany  
Centrifuge (Multifuge 4KR)  Heraeus Holding GmbH, Hanau, Germany  
ELISA plate  greiner bio-one, Frickenhausen, Germany 
ELISA Plate reader (Spectra Max 340pc384 Molecular Devices, Sunnyvale, USA  
Experion BioRad, Hercules, USA 
Falcon serological pipette, 15 mL  
Becton Dickinson Labware, Franklin Lakes, NJ. 
USA 
Falcon serological pipette, 50 mL  
Becton Dickinson Labware, Franklin Lakes, NJ. 
USA 
Filter (Whatman Nucleopore, 5 µm)  Carl Roth, Karlsruhe, Germany  
Freezer (-20°C)   Bosch GmbH, Stuttgart, Germany 
Freezer (-80°C)   Heraeus Holding GmbH, Hanau, Germany  
Fridge  Bosch GmbH, Stuttgart, Germany  
Glass mortar  VWR, Langenfeld, Germany 
Glass Pasteur Pipette  Brand GmbH + CO, Wertheim, Germany  
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Glass pipettes (1-20 ml)  Brand GmbH & Co KG, Wertheim, Germany 
Glass plates (1.5 mm)  Bio-Rad, Munich, Germany 
Glassware  Schott AG, Mainz, Germany 
Gloves Meditrade GmbH, Kiefersfelden, Germany  
Heating Block (Thermomixer comfort)  Eppendorf AG, Hamburg, Germany  
HTS Transwell 96 Permeable Support  
Corning GmbH  Life Sciences, Wiesbaden, 
Germany 
Ice machine (Scotsman AF 80)  Gastro Handel GmbH, Wien, Austria 
iCycler  Bio-rad, Munich, Germany 
Incubator Binder GmbH, Tuttlingen, Germany  
MACS multistand separator  
Miltenyi BiotecGmbH, Bergisch Gladbach, 
Germany 
MACS columns (MS)  Germany Miltenyi Biotech GmbH, Bergisch Gladbach  
MACS separator Germany 
Miltenyi Biotech GmbH, Bergisch Gladbach, 
Germany 
Microscope (Leica DM IL)  Leica Microsystems GmbH, Wetzlar,  Germany  
Multichannel pipette (300 µl)  Biohit, Göttingen, Germany 
NanoVue  GE Lifescience, Chalfont St Giles, Great Britain  
Needles (BD Microlance™, 21G)  BD™ Biosciences, Heidelberg, Germany  
Neubauer counting chamber  LO Laboroptik GmbH, Bad Homburg, Germany  
Petri dish VWR, Langenfeld, Germany 
PH meter  Mettler Toledo GmbH, Giessen, Germany  
Pipetboy (pipetus®-akku)  Hirschmann Laborgeräte, Eberstadt, Germany  
Power supply  Bio-Rad, Munich, Germany 
Qiagility Qiagen, Hilden, Germany 
Rotor-Gene Q Qiagen, Hilden, Germany 
Round-Bottom Tubes (5mL)  
Becton Dickinson Labware, Franklin Lakes, NJ. 
USA 
Sandwich-ELISA: 96well flat bottom Maxisorp 
Syringes (5 ml, 10 ml)  BD™ Biosciences, Heidelberg, Germany  
Thermo magnetic stirrer  IKA® GmbH & Co.KG, Staufen, Germany  
Thermocycler  Biometra GmbH, Göttingen, Germany  
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Vortex mixer (Minishaker)  IKA® GmbH & Co.KG, Staufen, Germany  
Water bath  VWR, Langenfeld, Germany 
Water purifier Milli-Q plus  Millipore, Schwalbach, Germany  
Weighing machine  Sartorius AG, Göttingen, Germany  
 
 
APPENDIX B: SOFTWARE  
 
Software Compagny and location 
BD FACS Diva BD Biosciences, Heidelberg, Germany  
FlowJo VX Tree Star,  Inc, Ashland, Oregon, USA 
GraphPad PRISM 5.02 GraphPad Software, Inc., La Jolla, USA  
Microsoft Redmond, Washington, USA  
RT2 profiler PCR Array data analysis 3.5 Qiagen, Hilden, Germany 
SoftMax Pro 5.0 Molecular Devices, Sunnyvale, USA  
 
 
APPENDIX C: CHEMICALS AND REAGENTS 
 
Chemicals and reagents Compagny and location 
1-Bromo-3-chloropropane (BCP)   Sigma-Aldrich GmbH, Munich, Germany  
Advanced RPMI 1640 (1x) 
 Life Technologies Corporation, Grand Island, NY, 
USA 
autoMACS running buffer  
Miltenyi Biotec GmbH, Bergisch Gladbach, 
Germany 
BSA  PAA Laboratories GmbH, Pasching, Austria  
Dimethyl sulfoxide (DMSO)   Sigma-Aldrich, Steinheim, Germany  
DNA-free Dulbecco’s PBS  
Life Technologies Corporation, Grand Island, NY, 
USA 
eBioscience coktail (plus inhibitor)  Thermo Fisher Scientific, Inc., Waltham, MA, USA  
ELISA kits (IL-5, IL-6, IL-10, IL-13, IL-17, IFN- R&D, Wiesbaden-Nordenstadt, Germany 
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alpha, TNF)  
ELISA kits Ready-SET-Go (IL-6, IL-10, IFN-
alpha, TNF)  
 Thermo Fisher Scientific, Inc., Waltham, MA, USA  
Ethanol  Merck KGAA, Darmstadt, Germany 
Experion kit BioRad, Hercules, USA 
Fetal Calf Serum, Standard Quality  PAA Laboratories GmbH, Pasching, Austria  
Fixation/Permeabilization Concentrate  ebioscience, San Diego, USA  
Gentamycin (50 mg mL-1)   PAA Laboratories GmbH, Pasching, Austria 
Griess Reagent Kit for Nitrite Determination 
(G-7921)  
Molecular Probes, Inc, Eugene Oregon, USA  
Hydrogen peroxide (H2O2)  Sigma-Aldrich GmbH, Munich, Germany  
Isofluran Prima Healthcare, Northumberland, UK  
Isopropanol  Merck KGAA, Darmstadt, Germany 
L-Glutamine 200 mM (100x)  
Life Technologies Corporation, Grand Island, NY, 
USA 
 L-NMMA Abcam, Cambridge, UK 
LPS  Sigma-Aldrich GmbH, Munich, Germany  
miRNeasy Kit  Qiagen, Hilden, Germany 
Monosodium phosphate  Merck KGAA, Darmstadt, Germany 
Paraformaldehyde  Merck KGAA, Darmstadt, Germany  
Penicillin Streptomycin 
Life Technologies Corporation, Grand Island, NY, 
USA 
Permeabilization Buffer (10x)  Ebioscience, San Diego, USA  
Stop solution 2N H2SO4  Merck KGAA, Darmstadt, Germany  
Streptavidin-Peroxidase  Roche Diagnostics GmbH, Mannheim, Germany  
TMB Sigma-Aldrich GmbH, Munich, Germany  
Trizol  Invitrogen  GmbH, Darmstadt, Germany  
Trypan blue 2 % in PBS Sigma-Aldrich GmbH, Munich, Germany  
Tween 20  Sigma-Aldrich GmbH, Munich, Germany  
 
APPENDIX D: BUFFERS AND SOLUTIONS 
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eBioscience ELISA 
Coating Buffer: dilute 10x coating buffer with DI water to 1x  
Capture Ab: 1:250, for 1 plate 20 µl of Ab solution to 5 ml coating buffer 
Wash buffer: 1x PBS, 0.05 % Tween 20 
Blocking buffer (1x Assay diluent): add 10 ml of 5x Assay diluent to 40 ml of  DI water  
Detection Ab: 1:250, for 1 plate add 20 µl of Ab solution to 5 ml of assay diluent 
Enzyme: Avidin-HRP: 1:250, for 1 plate  add 20 µl of enzyme solution to 5 ml of  assay diluent 
Substrate: 1x TMB solution (provided) 
Stop Solution: 2N H2SO4 (½ Liter: 26.6 ml H2SO4 +473 ml DI water) 
 
R&D Duo Set ELISA 
Washing buffer: 1 M PBS + 0.05 % Tween 20 pH 7.0-7.3 
Blocking buffer: 1x  PBS /1 % BSA 
Solution 4: 0.1 M NaH2PO4 in DI water, pH 5.5  
TMB: 60 mg 3,3`,5,5`Tetramethylenbenzidine in 10 ml DMSO 
Developer: 10 ml Solution 4 + 200 µl TMB + 2 µl H2O2 
Stopping reagent: 2 M H2SO4 (½ Liter: 26.6ml H2SO4 +473 ml DI water) 
 
BD ELISA 
Coating buffer: 0.1 M Na2HPO4 in DI water, pH 9.0  
Washing buffer: 1 M PBS + 0.05 % Tween 20 pH 7.0-7.3 
Blocking buffer: 1x  PBS /1 % BSA 
Solution 4: 0.1 M NAH2PO4 in DI water, pH 5.5  
TMB: 60 mg 3,3`,5,5`Tetramethylenbenzidine in 10 ml DMSO  
Developer: 10 ml Solution 4 + 200 µl TMB + 2 µl H2O2 
Stopping reagent: 2 M H2SO4 (½ Liter: 26.6 ml H2SO4 +473 ml DI water)  
 
Cell culture medium 
500ml RPMI 1640 medium 
5ml Penicillin (100μg/ml)/Streptomycin (100μg/ml) 
0.5 ml Gentamycin (50μg/ml) 
5ml L-glutamine (292.3μg/ml) 
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10% FCS 
 
FACS Buffer 
1xPBS with 2 % FCS 
 
PFA 4% solution (FACS)  
40g of PFA dissolved while heating (max 60°C) in 900ml 1x PBS. The solubility was increased by 
adding NaOH dropwise, top to 1 liter with 1x PBS. The Solution was then cooled and filtered and 
adjusted pH to 6.9 using dilute HCl. 
 
Permeabilization Buffer 
1:10 dilution with DI water 
 
Hinkelmann solution 
0.5% [wt/vol] eosin Y, 0.5% [wt/vol] phenol (both Merck) and 0.185% [vol/vol] 
formaldehyde (Sigma-Aldrich) in DI water.  
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APPENDIX E: GENE TABLE FOR PCR ARRAY 
 
Number of sorted cells from TC for PCR array 
Sorted cells Ly6C+  Ly6G+ 
Naive  76,000 15,000 
Naive_a 107,000 7,000 
Naive_b 191,000 2,000 
Group 1 1,200,000 7,100,000 
Group 2 1,100,000 4,400,000 
Group 3 1,400,000 7,600,000 
 
 
Position Symbol Description Gene name 
A01 Apcs Serum amyloid P-component Sap 
A02 C3 Complement component 3 AI255234/ASP/HSE-MSF/Plp 
A03 C5ar1 
Complement component 5a 
receptor 1 
C5aR/C5r1/Cd88/D7Msu1 
A04 Casp1 Caspase 1 ICE/Il1bc 
A05 Ccl12 
Chemokine (C-C motif) ligand 
12 
MCP-5/Scya12 
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A06 Ccl5 
Chemokine (C-C motif) ligand 
5 
MuRantes/RANTES/SISd/Scya5/TCP228 
A07 Ccr4 
Chemokine (C-C motif) 
receptor 4 
C-C CKR-4/CHEMR1/Cmkbr4/LESTR/Sdf1r 
A08 Ccr5 
Chemokine (C-C motif) 
receptor 5 
AM4-7/CD195/Cmkbr5 
A09 Ccr6 
Chemokine (C-C motif) 
receptor 6 
CC-CKR-6/CCR-6/Cmkbr6/KY411 
A10 Ccr8 
Chemokine (C-C motif) 
receptor 8 
C-C/C-C CKR-8/CC-CKR-8/CCR-8/CKR-8/Cmkbr8/mCCR8 
A11 Cd14 CD14 antigen - 
A12 Cd4 CD4 antigen L3T4/Ly-4 
B01 Cd40 CD40 antigen AI326936/Bp50/GP39/HIGM1/IGM/IMD3/T-BAM/TRAP/Tnfrsf5/p50 
B02 Cd40lg CD40 ligand CD154/CD40-L/Cd40l/HIGM1/IGM/IMD3/Ly-62/Ly62/T-BAM/TRAP/Tnfsf5/gp39 
B03 Cd80 CD80 antigen B71/Cd28l/Ly-53/Ly53/MIC17/TSA1 
B04 Cd86 CD86 antigen B7/B7-2/B7.2/B70/CLS1/Cd28l2/ETC-1/Ly-58/Ly58/MB7/MB7-2/TS/A-2 
B05 Cd8a CD8 antigen, alpha chain BB154331/Ly-2/Ly-35/Ly-B/Lyt-2 
B06 Crp 
C-reactive protein, pentraxin-
related 
AI255847 
B07 Csf2 
Colony stimulating factor 2 
(granulocyte-macrophage)  
Csfgm/GMCSF/Gm-CSf/MGI-IGM 
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B08 Cxcl10 
Chemokine (C-X-C motif) 
ligand 10 
C7/CRG-2/INP10/IP-10/IP10/Ifi10/Scyb10/gIP-10/mob-1 
B09 Cxcr3 
Chemokine (C-X-C motif) 
receptor 3 
Cd183/Cmkar3 
B10 Ddx58 
DEAD (Asp-Glu-Ala-Asp) box 
polypeptide 58 
6430573D20Rik/C330021E21/RIG-I/RLR-1 
B11 Fasl 
Fas ligand (TNF superfamily, 
member 6)  
APT1LG1/CD178/CD95-L/CD95L/Fas-L/Faslg/Tnfsf6/gld 
B12 Foxp3 Forkhead box P3 JM2/scurfin/sf 
C01 Gata3 GATA binding protein 3 Gata-3/jal 
C02 H2-Q10 
Histocompatibility 2, Q region 
locus 10 
H-2Q10/Q10/Qa10 
C03 H2-T23 
Histocompatibility 2, T region 
locus 23 
37b/37c/H-2T23/H2-Qa1/Qa-1/Qa-1(b)/Qa1/Qed-1/T18c/T18c(37)/T23b/T23d 
C04 Icam1 
Intercellular adhesion 
molecule 1 
CD54/Icam-1/Ly-47/MALA-2 
C05 Ifna2 Interferon alpha 2 Ifa2 
C06 Ifnar1 
Interferon (alpha and beta) 
receptor 1 
CD118/Ifar/Ifnar/Ifrc/Infar 
C07 Ifnb1 Interferon beta 1, fibroblast  IFN-beta/IFNB/Ifb 
C08 Ifng Interferon gamma IFN-g/Ifg 
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C09 Ifngr1 Interferon gamma receptor 1 CD119/IFN-gammaR/Ifgr/Ifngr/Nktar 
C10 Il10 Interleukin 10 CSIF/Il-10 
C11 Il13 Interleukin 13 Il-13 
C12 Il17a Interleukin 17A Ctla-8/Ctla8/IL-17/IL-17A/Il17 
D01 Il18 Interleukin 18 Igif/Il-18 
D02 Il1a Interleukin 1 alpha Il-1a 
D03 Il1b Interleukin 1 beta IL-1beta/Il-1b 
D04 Il1r1 Interleukin 1 receptor, type I  CD121a/CD121b/IL-1R1/IL-iR/Il1r-1 
D05 Il2 Interleukin 2 Il-2 
D06 Il23a 
Interleukin 23, alpha subunit 
p19 
IL-23/p19 
D07 Il4 Interleukin 4 BSF-1/Il-4 
D08 Il5 Interleukin 5 Il-5 
D09 Il6 Interleukin 6 Il-6 
D10 Irak1 
Interleukin-1 receptor-
associated kinase 1 
AA408924/IRAK/IRAK-1/IRAK1-S/IRAK1b/Il1rak/Plpk/mPLK 
D11 Irf3 Interferon regulatory factor 3 C920001K05Rik/IRF-3 
D12 Irf7 Interferon regulatory factor 7 - 
E01 Itgam Integrin alpha M CD11b/CD18/CR3/CR3A/Cd11b/F730045J24Rik/Ly-40/MAC1/Mac-1/Mac-1a 
E02 Jak2 Janus kinase 2 Fd17 
E03 Ly96 Lymphocyte antigen 96 ESOP-1/MD-2/MD2 
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E04 Lyz2 Lysozyme 2 AI326280/Lys/Lysm/Lyzs/Lzm/Lzm-s1/Lzp 
E05 Mapk1 
Mitogen-activated protein 
kinase 1 
9030612K14Rik/AA407128/AU018647/C78273/ERK/Erk2/MAPK2/PRKM2/Prkm1/p41mapk/p42mapk 
E06 Mapk8 
Mitogen-activated protein 
kinase 8 
AI849689/JNK/JNK1/Prkm8/SAPK1 
E07 Mbl2 
Mannose-binding lectin 
(protein C) 2 
L-MBP/MBL/MBL-C/MBP-C 
E08 Mpo Myeloperoxidase mKIAA4033 
E09 Mx1 
Myxovirus (influenza virus) 
resistance 1 
AI893580/Mx/Mx-1 
E10 Myd88 
Myeloid differentiation 
primary response gene 88 
- 
E11 Nfkb1 
Nuclear factor of  kappa light 
polypeptide gene enhancer in 
B-cells 1, p105 
NF-KB1/NF-kappaB/NF-kappaB1/p105/p50/p50/p105 
E12 Nfkbia 
Nuclear factor of  kappa light 
polypeptide gene enhancer in 
B-cells inhibitor, alpha 
AI462015/Nfkbi 
F01 Nlrp3 
NLR family, pyrin domain 
containing 3 
AGTAVPRL/AII/AVP/Cias1/FCAS/FCU/MWS/Mmig1/NALP3/Pypaf1 
F02 Nod1 Nucleotide-binding C230079P11/Card4/F830007N14Rik/Nlrc1 
Tamadaho R. S. E.  Appendix 
146 
 
oligomerization domain 
containing 1 
F03 Nod2 
Nucleotide-binding 
oligomerization domain 
containing 2 
ACUG/BLAU/CD/Card15/F830032C23Rik/IBD1/Nlrc2 
F04 Rag1 
Recombination activating 
gene 1 
Rag-1 
F05 Rorc 
RAR-related orphan receptor 
gamma 
Nr1f3/RORgamma/TOR/Thor 
F06 Slc11a1 
Solute carrier family 11 
(proton-coupled divalent 
metal ion transporters), 
member 1 
Bcg/Ity/Lsh/Nramp/Nramp1/ity 
F07 Stat1 
Signal transducer and 
activator of transcription 1 
2010005J02Rik/AA408197 
F08 Stat3 
Signal transducer and 
activator of transcription 3 
1110034C02Rik/AW109958/Aprf  
F09 Stat4 
Signal transducer and 
activator of transcription 4 
- 
F10 Stat6 
Signal transducer and 
activator of transcription 6 
- 
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F11 Tbx21 T-box 21 TBT1/Tbet/Tblym 
F12 Ticam1 
Toll-like receptor adaptor 
molecule 1 
AW046014/AW547018/TICAM-1/TRIF 
G01 Tlr1 Toll-like receptor 1 - 
G02 Tlr2 Toll-like receptor 2 Ly105 
G03 Tlr3 Toll-like receptor 3 AI957183 
G04 Tlr4 Toll-like receptor 4 Lps/Ly87/Ran/M1/Rasl2-8 
G05 Tlr5 Toll-like receptor 5 - 
G06 Tlr6 Toll-like receptor 6 - 
G07 Tlr7 Toll-like receptor 7 - 
G08 Tlr8 Toll-like receptor 8 - 
G09 Tlr9 Toll-like receptor 9 - 
G10 Tnf Tumor necrosis factor DIF/TNF-a/TNF-alpha/TNFSF2/TNFalpha/Tnfa/Tnfsf1a 
G11 Traf6 
Tnf receptor-associated factor 
6 
2310003F17Rik/AI851288/C630032O20Rik 
G12 Tyk2 Tyrosine kinase 2 JTK1 
H01 Actb Actin, beta Actx/E430023M04Rik/beta-actin 
H02 B2m Beta-2 microglobulin Ly-m11/beta2-m/beta2m 
H03 Gapdh 
Glyceraldehyde-3-phosphate 
dehydrogenase 
Gapd 
H04 Gusb Glucuronidase, beta AI747421/Gur/Gus/Gus-r/Gus-s/Gus-t/Gus-u/Gut/asd/g 
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H05 Hsp90ab1 
Heat shock protein 90 alpha 
(cytosolic), class B member 1 
90kDa/AL022974/C81438/Hsp84/Hsp84-1/Hsp90/Hspcb 
H06 MGDC 
Mouse Genomic DNA 
Contamination 
MIGX1B 
H07 RTC Reverse Transcription Control RTC 
H08 RTC Reverse Transcription Control RTC 
H09 RTC Reverse Transcription Control RTC 
H10 PPC Positive PCR Control  PPC 
H11 PPC Positive PCR Control  PPC 
H12 PPC Positive PCR Control  PPC 
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